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Among the factors important for maintaining productivity of recombinant proteins in 
mammalian cells, culture lifetime, cell density and cell viability are three simple but essential aspects 
that can greatly influence the final yield.  During cell culturing, the degradation of environmental 
conditions such as nutrient depletion and accumulation of toxic waste products, often lead to premature 
apoptotic cell death in cultures and suboptimal protein yield.  Although apoptosis has been extensively 
researched, the changes in the whole cell proteome during prolonged cultivation, where apoptosis is a 
major mode of cell death, have not been examined.  The work presented in this thesis is the first whole 
cell proteome analysis of non-induced apoptosis in mammalian cells.   
 
Flow cytometry (FCM) analyses of the level of activated executioner caspases, caspase 3 and 7, 
demonstrated the onset of apoptosis in CHO batch cultures after the exponential phase.  The monitoring 
of apoptotic cell death assesses the culture conditions at different time points and allows the association 
of changes in the protein abundances to the degradation of culture conditions, in particular the degree of 
apoptosis in the whole cultures.  The detection of activated caspase 8 and caspase 9, which trigger the 
extrinsic and intrinsic pathway respectively, has shown that the onset of apoptosis in CHO cells during 
prolonged cultivation predominantly is via the intrinsic pathway.   
 
To examine the proteomic changes in a monoclonal antibody-producing CHO cell culture at 
various phases of a batch culturing process, a differential in gel electrophoresis (DIGE) proteomic 
approach was employed in this study.  CHO protein samples at four time points during cultivation were 
compared.  A total of 40 differentially expressed protein spots were successfully identified by mass 
spectrometry sequencing, resulting in 28 unique protein identifications.  These proteins include four 
structural proteins of the cytoskeleton, ten endoplasmic reticulum and cytosolic chaperones and folding 
proteins, seven metabolic enzymes and seven other proteins of varied function.  The cleavage of 
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cytoskeletal proteins is a known consequence of apoptosis and the activation of executioner caspases.  
On the other hand, the induction of seven ER chaperone and foldases is a solid indication for the onset 
of unfolded protein response (UPR), which is triggered by cellular and ER stresses, many of which are 
present during prolonged batch cultures.  In addition, the upregulation of six glycolytic enzymes and 
another metabolic protein emphasizes a change in the energy metabolism likely occurred when culture 
conditions degraded and apoptosis advanced.  Interestingly, although a significant portion of proteins 
identified are well known housekeeping proteins, recent studies have shown that many of them exhibit a 
wide variety of other roles, including apoptosis regulation and execution.  Overall, this study shows that 
the most drastic changes in aging CHO cultures, where apoptosis is known to be part of, involve the 
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Chapter 1. Introduction 
 
1.1 Chinese Hamster Ovary Cell Line  
 
Mammalian cell cultures are the preferred expression hosts for the production of animal 
recombinant proteins due to their ability to ensure proper protein folding and posttranslational 
modifications.  Among the first few transfected mammalian cultures that were generated by non-viral 
gene delivery was the immortalized Chinese hamster ovary cells [1].  It was estimated that nearly 70% 
of all therapeutics produced today are made in CHO cells [2].  The biologics produced by these rodent 
cells brought in over $30 billion US dollars of worldwide annual sale [2].  As a result of its popularity 
and reliability in the commercial industry and research laboratories, CHO cells have been awarded and 
regarded as the “mammalian equivalent of the model bacterium Escherichia coli” [2].     
 
1.1.1 History and Characteristics of CHO Cell Lines 
 
The introduction of tissue cultures, including a continuous Chinese hamster (Cricetulus griseus) 
ovary cell line, began in 1957 when Dr. Theodore Puck created several mammalian cell cultures via 
organ explants of various human and animal sources [3].  Since the creation of the original CHO strain, 
CHBOC1, more CHO cell lines with different nutritional requirement and enzymatic deficiencies have 
been developed.  For instance, CHO-K1, which is a widely utilized proline-auxotrophic strain, was 
subcloned from CHBOC1.  As a derivative of CHO-K1, DUKX-B1 is deficient in dihydrofolate 
reductase (DHFR) due to subsequent mutation and gene inactivation [4].  In comparison, both dhfr 
alleles in the genome of DG44 cells were lost due to gene deletion, resulting in a more stable DHFR-
minus cell line [5].  To date, the American Type Culture Collection, which is a central depository for 
biological materials including many cell lines, microorganisms and bio-products, has 42 CHO cell lines 
and a few Chinese hamster lung and peritoneum cell lines [6].   
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Although CHO cells are naturally anchorage dependent cells that grow into a fibroblast or 
epithelial monolayer [6], adaptation into suspension culture has long been achieved.  Furthermore, 
many CHO cultures can be grown in serum-free, chemically defined synthetic medium [7,8], as 
opposed to the original CHO cell line which requires serum [3].  Ham’s 12, which was used for 
cultivating CHBOC1 originally, and alpha-modified minimal essential media (MEM) were among the 
more traditional CHO culturing media.  With the increase in popularity of CHO cells, many strain-
specific and generalized defined media have been formulated to support and enhance CHO cell growth.  
CDM4CHO, which is suitable for recombinant protein production and the protein-free medium 
SMF4CHO-Utility [9] are two examples of commercial CHO media available.  Other than choosing a 
medium that supplies the appropriate nutrients, maintaining proper temperature and pH of the culture 
medium is also important for optimal cell proliferation.  For Chinese hamster ovary cells, the medium 
should be maintained between 36 ºC and 38.5ºC with a pH range from 7 to 8.2 [10]. 
 
A normal diploid Chinese hamster cells has 22 chromosomes. However, karyotypic studies 
have shown that cells from CHBOC1 can display heterogeneity with varying number of chromosomes 
such as 21, 23 and 44 [11].  Similarly, this heterogeneity was observed in CHO-K1 with a modal 21 
chromosomes [12].  On the other hand, DK44 cells exhibit 20 chromosomes consistently [5].   
 
1.1.2 Utilization of CHO cells in Research and Industries 
 
Since their establishment, CHO cell lines have been heavily utilized in various fields of 
research, including genetics, cell cycle, DNA damage repair, toxicology and drug addiction.  For having 
a low chromosome numbers, being functional hemizygous in many genes, and displaying karyotype 
heterogeneity in the population, CHO cells have been used in cytogenetic studies [2].  Moreover, CHO 
cells can be reversibly synchronized at G1 phase with dimethyl sulfoxide (DMSO) and Lovastatin, to 
facilitate cell cycle studies [13,14].  By transfecting CHO cells with foreign proteins or exposing cells 
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to various compounds, studies on changes in mammalian cells due to these particles can be thoroughly 
monitored and investigated.  The examination of toxic effects of chemicals and therapeutics, and 
cellular responses to viral antigens has been carried out using CHO cultures by numerous research 
groups [2,15,16].  In addition to the study of the effects of foreign compounds, stable expression of 
proteins of interest can also allow the study of the associated cellular pathways.  Lastly, several CHO 
mutants deficient in DNA damage repair have been used to explore the mechanism of DNA interstrand 
cross-linking, which is often induced by anti-cancer drugs [17].  
 
In addition to the usage of CHO cells in research laboratories, the employment of biologics-
producing CHO cultures in commercial industries has also been widely executed for over 20 years.  In 
1987, the production of tissue plasminogen activator (tPa) using CHO cells became the first therapeutic 
recombinant protein produced in mammalian cells clinically approved.  Since then many protein 
products, including monoclonal antibodies (MAb), hormones and enzymes, have been manufactured 
using CHO cell cultures [2] for therapeutic and diagnostic purposes [18].  For instance, the CHO strain 
IgG-9β8 under investigation in this thesis was developed from the cell line CHO dhfr
-
-1 at Cangene 
Corporation in Mississauga.  It expresses a human IgG specific for the Rhesus D (RhD) antigen [19].  
Since RhD factors are implicated in several hematologic disorders, anti-RhD MAb might be an 
alternative to polyclonal anti-RhD prepared from human plasma for treating diseases such as 
haemolytic disease in newborns and idiopathic thrombocytopenic purpura [20].   
 
1.1.3 Protein Manufacturing using CHO Cultures 
 
The classical method for establishing a protein-producing CHO cell line is a time-consuming 
and laborious process which can take industries more than six months to develop a suitable expression 
host and culturing setting for a candidate therapeutic [2].  The first step in developing a high-producing 
cell line is the creation and delivery of a gene construct containing the gene of interest (GOI) and 
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selection genes into the host cell for chromosome integration.  Selection of transfected cells is carried 
out in cultures lacking a critical component and hence will not permit the survival of non-transfected 
cells.  The selection gene encoded in the transfected vector provides the missing component that is 
necessary for propagation of cells.  Dihydrofolate reductase (dhfr) and glutamine synthetase (gs), which 
are two frequently used selection genes in CHO cultures, work in conjunction with dhfr minus host 
cells and medium without glutamine respectively.  Expression of gene of interest can be significantly 
increased by exposing cells to a drug that blocks the enzymatic activity of the selection marker, in a 
process called amplification.  DHFR and GS are inhibited by methotrexate (MTX) and methionine 
sulphoximine (MSX) respectively [1].  By applying more selection pressure, the copy number of the 
inserted DNA increases, resulting in a cell population with varying integration sites, copy numbers, 
growth rate and specific GOI productivities.  Hence, after selection and amplification steps, screening 
must be done to isolate a small set of candidate protein-production cell lines.  The chosen clones are 
expanded through passaging to allow further evaluation, until finally a single cell line is selected for 
clinical trial and eventually into mass commercial production.  
 
Present day protein manufacturing processes can routinely yield 10 to 50 fold higher protein 
amounts than ones developed in the 1980s.  Typical cultures in the early 80s were maintained in simple 
week-long batch set up which had a maximal cell density of 2x10
6
 cells/mL, a specific productivity of 
less than 10ρg/cell per day and a final titre of 100mg/L [2,21].  With the development of more advance 
culturing systems, processes performed in recent years have demonstrated the ability to reach 10x10
6
 
cells/mL and maintain high viability for weeks.  The final protein harvest can now reach 1-5g/L with 
specific productivity up to 90ρg/cell per day [21].  The improvement of yield over time was tightly 
associated with having a better understanding of gene expression, metabolism, growth and apoptosis in 
mammalian cell cultures, host cell engineering, cell line screening methods and manufacturing 
procedures.   
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With the aim of establishing high-yield CHO cell lines, numerous approaches have been 
suggested and employed by researchers and industries over the years.  These methods can roughly be 
classified as i) genetic means, which include vector designing, genetic modification of host cell, or as ii) 
environment modification, which can involve the optimization of medium and culturing conditions such 
as temperature and pH, and chemical supplementation.  These strategies may affect culture longevity, 
cell density, cell viability or protein productivity, leading to an increase in the total product yield. 
 
1.1.4 Cell Death in Cell Cultures and its Effect on Protein Manufacturing 
 
Although apoptosis, which is a type of cellular suicide, was first described and characterised in 
the 1970s, the concept that many cell lines undergo apoptotic cell death in response to the stressful 
culture environment in bioreactors was first suggested by Al-Rubeai in 1990 [22].  The identification of 
apoptosis in commercially important animal cell lines such as hybridoma, plasmacytoma and CHO cell 
lines have been documented using various detection methods.  Some of these assays were electron and 
fluorescence microscopic examination of nuclear morphology, DNA gel electrophoresis, which can 
show the presence of DNA fragmentation, Western blot identification of cleaved caspase substrates and 
flow cytometry detection of apoptotic proteins [22-25].  High levels of apoptotic cell deaths have been 
observed at the end of CHO batch cultures, though the precise level of apoptosis in the cell population 
could vary due to differences between cell lines, culture conditions and the employed detection assays.  
In one study, more than 95% of the cell death that occurred during batch cultivation of a serum-free γ-
interferon-producing CHO cell cultures was reported to be due to apoptosis [26].  Meanwhile, a high 
correlation (R
2
 = 0.986, n=8) between apoptosis and total cell death in cultures, as determined by 
Trypan Blue assays, was noted in another serum-free CHO batch culture [24].  In this study, it was 
further concluded that the predominant apoptotic cell death was unrelated to the production of a protein 
product.  Despite these variations, apoptosis still accounts for the majority of cell death occurring in 
bioreactors during the production of biopharmaceuticals from animal cell lines [24,27].   
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The induction of apoptosis in cell cultures can be triggered by many detrimental stresses 
(details in Section 1.2 below).  Nutrient limitation, including deprivation of glucose, essential amino 
acids and non-essential amino acids, is one of the primary causes leading to cell death during the 
stationary and death phase of batch culture [23,28,29].  Other possible causes of cell death in 
bioreactors include extreme oxygen levels (hyperoxia and hypoxia) and mechanical agitation in the 
hydrodynamic environment [27].  Regardless of what triggers apoptosis in cell cultures, it poses a major 
limiting factor in the production of recombinant proteins [24].  Ongoing cell death in bioreactors makes 
the maintenance of high cell density with high viability difficult.  Not only can this decrease in total 
viable cell number reduce the final yield, the release of cellular remains and associated degradative 
enzymes into the medium can also complicate purification and negatively affect the quality of the 
products [30-32].  At the very basic, maintaining viability and prolonging cultivation period via 
preventing or delaying apoptosis can be two straightforward strategies for increasing productivity.  
Hence, the understanding of cell death has been an important component in the optimization of 
recombinant protein producing cultures.   
 
1.2 Apoptosis  
 
As a mode of programmed cell death (PCD), apoptosis is a controlled and regulated mechanism 
for cell death triggered by external death stimuli or internal cell stress signals.  Apoptotic cells can be 
characterized by distinct morphological changes including cell shrinkage, nuclear DNA fragmentation, 
chromatin condensation, membrane blebbing and the formation of apoptotic bodies [33,34].  The term 
apoptosis was first defined in 1972 by Kerr, Wyllie and Currie to describe the morphologies that had 
been observed in this particular type of cell death [35].  Apoptosis differs from necrosis, which is an 
energy independent and passive way of cell death.  The morphologies of necrosis include cell swelling, 
karyolysis (nonspecific DNA fragmentation), membrane disruption, organelle lysis and finally 
disruption of the cell membrane [33,34,36].  Moreover, leakage of cellular proteins such as lysosomal 
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enzymes from necrotic cells also generates inflammatory response to surrounding cells causing further 
damages.  Such nonspecific amplifying of cell deaths does not occur with apoptotic cells as the cellular 
contents are enclosed in apoptotic bodies and not released directly into the extracellular space.   
 
Apoptosis can act as a form of natural defense mechanism to immune reactions or against 
disease.  Its proper function is also crucial during development and aging to maintain cell populations 
and achieve homeostasis in tissues [34].  Different cells can have diverse response to the same stimuli 
and conditions.  As a form of PCD, apoptosis triggers cell suicides via “genetically determined 
elimination” [34].    
 
1.2.1 Morphological Progress of Apoptotic Cells 
  
During the early stage of apoptosis, cell shrinkage occurs due to the breakdown of the structural 
proteins in the cytoskeleton (Figure 1-1).  This shrinkage packs the organelles closer and condenses the 
cytoplasm.  Next, the hallmark of apoptosis, pyknosis or the irreversible condensation of nucleus, 
occurs [35,37].  These changes to cell size and chromatin are both visible under light microscope [35].  
Blebs, which are irregular bulging of the plasma membrane, begin developing in these apoptotic cells.   
Following extensive blebbing, nuclear fragmentation known as karyorrhexis and the fragmentation of 
DNA occur.  Lastly, the cells disintegrate into individual apoptotic bodies, which enclose a portion of 
the cytoplasm including organelles and cellular proteins.  In vivo, apoptotic bodies will be engulfed by 
macrophages via phagocytosis, which ensures a clean and efficient removal of the apoptotic cells that 
does not cause inflammatory responses in surrounding cells.  Due to the lack of phagocytic cells, 
apoptotic bodies likely remained in culture longer than they normally exist in vivo [24].  The process of 
apoptosis from initiation to the formation of apoptotic bodies is thought to be completed in hours; 
studies have suggested it can be as quick as 1-3 hours [35].   
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Chromatin fragmentation occurs when chromatin breaks into large fragments inside the 
original nuclear membrane.  When each chromatin fragment is enclosed by a membrane, this 
phenomenon is termed nuclear fragmentation [38].  Pyknosis has been associated with the reduction 
of cellular and nuclear volume [37].   
 
Another biochemical feature of apoptosis worth noting is the exposure of cell surface 
phagocytic recognition markers.  Among these, the externalization of phosphatidylserine (PS), which 
normally resides in the inner-leaflet of the cellular membrane [34], is a well-known and commonly used 
characteristic for the detection of apoptosis.   Comparing to other apoptosis features, exposure of PS 




Figure 1-1. Morphological changes of a cell as apoptosis progresses.  Modified from [41]. 
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1.2.2 Caspases - Important Initiator and Executioner of Apoptosis 
  
Many morphological changes observed in cells undergoing apoptosis are caused by a cysteine 
protease called caspase 3.  In addition to caspase 3, many other members of the cysteinyl aspartic acid 
protease (caspase) protein family have been associated with apoptosis.  Currently, there are at least 14 
mammalian caspases that have been identified but not all take part in the process of apoptosis.  The 
apoptotic caspases are categorized into 2 classes: initiator caspases which react to apoptotic stimuli in 
cells and signal the onset of programmed cell death, and effector caspases which are activated by 
initiator caspases and are responsible for the proteolytic cleavage of various essential cellular proteins, 
leading to cell death (see Figure 1-2) [42,43]. 
 
     
Figure 1-2. Structures of processed mammalian caspases and phylogenetic relationship between 
apoptotic members of the caspase protein family.  Figure based on [43-45]. The intra-chain 
activation cleavage which separates the large and small subunit is indicated by the black arrows.  
Sometimes, additional cleavage removes a short linker sequence between the two subunits.    
 
Caspases typically share a consensus substrate cleavage site consisting of the amino acid 
sequence X-X-X-Asp where X can be any amino acid.  They are synthesized as a single chain zymogen 
           effector caspases   linker residues 
           initiator caspases (extrinsic)                 death effector domain 
           initiator caspases (intrinsic)               caspase recruitment domain 
N-peptide  Large subunit       small subunit 
            ~p20               ~p10                                         
 
caspase 3 (277aa) 
caspase 7 (303 aa) 
caspase 6 (293 aa) 
 
caspase 8 (479 aa) 
caspase 10 (521 aa) 
 
caspase 9 (416 aa) 






that requires proteolytic activation during apoptosis [43,46].  Activated caspases are heterotetramers 
consisting of two set of large and small subunits [47].  Initiator caspases contain either the death 
effector domain (DED) or caspase recruitment domain (CARD) (see Figure 1-2), which allows them to 
be recruited by adaptor proteins and be activated.  After the recruitment and autoproteolytic cleavage, 
each molecule of caspases is cleaved into 2 units: a p10 small subunit plus a p20 subunit [43,48].    
 
1.2.3 Mechanism and Pathways of Apoptosis  
 
Mammalian cells can undergo apoptosis through various signalling pathways initiated at 
different cellular locations including mitochondria, the cell surface and the endoplasmic reticulum, in 
response to varying stimuli.  The extrinsic and intrinsic pathways are two major cell death-inducing 
signalling pathways that are well characterized and studied.  More recently, other mechanisms such as 
the ER pathway [33] and the perforin/granzyme pathway have also been discovered [34].  The 
following subsection introduces the two major pathways and the key proteins associated with them.  
 
1.2.3.1 Overview of the Intrinsic Pathway 
 
The intrinsic or mitochondrial pathway (see Figure 1-3) can be triggered by intracellular cell 
stress signals generated from a variety of non-receptor mediated stimuli including growth factor 
withdrawal, Ca
2+
 flux, UV irradiation and toxin accumulation [33].  Stimuli can either involve the 
withdrawal of survival factors which results in the failure to continue suppressing death programs or the 
direct introduction of apoptotic factors such as toxins, radiation, free radicals and unfolded proteins 
[34,49].   
 
The Bcl-2 protein family, consisting of at least 25 members (Table 1-1 and 1-2) [34], is known 
for the sensing of various types of intrinsic stress signals and the control of subsequent mitochondrial 
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response.  Upon the detection of intracellular stimuli, Bcl-2 members migrate to the mitochondria and 
cause changes to the mitochondrial membrane, eventually leading to mitochondrial outer membrane 
permeabilization (MOMP).  As a result, apoptosis progresses further by the loss of mitochondrial 
transmembrane potential and the release of pro-apoptotic molecules from the intermembrane space 
(IMS) into the cytosol [33,50].   
 
Among the released proteins, cytochrome c, Smac/DIABLO, HtrA2/Omi are important in the 
activation of initiator caspase 9 and subsequent apoptotic execution phase.  Once cytochrome c is 
released into the cytosol, it recruits Apaf-1 and procaspase 9 to form the apoptosome complex which 
then triggers the autoproteolytic activation of procaspase 9.  The active caspase 9 then begin the 
execution of apoptosis by activating caspase 3.  Meanwhile, Smac/DIABLO and HtrA2/Omi neutralize 
the activity of IAP (inhibitors of apoptosis proteins), which can suppress caspases.  Moreover, AIF, 
endonuclease G and CAD are also released from the mitochondria.  Both AIF (apoptosis inducing 
factor) and endonuclease G require no activation by caspases.  Upon release from the mitochondria, 
they translocate to the nucleus and interact with chromatin.  AIF cuts DNA into large fragments of 50-
300kb and causes condensation of peripheral nuclear chromatin, while endonuclease G produces 
oligonucleosomal fragments.  Meanwhile, the released CAD protein requires translocation to the 
nucleus and activation by caspase cleavage before it can also produce oligonucleosomal DNA 




































Anti-apoptotic Bcl-2 proteins 
Pro-apoptotic BH3-only proteins 


















































Bcl-2 Protein Family 
Members of the Bcl-2 protein family all contain at least one of the four Bcl-2 homology (BH) 
domains.  Pro-survival Bcl-2 family members are multidomain proteins containing at least three of the 
four BH domains: BH1, BH2, BH3 and BH4; while pro-apoptotic Bcl-2 members can be subdivided 
into multidomain proteins with BH1-3 domains, and BH3-only [34,53,54].  BH3-only proteins sense 
intracellular stress signals and in response, trigger cell death by inducing the oligomerization of pro-
apoptotic BH123 proteins at the outer mitochondrial membrane.  The anti-apoptotic Bcl-2 members 
promote cell survival by neutralizing the BH123 molecules.  Hence the ratio and interaction between 
anti- and pro-apoptotic Bcl-2 proteins determine whether cells will commit to apoptosis [51].  Other 
than being sensors to stimuli, some BH3-only proteins can also release BH123 proteins from their 
sequestering anti-apoptotic Bcl-2 relatives.     
 







BAX Bcl2 associated X protein  BH123 BCL2L4 
BAK Bcl2 antagonist killer 1 BH123 BCL2L7 
BOK Bcl2-related ovarian killer BH123 BCL2L9 
BID BH3 interacting domain death agonist BH3 p22 BID 
BAD Bcl2 antagonist of cell death BH3 BBC6, BCL2L8 
BIM Bcl2 interacting mediator of cell death BH3 BCL2L11, BOD 
BIK Bcl2 interacting killer BH3 NBK, BP4, BIP1 
BLK Bik-like killer protein BH3 BIKLK 
PUMA p53 up-regulated modulator of apoptosis BH3 BBC3 
Bcl-XS Bcl2-like protein 1, short isoform BH34  
Noxa* Phorbol-12-myristate-13-acetate-induced protein 1 BH3 PMAIP1 
BMF Bcl-2 modifying factor BH3  
* Noxa is Latin for damage. 













Bcl-2 B-cell lymphoma protein 2;  BH1234  
Bcl-XL Bcl2-like protein 1, long isoform BH1234  
MCL1 Myeloid cell leukemia sequence 1 BH123 BCL2L3, EAT 
BCL-W BCL2 like protein 2 BH1234 BCL2L2 
BFL-1 Bcl-2 related protein A1 BH123 BCL2L5, GRS, BCL2A1 
BCL-B BCL2 like protein 10 BH1234 BCL2L10, Boo, Diva 
Abbreviation: BCL2L, Bcl2-like protein 
 
1.2.3.2 Overview of Extrinsic Pathway 
 
The extrinsic pathway, also known as the death receptor pathway, is mediated by death ligands 
and death receptors.  Apoptosis is initiated by the binding of death ligands (Table 1-3) to their 
corresponding cell surface death receptors, followed by the trimerization of the ligand-receptor pairs at 
the membrane (see Figure 1-4 and 1-5).  Death receptors contain cysteine-rich extracellular domains 
and a cytoplasmic death domain (DD) with roughly 80 residues.  After ligand binding, cytoplasmic 
adaptor proteins are recruited to the plasma membrane via homophilic DD interaction between receptor 
and the adaptor [33,56].  Different death receptors associate with different set of adaptor proteins.  For 
example, Fas binds to the adaptor Fas-associated death domain (FADD) while TNF receptor recruits the 
adaptor protein TRADD which further interacts with FADD and RIP adaptor proteins.  Next by 
dimerization of the death effector domains (DED), FADD adaptor proteins associate with procaspase 
8 to form a signalling complex.  The autoproteolytic activation of caspase 8 is due to induced proximity 
and dimerization when recruited to this complex.  Once activated, caspase 8 is then released from the 
complex as a heterotetramer containing two p18 and two p10 subunits [33].  The initiator caspases then 
activate the effector caspases such as caspase 3, 6 and 7.  Their activation marks the beginning of 
apoptosis’ execution phase.   
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In addition to caspase 8, another similar DED-containing protease, caspase 10 has been shown 
to associate with the signalling complex while not being essential for cell death signalling.  In vivo 
study demonstrated that it cannot replace caspase 8 in inducing apoptosis but its function in the 
complex remains unclear [33].   
 
Death receptors and their corresponding death ligands 
As members of the Tumour Necrosis Factor (TNF) superfamily [57], death receptors can bind 
with at least one type of death ligand expressed on adjacent cells.  Table 1-3 shows the six currently 
characterized non-decoy, membrane bound death receptors that are involved in apoptosis.  Decoy 
receptors have both membrane bound and soluble types.  They compete and interfere with functional 
death receptors by binding to death ligands and thus affect the sensitivity of cells to death-receptor-
mediated apoptosis.  Soluble decoy receptors may inactivate death ligands on the surface of nearby cells 
while membrane bound decoys may decrease the host cell’s sensitivity to external apoptotic signals 
[42,58].  Moreover, membrane bound Fas ligands can be cleaved by cell surface matrix 
metalloproteinase-7 (MMP-7) into their soluble less-active forms, which bind to and block the receptors 
on adjacent cells [42].  Similarly, membrane bound TNFα can be cleaved by metalloprotease TNF alpha 
converting enzyme into its soluble form. 
 
   Table 1-3. Death ligand and receptor pairs [42,50] 
Death receptor and aliases Death ligand 
TNFR1 TNFα, LTα 
Fas/CD95/Apo1 FasL 









Among the identified death receptors, the Fas pathway is the most characterized and best 
understood [50,59].  Upon Fas ligand binding, the Fas receptor recruits an adaptor protein called Fas-
associated death domain (FADD) through the interaction between homologous death domains (DD) 
present on both proteins.  The resulting complex is termed the death-inducing signalling complex 
(DISC) (Figure 1-4).  Depending on cell types, Fas-mediated apoptosis may require the participation of 
mitochondria (see section 1.2.3.3).    
 
TRAIL pathway 
TRAIL-R1 and TRAIL-R2 are two functional (i.e. non-decoy) receptors identified that are 
capable of inducing TRAIL-mediated apoptosis.  TRAIL stands for tumor necrosis factor α-related 
apoptosis-inducing ligand.  Although research studies have found contradictory results, it has now been 
clear that both TRAIL receptors transduce death signals through the adaptor protein FADD as in the 
FAS pathway [60,61].  Although the ligation of TRAIL to TRAIL-R1 and TRAIL-R2 can activate other 
nonapoptotic pathways such as the NF-κB and JNK pathways (details below in “TNF pathway” section), 
apoptosis is the predominant result of TRAIL binding [62] (Figure 1-4).  As with TNF-mediated cell 
death, the recruitment of adaptor protein RIP to the ligand-receptor complex is necessary for the 
activation of NF-κB and JNK [52,60].  In addition to RIP, TRAF2 is also required for the JNK pathway 
[52].  As explained in Section 1.2.3.3, TRAIL can trigger apoptosis via different paths depending on the 































Figure 1-4. Apoptosis initiated by FasL and TRAIL death ligands.  Figure based on [33,56,63]. 
Dotted lines indicate reactions occurred in Type II cells.  Abbreviations: DD, death domain; DED, 




























































































Under the non-induced condition, the death domains of ubiquitously expressed TNF-R1 
receptors are blocked by the silencer of death domain (SODD).  The release of SODD from TNF-R1 is 
triggered by the binding of death ligand to the receptor, which subsequently recruits the adaptor protein 
TRADD (see Figure 1-5).  TRAF2 (TNF receptor-associated factor 2) and RIP (DD-containing 
receptor-interacting kinase) associate with TRADD at its amino-terminal DD and carboxy-terminal DD 
respectively into TNFR signalling complex I.  When TRADD, TRAF2 and RIP disassociates from the 
plasma membrane, they further recruits FADD and procaspase 8, forming the apoptotic cytoplasmic 
complex II [64].  Although it is widely documented that this complex II facilitates the activation of 
caspase 8 as described for DISC in the Fas pathway, there are still some controversies regarding the 
composition of the complex.   
 
Signalling complex I activates the pro-survival NF-κB by removing its inhibitor IκB.  Once 
activated the NF-κB translocates into the nucleus where it act as the transcriptional factor for many pro-
survival genes.  Their targets include cFLIP, IEX-1L, Bf1-1/A1, XIAP, cIAP1, cIAP2 and Bcl-XL [33].  
When present, FLIP binds to procaspase 8 and prevents its activation.  Since TNF activates the anti-
apoptotic NF-κB pathways, it does not induce cell death spontaneously as Fas and TRAIL signalling 
pathways.   The activation of TNF-induced apoptosis is masked by the simultaneous activation of NF-
κB in vivo unless the anti-apoptotic pathway is inhibited.   
 
 Furthermore, TNF binding also triggers the c-Jun N-terminal kinase (JNK) pathway by 
activating JNK kinase, allowing it to translocate into the nucleus and enhance activity of transcription 
factors such as c-Jun and ATF2.  As one of the activator protein-1 (AP-1), c-Jun participates in the 
regulating of proliferation, differentiation and apoptosis.  However, the exact mechanism and whether 


















































Figure 1-5. Extrinsic apoptotic pathway triggered by TNF.  Figure based on [33,64]. Abbreviations: 
DD, death domain; DED, death-effector domain; DISC, death-inducing signalling domain; IKK, IκB 
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Other death receptor mediated pathways 
Although not as well characterized as the TNF or FAS pathways, the ligand Apo3L and its 
corresponding receptor DR3 (Apo3) have been shown to be fairly similar to TNF and TNF-R1.  
Binding of Apo3L to its receptor activates apoptosis via the recruitment of TRADD, FADD and caspase 
8, as well as the induction of NF- κB pathway by TRADD, TRAF2 and RIP [52].   
 
1.2.3.3 Crosstalk between the Extrinsic and Intrinsic Pathway 
 
Cells undergoing Fas- and TRAIL induced apoptosis can be divided into two types: type I and 
type II cells (Figure 1-4).  Death of type I cells can proceed without mitochondrial involvement while in 
type II cells, participation of mitochondria is required [63,66].  In type I cells, sufficient activation of 
caspase 8 in DISC induce apoptosis directly.  Since only small amount of FADD and caspase 8 are 
recruited to DISC in type II cells, amplification via the mitochondria is necessary to induce cell death.  
The involvement of mitochondria in death receptor mediated apoptosis begins by the cleavage of a pro-
apoptotic Bcl-2 protein, Bid, by the small level of activated caspase 8 present.  Following the 
translocation of cleaved Bid (tBid) to the mitochondria membrane, mitochondrial dysfunction and 
apoptosome formation occur [33].  However, the activation of caspase 9 from the apoptosome 
activation alone does not compensate for the weak DISC and caspase 8 activation.  The inhibition of 
caspase 9 was shown not to prevent the activation of caspase 3 nor the execution of TRAIL-mediated 
apoptosis.  Instead, the release of Smac/DIABLO following the translocation of Bax, which was 
induced by tBid, was necessary for the removal of XIAP from caspase 3 and its subsequent processing 
and activation by caspase 8 [48].  The fully activated caspase 3 can then cleave proteins such as XIAP 
[33] and activate more caspase 8 to complete an amplification feedback loop [59].  In contrast, studies 
have suggested that stress signals can sensitize cells to death signal pathways [33,42] although the exact 
mechanisms remain unclear.   
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This cross talk indicates that proteins involved in apoptosis are not all explicit to a particular 
pathway but exhibit more complicated roles depending on the cell type and death stimulating condition.  
However, at the moment it is unclear which type CHO cells belong to and whether the different CHO 
cell line behaves similarly under various conditions.   
 
 1.2.3.4. Endoplasmic Reticulum Pathway 
 
Many cellular stresses, such as oxidative stress, nutrient (glucose) deprivation, protein overload, 
hypoxia, inhibition of proper protein glycosylation and disturbances of calcium mobilization, can lead 
to an increase in misfolded protein accumulation in the ER lumen [67] by affecting protein 
glycosylation and inducing protein denaturation [68].  The alteration of ER homeostasis caused by these 
factors results in ER stress and provokes the unfolded protein response (UPR), which involves signal 
transduction between ER and the nucleus.  The cell responds to such stress by directly reducing protein 
translation, increasing translation of ER chaperones to facilitate refolding of the unfolded proteins and 
degrading misfolded proteins that failed to get refolded correctly via ER-associated degradation [67].  If 
this stress continues and UPR persists, apoptosis will be initiated at the ER by the release of calcium 
ions into the cytosol.  Calcium ions and cytochrome c facilitate communication and amplification of 
apoptotic signals between the ER and mitochondria.  The released Ca
2+
 ions are quickly absorbed by 
mitochondria, leading to a mass efflux of cytochrome c from all mitochondria.  Upon binding of 
cytochrome c to the InsP3 receptors on the ER membrane, calcium release is further enhanced.  It was 
reported that both pro- and anti-apoptotic Bcl-2 family members also locate on the ER to facilitate the 
regulation of Ca
2+
 resting store and release [53].  The exact mechanisms of ER-mediated apoptosis are 
still under investigation.  During ER-mediated apoptosis, the ER-localized caspase 12 becomes 
activated by a calcium-dependent protease called calpain and translocates to the cytosol, where it 
cleaves procaspase 9 [33,69].  It has been shown that caspase 12 responds and activates only during ER 
stresses and not by other death stimuli [70].  While the mitochondria has been reported to respond to 
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calcium flux from ER, the release of cytochrome c and the formation of apoptosome were shown not 
essential for the induction of ER-mediated cell death.  To date, studies seem to suggest that ER stress 
triggered apoptosis can be signalled through both mitochondrial-dependent and independent pathways 
[71].   
  
1.2.4 Proteolytic Targets of Caspases  
 
As mentioned in 1.2.2, known apoptotic caspases include caspase 2, 3, 6, 7, 8, 9 and 10.  Out of 
these executioner molecules, caspase 3 is the dominant effector targeting and cleaving a huge number 
of cellular proteins upon its activation.  At least 280 substrates were identified [72] and they can be 
roughly divided into categories such as mediators and regulators of apoptosis, structuring proteins, 
DNA repair proteins and cell cycle proteins [46].  However when these proteins are cleaved during 
apoptosis and the completeness of cleavage can vary.  Moreover, some proteins appeared to be targeted 
by caspases in certain cell types or conditions only [72]. 
   
1.2.4.1 Substrates whose Cleavage Results in Key Morphological Changes  
 
The early indicators of apoptosis, chromatin condensation and nuclear remodelling, are 
achieved by the cleavage of Acinus and Helicard proteins [72].  Acinus, which stands for apoptotic 
chromatin condensation inducer in the nucleus, has been shown to induce chromatin condensation 
without DNA fragmentation in vitro [73].  The cleavage and activation of cytoplasmic Helicard, which 
is a CARD-containing DNA helicase, by caspase leads to its localization to the nucleus where it can 
alter chromatin architecture.  It was shown that the active Helicard fragments accelerated DNA 
degradation in apoptotic cells, likely by unwinding the DNA and allowing easy access of caspase-
activated DNAse (CAD) to the DNA [74].     
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Internucleosomal DNA degradation is a major characteristic of apoptosis that is caused by the 
work of the endonuclease CAD.  In normal healthy cells, the DNA fragmentation factor 45kD subunit 
(DFF45), also known as the inhibitor of CAD (ICAD) prevents CAD from digesting cellular DNA.  The 
cleavage of ICAD’s N-terminal CIDE-N interaction domain by activated caspase 3 during apoptosis 
removes its suppression on CAD [75].  In apoptotic cells, the DNA digestion occurs at 
internucleosomal sites, producing small (multiples of 185 bp) double-stranded fragments of DNA.  
However less extensive DNA degradation resulting in fragments of sizes 50 – 300 kb also occurs in 
some cell types [76].  Although AIF and endonuclease G released from the mitochondria also assist in 
DNA fragmentation, their DNAse activities are caspase-independent [74]. 
 
Furthermore, activation of pro-apoptotic kinases such as ROCK1 kinase and p21-activated 
kinase 2 (PAK2) are necessary for the morphological change to cell membranes during apoptosis.   
Activation of ROCK1 kinase leads to membrane blebbing, while PAK2 is involved in the formation of 
apoptotic bodies [33]. 
 
1.2.4.2 Apoptotic Proteins 
 
Many proteins involved directly in the apoptosis pathways are targeted by caspases upon their 
activation.  Proteins with anti-apoptotic nature are inactivated when they are proteolytically cleaved by 
caspases.  On the other hand, some pro-apoptotic proteins must be activated by caspases in order to 
carry out their apoptotic responsibilities.   
 
Anti-apoptotic proteins including Bcl-2, Bcl-XL, IAPs and FLIP-L are also cleaved by caspases 
[33].  The cleavage of Bcl-2 and Bcl-XL are related to sensitivity of the mitochondrial pathway.  
However it is unclear whether this is a ubiquitous feedback mechanism or a stimulus-specific event.  
Several pro-survival protein kinases have been identified as caspase targets after the initiation of 
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apoptosis.   As part of the signalling component of the DISC complex in the TNF extrinsic pathway, 
RIP kinase activates the pro-survival NF-κB pathway.  It was shown that RIP can be cleaved by caspase 
8 leading to the removal of this anti-apoptotic inhibition from NF-κB.  In addition to RIP, Focal 
adhesion kinase (FAK), which typically transduces survival signals from the extracellular matrix, is 
another anti-apoptotic kinase targeted by caspases.  In vivo, FAK transduces survival signals from the 
extracellular matrix and, as the name suggests, regulates focal adhesion formation in adherent cells.  
Death ligands such as FAS and TRAIL have been shown to trigger the cleavage of FAK by caspases 3, 
6 and 7 in both adherent and suspension cells early in the apoptosis stage [77].   
 
1.2.4.3 Cytoskeletal Proteins 
 
Proteolyses of several structural proteins lead to the several morphologies observed in cell 
shape during apoptosis.  Cleavage of nuclear lamins is responsible for the nuclear shrinkage and 
budding.  The loss of overall cell shape is due to the cleavage of fodrin and gelsolin, which leads to the 
disruption of actin filament network [33].  The constitutively active fragment of the cleaved gelsolin 
can depolymerize F-actin.  Cells deficient in gelsolin showed greatly delayed membrane blebbing 
suggesting that actin reorganization by gelsolin is required for membrane blebbing [72].  In addition, 
intermediate filament proteins such as keratin 18, keratin 19 and vimentin are also cleaved by caspases 
[33], which affects the maintenance of the cytoskeletal architecture.   
 
1.2.4.4 DNA Repair Proteins 
 
Many DNA repair proteins are cleaved and inactivated during cell death for the conservation of 
cellular resources and energy.  Since apoptosis is a regulated energy-dependant mechanism, proper 
balance and utilization of cellular energy is important for the successful execution of apoptosis.  It was 
found that the depletion of cellular ATP can abrogate apoptosis and induce necrosis instead [78].  
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Meanwhile, inhibition of DNA repair promotes the apoptosis process [72].  DNA repair proteins 
including DNA-dependent protein kinase (DNA-PK), Rad51, ATM and poly(ADP-ribose)polymerase 
(PARP) are known substrates of caspases [33,72].  The cleavage of PARP especially has become a 
common protein marker for detection of apoptosis [48,79,80].  When activated by DNA damage, PARP 
catalyzes the attachment of ADP-ribose polymers to nuclear proteins and facilitates DNA repair.  Since 
this process consumes large amount of NAD
+
 thus indirectly depleting ATP resources, the cleavage and 
inactivation of PARP during apoptosis likely is carried out by caspases to prevent a huge energy loss 
[33,72]. 
 
1.2.4.5 Cell Cycle Proteins 
 
During the late phase of apoptosis, several cell cycle-associated factors become activated by 





 and Rb [33].  As a critical component of the G2/M cell cycle checkpoint 
machinery, Wee1 mediates cell cycle arrest by phosphorylating and inactivating the cell cycle-
regulatory kinase CDC2 and CDK2.  Following the cleavage and inactivation of Wee1, cell cycle 




 results in increased 
CDK2 activity that will also allow cell cycle progression [82].  Moreover, the inactivation of the 
anaphase-promoting complex via cleavage of its component CDC27 results in increased activity of 
CDK activity as well [81].  Since the cell has irreversibly committed to apoptosis, continuing DNA 
checkpoint and repair is meaningless and even energy-wasting.  The cleavage of cell cycle proteins by 
caspases during apoptosis hence helps direct resources to undergo apoptosis [83].  Surprisingly in 
several studies, cleavage of cell cycle regulators has shown pro-apoptotic consequences.  The loss of 
proliferation inhibitor retinoblastoma (Rb) has been shown to promote the accumulation of procaspases 
[84].  In another case, CDC2 phosphorylated and activated the pro-apoptotic Bcl-2 family member Bad 
by inhibiting its interaction with AKT [85].   
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1.3 Detection of Apoptosis using Flow Cytometry 
 
Flow cytometry (FCM) analysis allows multi-parametric characterization of individual intact 
cells.  By measuring the intensities of scattered light and emitted fluorescence, a flow cytometer senses 
particles in a liquid stream as they pass through a laser beam (see Figure 1-6).  The intensities of front 
and side scattered lights for each detected cell correlate to its size and granularity.  When cells labelled 
with fluorochrome-linked antibodies or stained with fluorescent dyes are excited by a laser beam, 
florescence is emitted over specific wavelengths and can be measured [86].  Every fluorophore has 
optimal but not necessarily unique excitation and emission wavelengths.  When more than one 
fluorophore is used on the same cell sample, multiple characteristics of each cell within a population 
can be identified simultaneously.   
  
One common indicator of apoptosis involves the examination of activated caspases within cells.  
The fluorescent inhibitor of caspase (FLICA) methodology utilizes synthetic peptide caspase inhibitor 
for the detection of activated caspases.  It contains 3 components: a chemical group such as 
fluoromethyl ketone (FMK) to covalently bind to a cysteine, a short caspase-specific recognition 
peptide and a fluorescent reporter group [87].  Since the peptide sequence was based on the substrate 
cleavage sites of caspases, FLICA is an irreversible, competitive pseudo-substrate for active caspases.  
For caspase 3 and 7, the recognition sequence is aspartic acid-glutamic acid-valine-aspartic acid 
(DEVD); while leucine-glutamic acid-threonine-aspartic acid (LETD) and leucine-glutamic acid-
histidine-aspartic acid (LEHD) are for caspase 8 and 9 respectively [87,88].  The FAM FLICA caspase 
kits which use carboxyfluorescein (FAM) labelled FMK peptide inhibitor of caspases, were utilized in 






Figure 1-6. Main components of a flow cytometer.  Figure based on [89,90]. 
 
 
After entering the cell, FLICA molecules covalently bind to reactive cysteine residues on the 
large subunits of the active caspase heterodimer with 1:1 stoichiometry.  Only bound FLICA reagents 
will be retained within cells while the free FLICA molecules get rinsed out during washing [87].  Hence 
the fluorescent signal intensity corresponds to the amount of activated caspases present within the cells 
when reagents are added.  Propidium iodide (PI) can be used as a membrane integrity or dead cell stain 
along with the activated caspase-binding FLICA stain.  PI only penetrates damaged cell membranes and 
intercalates with DNA, thus leaving viable cells unstained.  The penetration of PI across leaky plasma 
Legend                  
 
                = Fluorescence  
















membranes can help assess viability of apoptotic cells and identify the progression of apoptosis since 
disturbance of membrane integrity is not observable until late stages of apoptosis [91].   
 
In this thesis, cells are considered live or viable by the exclusion of membrane integrity dye 
such as PI, whereas dead cells show positive PI intensity in FCM analysis.  Meanwhile, the occurrence 
of apoptosis is determined by the presence of activated executioner caspases as indicated by a positive 
FLICA intensity.  Therefore, using this bi-color assay, cells can be categorized as i) C3-PI- (live non-
apoptotic) cells that posses intact membrane and no activated caspases 3 and 7, ii) C3+PI- (early 
apoptotic) cells that contain significant number of activated caspases 3 and 7 yet still maintain their 
membrane integrity, iii) C3+PI+ (late apoptotic) cells which have non-intact membrane and activated 
caspases 3 and 7, and iv) C3-PI+ (primary and secondary necrotic) cells that displayed a damaged 
membrane but no activated caspase (see Table 1-4).  These C3-PI+ cells could be either the caspase-
independent necrotic or very late apoptotic cells which have lost their ability to bind FLICA [87,92,93].  
The absence of FLICA signal has been reported in cells at late stage of apoptosis [87,92] and suggested 
to reflect the inactivation, degradation or secretion of activated caspases out of the cells.  In particular, 
the extracellular secretion of activated caspase subunits has been observed at the final stages of 
apoptosis [47,94] when the caspase-mediated cleavage of essential cellular proteins was likely 
completed.  Some studies have termed apoptotic cells at the late stage as secondary necrotic cells for 
their resemblance to primary necrotic cells.  The baseline signal intensity of non-stained cells can be 
used to determine the threshold (minimum intensity) for a positive signal.  Using the thresholds in 
subsequent FCM analyses with labelled samples, cells with non-specific fluorescence can then be 






Table 1-4. Interpretation of results for the bi-color flow cytometry analyses for caspase 3  
Cell type Cell Condition 
Activated  





C3-PI- Healthy, nonapoptotic  - - 
C3+PI- “early” apoptotic + - 
C3+PI+ “late” apoptotic + + 
C3-PI+ 
Primary necrotic or 
secondary necrotic 
- + 
+: positive as intensity past the cutoff threshold  
-: negative as intensity below the threshold 
C3: caspase 3 
 
Similarly, FCM caspase 8 and caspase 9 tests can also categorize cells into four subpopulations.  
However, unlike caspase 3 and 7 which are common to all apoptotic pathways, FCM caspase 8 assay 
preferentially recognizes caspases specific to the extrinsic pathway.  The activation of caspase 9, which 
may be involved in both mitochondrial and ER-mediated apoptotic pathways, can be detected with the 
FCM caspase 9 assay.  Since they represent the initiation of apoptosis only, interpretation of these 














1.4 Comparative Proteomic Analysis  
 
Proteome analysis is a powerful method in screening changes between two protein mixtures 
thus allowing faster identification of a set of differentially expressed proteins than traditional 
biochemical assays such as the western blot.  Two-dimensional gel electrophoresis, or more specifically 
differential in gel electrophoresis, is often used to separate and select proteins with varying abundances 
between samples.  These proteins are then identified by sequencing using a mass spectrometer.  
Proteomic analyses are comparable to microarray analyses except that changes in protein expression 
instead of mRNA expression are exploited.  
 
1.4.1 Two-dimensional Gel Electrophoresis  
 
As a powerful technique for analyzing whole proteomes, two-dimensional gel electrophoresis 
(2D GE) separates and displays proteins from a mixture onto a polyacrylamide gel according to their 
isoelectric points (pI) and molecular weights (MW).  This technique requires two separate steps: the 
first dimension step, isoelectric focusing (IEF), separates proteins horizontally across a gel strip with 
pH gradient according to their pI; the second dimension, sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) allows proteins to migrate vertically down a 2D gel piece from the gel 
strip based on their sizes.  Each spot on the resulting 2D array corresponds to one protein in the original 
proteome.  Information such as MW, pI and abundance on thousands of protein spots resolved in a 
single gel can be readily obtained after gel visualization.   
 
Differentially in gel electrophoresis (DIGE) is a method modified from the traditional 2D GE 
technique.  It is the method employed in this study.  Unlike 2D gels, DIGE gels can accommodate 
multiple protein samples per gel by pre-staining them with spectrally distinct, fluorescent dyes called 
the CyDye DIGE Fluors – Cy2, Cy3 and Cy5.  Protein spots are detected and quantified by the intensity 
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of the emitted fluorescence when they are scanned with a specific excitation wavelength corresponding 
to each CyDye.  After scanning a gel on these three channels, the single color images resulted were 
overlapped to create a gel image showing all three protein samples loaded on that gel.  Gel images from 
all gels in an experiment can then be analyzed together by computer software such as DeCyder (GE 
Healthcare, Quebec) and subjected to statistical analyses to derive a list of proteins with altered 
expression between samples (see Figure 1-7).   
 
In the DIGE system, expression levels between two protein samples can be directly compared 
on a single gel, eliminating the problem of gel-to-gel variability as experienced in the traditional 
method.  Another improvement of DIGE is the inclusion of a third sample, an internal standard, which 
consists of equal amount of all biological protein samples in the experiment.  Introducing the same 
internal standard into all gels helps to separate experimental variation from real biological difference 
[95] and thus allow more confident comparison between multiple protein samples both within 
individual gel and across gels.  In the DeCyder software, processed abundance data are represented as 
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Image Analysis in DeCyder 
DIA: spot detection and protein abundance 
data processing 
 
BVA: cross gel spot matching, statistical tests 
and select list of differentially expressed 
proteins for identification 
Protein Identification with 
Mass Spectrometry 
Figure 1-7. Stages of Differential In Gel Electrophoresis Analysis. Abbreviations: BVA, Biological 
















CyDye DIGE fluor minimal dye Cy3 and Cy5 can detect a minimum of 0.025ng protein per 
spot, while Cy2 is slightly less sensitive and has a minimal detectable protein amount of 0.075ng.  
However, comparing to silver stain, which can detect above 1ng [95] and colloidal Coomassie Brilliant 
Blue G250 staining with sensitivity around 10ng [96], CyDyes are clearly superior in terms of 
sensitivity for staining protein gels.  CyDye fluor minimal dyes contain an NHS-ester reactive group 
that can covalently bind to lysine residues in proteins by an amide linkage.  As the name implies, a very 
small amount of dye is required for labelling a protein mixture as compared to the alternative CyDye 
DIGE fluor saturation dyes.  Due to the small ratio of dye to protein, this “minimal labelling” method 
can ensure that most visualized proteins are labelled with a single dye molecule only [95,96].  The 
binding of CyDyes to proteins does not alter the pI of the proteins significantly because the addition of 
the +1 charged dye replaces the loss of a positive charge from the lysine residue (see Figure 1-8).  In 
addition, all three CyDyes have a mass of approximately 500 Da, thus the increase in molecular weights 
between protein samples will be consistent.  As a result, the same protein labelled with any CyDye will 
migrate to the same location on the 2D gel [97].   
 
 
Figure 1-8. Amide bond formation during the binding of CyDye to protein.  Modified from [98]. 
     
 
      
 
 










(CyDye bound protein)        
  
+  R’     NHR 
+ HO      N 
O 
O 














Statistical Analyses: t-test and ANOVA 
The t-test is a statistical hypothesis test that checks if the means from two groups are equal.  
Meanwhile, ANOVA generalizes Student’s two-sample t-test to compare means from three or more 
groups. Research data such as protein abundances from two different time points can be converted into 
a single numerical value called the test statistic, such as t statistic and F statistic.  Subsequently, a p-
value generated from the test statistic is used to determine the probability of obtaining a difference in 
protein expression as large as (or larger than) the one observed if there is no real change between the 
samples.  Hence, the smaller the p-value is, the less likely that the observed difference occurs just by 
chance.  Since each spot in the DIGE experiment will be subjected to hypothesis testing, each statistics 
method will test over 1000 hypotheses.  With multiple testing, the accumulated number of false 
positives might be overwhelming, considering the small total number of positives selected.  For 
example, if 1000 tests are performed with p-value significance level at 5%, overall 50 false positives are 
expected in the absence of any real effects.  Since the 5% p-value significance level is no longer 
directly indicative of the overall false positive rate, interpretation of DIGE results becomes difficult.  In 
this case, multiple testing correction methods such as the false discovery rate (FDR) correction can be 
applied to adjust p-values.  The FDR is defined as the ratio of false positives over total statistically 
determined positives [99].  The FDR correction ranks all p-values and selects the largest p-value, 
denoted pr, such that the resulting FDR value will be below the desired threshold.  All protein spots 
with a p-value smaller than pr will then be selected as candidate differentially expressed proteins.  By 
selecting based on an FDR significance level instead, the overall false positive error rate for multiple 
testing can be kept constant and known.   
 
When there are more than two groups, a large number of t-tests is required to fully compare 
between each  pairing of two groups.  Performing multiple pairwise t-tests would largely increase the 
chance of committing type I errors, also known as false positives.  As a result, the ANOVA test is more 
advantageous when comparing multiple groups, although it does not indicate which groups differ from 
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the rest.  Hence to better distinguish true differentially expressed proteins and identify the variation 
pattern of the abundance, both t-tests and ANOVA were performed in this study. 
 
1.4.2 Protein Identification via Mass Spectrometry  
 
Protein identification involves three steps: digestion of gel-separated protein spots, peptide 
sequencing by tandem mass spectrometry, and protein database searches.  Tandem mass spectrometry 
(MS), also known as MS/MS spectrometry, generates protein sequences by subjecting digested protein 
molecules to two rounds of mass spectrometry analysis.  The first MS analysis measures the mass of all 
the detectable peptides from the original protein digest.  Subsequently, each peptide is further 
fragmented by bombarding with energy before the mass to charge ratios of the resulting fragments are 
measured [100].  From the tandem mass spectrum, sequences of peptides can be computationally 
determined using various types of algorithms and searched against protein databases in order to obtain 
an identity of the original protein species.   
 
A mass spectrometer typically consists of 3 components: an ion source, which creates charged 
molecules from the protein digest; a mass analyzer that separates ions based on their mass to charge 
(m/z) ratios with electromagnetic fields; and a detector, which measures the intensity of the ions [101].  
Electrospray ionization and matrix-assisted laser desorption ionization are two common ionization 
methods employed in conjunction with mass separation methods such as the time-of-flight, the 
quadrupole and the ion trap method.  The resulting mass spectrum from MS analysis is a plot showing 
ion-abundance versus m/z.  Sometimes liquid chromatography can be coupled with MS analysis, which 





1.5 Objectives of this Project 
 
Since first being described in 1972 [35], apoptosis has been a topic actively and extensively 
investigated by many research groups.  It was reported and widely accepted as the main mode of culture 
cell death, affecting viability, culture longevity and finally protein production in bioreactors.  Some 
studies placed their focus on understanding the effect of an apoptotic inducer in a particular cell line 
and set up.  For instance, how treatment induces apoptosis in cancer cells, or how an induced apoptotic 
pathway changes the proteome of treated cells were of common interest.  Meanwhile, other researchers 
focus on delaying and reducing the level of apoptosis within cultures for the sake of process 
optimization.  The effects of various optimization strategies including genetic modification of cell 
genomes and chemical supplements on productivity, cell growth and viability in cultures were tested.  
The findings on apoptosis were often generalized, combined, and applied to many other studies with the 
assumption that the mechanism of apoptosis triggered was similar or in a sense, irrelevant.   
  
The main goal of this research project was to study the whole cell proteome of anti-Rhesus D 
factor-producing CHO cells at various phases of the cultivation period as apoptotic cell death advanced 
in the population.  Using proteomic techniques such as gel electrophoresis and mass spectrometry, 
proteins that vary their expression level during the degradation of culture conditions, and upon the onset 
and execution of apoptosis were identified.  Although it is not the only cellular pathways affected 
during prolonged cultivation, apoptosis is of special interest.  The specific apoptotic pathway triggered 
in protein-producing CHO cells, which was maintained in batch cultures mimicking typical industrial 
bioreactor setting, was investigated.  The presence of apoptosis and the advancement of apoptotic cell 
death in cultures were regularly examined via flow cytometry assays.  The detection of apoptosis with 
FCM technique allows the association of changes observed in gel electrophoresis to changes in the 
culture conditions and health of cells over time.  In contrast to previous studies, the approach employed 
in this work did not involve the induction of apoptosis by an apoptotic agent.  In fact, the present work 
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is the first systematic proteomics study of non-induced apoptosis in mammalian cell lines.  The ultimate 
objective of this project is to provide more biological foundation for the construction of a strategy 
which improves productivity by reducing the amount of apoptotic cell death in bioreactors.  Since 
factors crucial in delaying the onset of apoptosis can be inferred by knowing the proteins involved and 
the specific pathway initiated in CHO cultures, potential means of inhibiting apoptosis in bioprocesses 
can be developed.   
 
1.6 Overview of Thesis 
 
In Chapter 2, the progression of cell growth and apoptotic cell death in CHO batch cultures 
throughout the two-week cultivation period is discussed.  In addition to a continuous monitoring of cell 
density and viability via Trypan Blue cell counting, flow cytometry analysis of apoptosis progression 
was conducted via the quantification of activated caspases within cells.  By measuring two major 
initiator caspases, the death receptor-associated initiator caspase 8 and the mitochondrial/ER pathway-
associated initiator caspase 9, the pathway responsible for triggering cell death in CHO cells cultured in 
spinner flasks was investigated.  Protein samples at four time points (day 2.5: late exponential phase, 
day 4.5: early stationary phase, day 5.5: mid-stationary phase and day 8.5: early death phase) during the 
culturing period were collected.   
 
In Chapter 3, results of proteomic analyses comparing whole cell proteomes between the four 
time points are shown and discussed.  Of the differentially expressed proteins identified, they can be 
classified into three major categories based on their typical functions.  Other than the detection of 
cytoskeletal proteins that are known targets of caspases, a significant number of chaperones and 
metabolic enzymes displayed changes in their protein abundance over time as nutrient depletion, waste 
product accumulation and apoptosis occurred over time.  Among these, the simultaneous upregulation 
of seven ER molecular chaperones and foldases strongly suggest that onset of unfolded protein response 
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(UPR), which can be triggered by a variety of cellular and ER stresses.  In addition, the induction of six 
out of the ten glycolytic enzymes and a post-glycolysis metabolic enzyme implies noteworthy changes 
in glucose metabolism.  The potential involvement of UPR and energy metabolism, as well as the 
functions of all identified proteins in CHO cells subjected to stresses caused by natural “aging” in the 
culturing process and the onset of apoptosis are discussed. 
   
Lastly, the implications of the findings of this work and possible future works are mentioned 
and proposed in Chapter 4.  Due to the limited number of CHO protein reference maps available to date, 
the DIGE gels and protein identifications obtained in this study will be an informative addition to the 
current CHO 2D gel database.  Most importantly, as the first system-wide proteomic study of non-
induced apoptosis in mammalian cells, findings from this study will expand current knowledge of 
intracellular changes of cell cultured in bioreactors that have undergone stresses brought by the natural 




Chapter 2. Monitoring CHO Cell Growth and  




During cultivation of mammalian cells, the health and condition of cell cultures need constant 
monitoring.  Cell counting utilizing the Trypan Blue stain provides information on cell growth, cell 
density and viability of the culture.  Meanwhile the presence and progress of apoptosis requires the 
more sensitive and informative flow cytometry (FCM) technique.  Flow cytometry measures cell size, 
cell granularity (denseness of cellular contents) and fluorescent intensity of labelled cells individually.  
By staining cell samples with two fluorescent dyes: fluorescent inhibitor of caspase (FLICA) and 
propidium iodide (PI), cells can be classified into four subpopulations depending on whether they are 
apoptotic and their membrane permeability.  The objective of this study is to examine the composition 
of cultures during prolonged cultivation and monitor their changes inflicted by the death of cells.  
Special attention will be given to the beginning and advancement of apoptotic cell death in cultures 
over time.  Several major time points will be selected for subsequent whole cell quantitative proteome 
analyses based on the culture composition.  Consequently, FCM associates protein samples collected 
from cultures at different phase to the degradation of culture condition and the progression of apoptotic 
cell death.  Other than the detection of apoptosis, FCM can also be used to examine the type of 
apoptotic pathway triggered by measuring the levels of two major initiator caspases, caspase 8 and 







2.2 Materials and Methods  
2.2.1 Cell Culture Maintenance 
 
Chinese hamster ovary cell line IgG-9β8 (Cangene Corp., Mississauga) was cultured in SFX-
CHO medium (Hyclone) supplemented with 1% Fetal Bovine Serum (#16000-077, Invitrogen, 
Burlington) and 4mM L-glutamine.  Cells were grown in a 37ºC, 5% CO2 water jacketed incubator with 
high humidity.  Since CHO cells are naturally adherent cells, frozen cells were revived and grown 
initially into disposable tissue culture flasks (T-flasks) for several passages to allow recovery and 
proliferation.  To reduce damage during passaging, cells were detached from T-flasks with a trypsin-
like enzyme, TrypLE Express (#12605, Invitrogen, Burlington).  Once sufficient density and volume of 
culture were achieved, cells were detached and transferred into 250mL Flat bottom adjustable hanging 
bar spinner flasks (#1967-00250, Bellco Glass, NY) to begin adaption into a suspended culture.  During 
volume expansion, spinner flasks of sizes 500mL (#1967-00500, Bellco, NY) and 1L (#1967-01000, 
Bellco, NY) were required to maintain sufficient culture in a single flask.  All experiments were 
performed with a set of four 500mL spinner flask cultures in a batch culture set up.  Cultures of the 
same experiment were typically seeded from the same “parent’ culture to obtain replicates with less 
variation.  The number of passages taken was maintained low to avoid possible alterations to the cell 
line, even though CHO cell line is immortalized, which theoretically can proliferate indefinitely.  Initial 
seeding concentration in T-flasks was 0.2x10
6
 cells/mL while that in the spinner flasks was 0.25x10
6
 
cells/mL.   
 
In between subculturing, used spinner flasks were first diluted with ultra pure water and 
autoclaved, then soaked and washed in 1% Terg-A-zyme enzyme detergent (Z23287, Sigma, Oakville).  




2.2.2 Culture Viability Assay with Trypan Blue Exclusion Method 
 
Trypan Blue dye penetrates damaged membranes of dead cells providing them a dark blue color 
while leaving live cells unstained [79].  Hence this assay can differentiate between viable and nonviable 
cells and quantify the two populations.  The Trypan Blue assay cannot distinguish between different 
forms of cell death such as necrosis and apoptosis.  This procedure was mainly used to determine 
viability and cell count.  Cell count was performed by mixing equal ratios of Trypan Blue dye with a 
culture sample, then loading the mixture onto a hemacytometer.   After correcting for the dilution factor, 
the cell concentration of the original sample was obtained. Two cell counts, dead (xD) and viable (xV) 
cell densities, were obtained from this assay and they are used to generate the percent viability (%V) 
and total cell density (xT) of the cultures: 
 




 × 100% 
 
2.2.3 Detection of Apoptosis using Flow Cytometry 
 
Experimental Setup and cell sample preparation 
Cultures from the two experiments conducted were prepared and maintained in the same 
fashion.  However, slightly different flow cytometry analyses were performed in each.  For run A, only 
the quantification of executioner proteins, caspase 3 and 7, were completed to detect the presence of 
apoptosis.  In addition to testing the presence and level of apoptosis via activated caspase 3 and 7 
amount, two additional FCM assays focusing on the initiator caspases, caspase 8 and 9, were done in 
run B.  For the detection of caspase 3/7, caspase 8 and caspase 9, the FAM FLICA caspase 3&7 kit 
(ICT094, AbD Serotec, UK), FAM FLICA caspase 8 kit (ICT910, AbD Serotec, UK) and FAM FLICA 
42 
caspase 9 kit (ICT913, AbD Serotec, UK) were used respectively.  Three aliquots of each culture 
sample were collected and each subjected to sample preparation for one of the three caspase assays.   
 
The flow cytometry (FCM) negative controls were collected at 2.5 days after seeding, during 
which time the cells actively proliferated in exponential phase and culture conditions were near optimal.  
Four aliquots of each culture were prepared: unstained, stained with apoptotic reagent only, stained with 
propidium iodide (PI) only and stained with both apoptotic reagent and PI.  These 4 samples were 
necessary for setting the thresholds for subsequent FCM data analyses.  For the remaining time points, 
two aliquots of each culture were collected: unstained and labelled with both apoptotic reagent and PI.   
 
For each caspase assay, 10μL of 30X FLICA reagent was added to 3x10
5
 cells in a 5mL FCM 
round bottom tube for each test.  Cells were incubated for 60 minutes in a 37ºC, 5% CO2 incubator 
where tubes were gently agitated by flicking every 20 minutes to ensure proper distribution of the 
reagent and to minimize settling of cells.  Afterwards, cell mixtures were washed twice with 2mL and 
1mL of 1x wash buffer (provided in the FLICA kit).  In between each wash, cells were pelleted using 5 
minute centrifugation at 1000rpm.   After the last wash, 400μL 1x wash buffer was added to resuspend 
the pellets.  Each desired tube was supplemented with 2μL PI and incubated for at least 5 minutes on 
ice prior to FCM analysis.   
 
The FCM analyses were performed on a Becton Dickinson FACS Vantage SE with a 488nm 
excitation and FL1-H and FL3-H detection filters for measuring FLICA and PI intensities respectively.  
A total of 20000 events (cell counts) were captured in each test.  
 
Data analysis of flow cytometry results 
Dotplots comparing apoptotic reagent (FLICA) intensity to PI intensity and single parameter 
histograms were generated using Windows Multiple Document Interface for Flow Cytometry (WinMDI) 
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v2.9 written by Joseph Trotter (The Scripps Research Institute, San Diego, USA).  Each point on the 
dotplot corresponds to a detected cell particle from the FCM run.  Due to background signals from 
unstained cells, intensity thresholds are set to reduce false positives for each stain.  To set the cut off 
threshold for the x-axis, which corresponds to the intensity of the apoptotic reagent, the maximum x-
axis intensity of day 2.5 cells that were stained only with PI was used.  Conversely, the maximal y-axis 
intensity was set according to the maximum y-axis intensity from day 2.5 cells stained with apoptotic 
reagent only.  To eliminate the effect of outliers, the exact values of the two thresholds were set to at 
least 95
th
 percentile of the background distribution.   
 
2.3 Results 
2.3.1 CHO Cell Growth and Viability during Cultivation 
 
Each culturing experiment consists of four duplicate CHO cultures seeded from the same 
original culture.  Figure 2-1a shows the average viable growth curve, 2-1b shows the average total cell 
density curve and 2-2 shows the average viability trend for two separate experiments, run A and B.  The 
viable and total cell density curves, obtained from Trypan Blue assays, show some variations between 
runs especially during the first 8 days due to better growth rates in run B.  Maximum viable cell 
densities achieved in run A and B were between 1-1.2 x10
6
 and 1.4-1.6 x10
6
 cells/mL respectively.  
Deviations introduced in the culture conditions such as passage number, actual seeded cell 
concentrations and the stresses from the subculturing procedure could influence and affect cell growth.  
For instance, run A and run B were initialized at passage 22 and 27 respectively to ensure sufficient and 
proper adaptation of CHO cells in suspended cultures.  On the other hand, the viability curves were 
fairly consistent between the two runs, suggesting the occurrence of cell death was similar proportion-
wise.  During the time course experiment, CHO cultures exhibited high viability above the 90% range 
until day 8 to 10 when a significant increase in cell death began, which was observed by the sharp drop 




Figure 2-1. Average viable and total cell density curves observed in run A and B based on Trypan 
Blue exclusion assays.  a) Viable cell density; b) total (viable + nonviable) cell density.  Each run 
consisted of 4 replicate CHO cultures, which resulted in one average density curve. Error bars 
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Figure 2-2. Average CHO culture viability throughout run A and B experiments based on Trypan 
Blue assays.  Viability is calculated from the viable and total cell counts.   
 
2.3.2 Detection of Apoptosis in CHO Cells 
 
During the 17 day culturing process, flow cytometry was used to monitor the progress of 
apoptosis and cell death in the spinner flasks.  Both caspase 3 and 7 are executioner caspases 
responsible for many phenotypes observed in cells undergoing apoptosis.  Since their activation and 
activities are common to both intrinsic and extrinsic pathways, FCM analysis of caspase 3 and 7 
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2.3.2.1 Setting Parameter Thresholds  
 
The culture sample taken on day 2.5 was considered as the healthy reference sample or negative 
control, where the amount of apoptosis within culture is expected to be minimal.  Figure 2-3 shows a 
series of dotplot analyses typically done to set the thresholds for the two parameters, namely the 
minimum FLICA intensity which corresponds to the presence of activated caspases 3 and the minimum 
PI intensity which indicates permeable membrane.  For each dotplot, all 20000 events or cells detected 
were plotted.  Day 2.5 culture incubated only with PI (Figure 2-3b) should reveal cells with fairly low 
intensity for FLICA, corresponding to background noises.  It was used to set the appropriate FLICA (x-
axis) cutoff by ensuring most cells have negative readings for activated caspase.  To determine the 
threshold for the PI parameter, day 2.5 culture incubated with only FLICA reagent (Figure 2-3c) was 
examined in a similar fashion.  Negative control from a day 2.5 culture with no dyes added (Figure 2-3a) 
showed background signals for both parameters.  As a result, it was used to check that the correctness 
of the two thresholds and any potential technical problems that might have occurred during FCM 
sample preparation.  For illustration purposes, Figure 2-3d and 2-3e shows the caspase 3 and PI results 
for samples of a single culture collected on day 2.5 and day 9.5 respectively.  An increase in the 
apoptotic dead subpopulation and a decrease in the healthy subpopulation were apparent as time 
progressed.  A separate pair of thresholds was set for each culture following the procedure above.  
Appendix A.2 shows a full set of dotplots for one of the four CHO cultures of run A.  Although the 
thresholds were determined for each CHO culture sample individually, they were comparable between 
the four replicates (see Appendix A.2.2).   
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Figure 2-3. Flow cytometry raw data presented as dotplots for the negative controls and an 
apoptotic culture sample.  Each plot, which corresponds to one FCM test, contains 20000 data points.  
Each dot in the plot represents one cell.  Positive propidium iodide (PI) intensity corresponds to loss of 
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c) Day 2.5 cells with FLICA only d) Day 2.5 cells with 
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LR (lower right) = C3+PI- (early apoptotic) cells 
UR (upper right) = C3+PI+ (late apoptotic) cells 




2.3.2.2 Apoptosis Progression over Time in run A and B 
 
Flow cytometry analyses were conducted repeatedly over the cultivation period in both run A 
and B until the fraction of healthy (live and non-apoptotic) cells dropped below 30% of the culture.  As 
Figure 2-4 demonstrates, the exact timing when cultures in the two experiments reached 30% was 
different.  Figure 2-4a shows the average trend of the four replicate spinner flask cultures in run A 
experiment.  Based on their PI and FLICA intensities, cells were distinguished into C3-PI- (healthy), 
C3+PI- (early apoptotic), C3+PI+ (late apoptotic) and C3-PI+ (primary or secondary necrotic) cells (see 
section 1.3).  From the figure, an obvious decrease in healthy subpopulation could be seen as the culture 
aged.  The healthy cells made up over 70% of the culture until day 9.5 when a sudden decrease in this 
cell type occurred.  A sharp drop of healthy cell population from 70% to 30% happened over a period of 
approximately 2 days.  Consequently, the amount of apoptotic cells which tested positive for activated 
caspase 3 increased over time.  Initially, the abundance of apoptotic cells was gradually increasing and 
cells retained membrane integrity.  The peak amount of the early apoptotic cell population occurred 
between day 5.5 and 8.5 as shown in Figure 2-4a.  However, after day 8.5, the proportion of late 
apoptotic cells (which are no longer viable) exceeded that of the early apoptotic cells.  The total 
apoptotic percentage remained 30% of the total cell count until day 9.5, when the rate of death and/or 
apoptosis went up noticeably as exhibited by the late apoptotic cell population.  During run A, C3-PI+ 
cells, which correspond to primary and secondary necrotic cells (i.e. cells which resembled necrotic 






Figure 2-4. Apoptosis progression in run A and run B based on FCM caspase 3/7 assay, 
represented by percentage.  a) run A; b) run B.  FCM assays were performed for two additional time 
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When the same FCM experiment was repeated in run B, a similar general pattern for the 
progression of apoptosis and cell death was observed (Figure 2-4b) between the two runs.  Nevertheless, 
the exact development of different subpopulations varied slightly between the two experiments.  Two 
additional FCM time points near the end of the culturing process were collected in run B.  Based on 
FCM assays, the decrease in healthy population seemed to be more gradual over time, as opposed to the 
more sudden drop observed in run A.  The decrease of viability from 60% to 20% took about 8 days in 
run B as opposed to the 40% decrease in viability in run A which happened over 2 days.  Similarly the 
increase in the late apoptotic subpopulation was fairly constant and more gradual in run B.  These 
variations between experiments could be contributed by a 1-2 day delay in apoptosis progression such 
that the process was merely prolonged in run B.  Furthermore, instead of increasing suddenly around 
day 5.5 as in run A, the percentage of early apoptotic cells remained constant between 10 to 15% from 
day 4.5 to 8.5 with perhaps a small peak on day 8.5.  Soon after, the early apoptotic cells advanced into 
the late apoptotic phase and were mostly dead by day 10.5.  A more apparent deviation between run A 
and B involves a significant elevation in the amount of C3-PI+ cells within the cultures after day 8.5.  
In run A, minimal percentage (<5%) of the culture fall into this category from day 2.5 until the last 
FCM sampling time point, day 11.5; while in run B, the increase started after day 8.5and continued 
until day 16.5 when the average level of these cells between four culture replicates was 38%.   
 
Instead of comparing percentages, the changes in the four cell subpopulations over time were 
also examined as cell counts (see Figure 2-5).  Comparison between the two representations 
(percentages versus cell densities) did not show any drastic difference in the overall patterns.  The total 
dead cell counts in both runs were plotted and examined as well (see Figure 2-6).  A consistent increase 
in the number of dead cells (caused by either apoptosis or necrosis) in both set of experiments were 
observed, though run A showed slightly slower accumulation of dead cells than run B.  Moreover, 
Figure 2-7 shows an alternative view of the flow cytometry results by comparing between total 
apoptotic cells and the caspase-negative dead cells.  In any case, the general trend of apoptosis 
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progression remained similar between the duplicate batches of experiments, although the exact timing 
and trend observed during cultivation seemed to deviate somewhat.   
 
 
Figure 2-5. Apoptosis progression in run A and run B based on FCM caspase 3/7 assay, 
represented by cell numbers.  This figure uses an alternative representation of subpopulation 
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Figure 2-6. Total cell death as measured by FCM caspase 3/7 assay in run A and B.  Cell death is 
determined by a positive propidium iodide intensity (i.e. C3+PI+ cells plus C3-PI+ cells).  
Abbreviations: C3, caspase 3; PI, propidium iodide 
 
 
Figure 2-7. Comparison between caspase-positive cells to caspase-negative dead cell density as 
determined by FCM caspase 3/7 assay in run A and B.  C3-PI+ cells can be a mix of primary 
necrotic and very late apoptotic cells that have lost its ability to bind FLICA.  Abbreviations: C3, 
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2.3.3 The Apoptotic Pathways Activated in CHO cultures 
 
Flow cytometry assays on the amount of activated caspase 3/7, caspase 8 and caspase 9 were 
performed to monitor and compare the onset of various apoptotic pathways in run B.  Activated caspase 
8 in cells indicate the involvement of extrinsic pathway while activated caspase 9 signals the 
participation of intrinsic (mitochondrial) and possibly ER pathways in triggering apoptosis.  Therefore 
by tracking the activation of these two proteins, more information on the apoptotic pathway initiated in 
this particular CHO culture setting was obtained.  As mentioned previously in 2.3.2.2, caspases 3/7 
results for run B were shown in Figure 2-4b and Figure 2-5.  After the same analyses were done to the 
raw FCM data for both caspase 8 and caspase 9 methods, Figure 2-8 (and Figure A-4 in Appendix A) 
was generated to better examine and compare the results from the three caspase tests.  Figure 2-8a 
shows the percentage of C-PI- cells as determined by the presence of different activated caspases, 
namely caspase 3, caspase 8 and caspase 9.  Although a general decrease in the C-PI- cell population 
was observed regardless which caspase was measured, the proportion of cells with no caspase 9 
activation appeared to be significantly less when compared to that of caspase 3 and caspase 8.  A 
corresponding trend can also be seen in Figure 2-8b which shows the levels of the C+PI- cells.  T-tests 
were done to investigate whether the differences between the three FCM caspases assays are 
statistically significant when used to classify each subpopulation (Table 2-1).  It can be seen that when 
the curves in Figure 2-8 deviate, the corresponding p-values were less than 0.05 indicating statistical 
significance.  The level of cells showing activated caspase 3 and activated caspase 8 did not differ by 
much when examining Figure 2-8, and in most cases it was not statistically different (Table 2-1).   
 
 When looking at the C+PI+ cells (Figure 2-8c), a steady increase in cells having activated 
caspases is seen, regardless of the kind of caspase tested for.  According to t-tests, these C+PI+ cells did 
not exhibit significant differences between the three FCM tests until after day 9.5 or 10.5.  This increase 
in late apoptotic (C+PI+) cells corresponds with the decrease in early apoptotic cells (C+PI-) over time 
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(Figure 2-8b), suggesting that many early apoptotic cells observed in earlier time points (before day 8.5) 
had lost their membrane integrity and became dead as characterized by the PI result.  The rate of 
healthy cells entering the early apoptotic phase appeared to decrease after day 5.5 when most 
transformation occurred as early apoptotic cells entered late apoptotic phase, which could be interpreted 
from the sharp drop in early apoptotic subpopulation after day 8.5.  Lastly, the proportion of primary 
and secondary necrotic cells (C-PI+) in cultures also increased as the cultures grew older.  At the last 
time point near day 16, both caspase 3 and caspase 8 FCM methods showed about 35% of the cultures 
to be dead with no detectable activated caspase signals.   However based on the FCM caspase 9 method, 
only 20% was determined to be caspase-independent dead cells.  This phenomenon could be explained 
by the presence of dead cells with activated caspase 9 the might not be categorized properly when 
testing for caspase 3 or caspase 8.  However, since executioner caspases such as caspase 3 were 
necessary to cause death of apoptotic cells, it is unclear why activated caspase 3 detection did not pick 
up as many apoptotic dead cells as the caspase 9 method towards the end of the culturing process.  
Whether the specific inhibition rate and turnover rate vary between different caspases play a role in this 
observation is to be considered.   
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Figure 2-8. Comparison between cell subpopulations based on three FCM caspases assays of run 
B cultures. a) C-PI-, b) C+PI-, c) C+PI+, d) C-PI+ subpopulations.  Caspase 8 and 9 are pathway-
specific initiator caspases while caspase 3 is the common executioner caspases in different apoptotic 
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Table 2-1. T-test comparison between a subpopulation from three FCM caspase assays.  Each t-
test was performed between FCM percentages from the four replicates measured by two FCM assays.  
A p-value less than 0.05 indicates that the differences between two assays is statistically significant and 
is highlighted in yellow below. Abbreviations: C9, caspase 9; C8, caspase 8; C3, caspase 3; C, caspase; 




C9 vs. C3  
t-test p-value 
C8 vs. C3  
t-test p-value 
C8 vs. C9  
t-test p-value 
2.5 0.09250 0.84540 0.00395 
3.5 0.01245 0.19920 0.00883 
4.5 0.01233 0.30130 0.04448 
5.5 0.00549 0.16570 0.00513 
8.5 0.00074 0.13810 0.00308 
9.5 0.00209 0.97700 0.00393 
10.5 0.06590 0.00577 0.11860 
11.5 0.02082 0.61850 0.00836 
12.5 0.07668 0.09405 0.12310 




C9 vs. C3  
t-test p-value 
C8 vs. C3  
t-test p-value 
C8 vs. C9  
t-test p-value 
2.5 0.11892 0.74915 0.0147 
3.5 0.01199 0.18885 0.00901 
4.5 0.01249 0.38015 0.04106 
5.5 0.00491 0.1337 0.00521 
8.5 0.00086 0.14239 0.00255 
9.5 0.00260 0.26422 0.00345 
10.5 0.07314 0.56857 0.09728 
11.5 0.01276 0.96326 0.01263 
12.5 0.03608 0.72875 0.03285 




C9 vs. C3  
t-test p-value 
C8 vs. C3  
t-test p-value 
C8 vs. C9  
t-test p-value 
2.5 0.84301 0.65571 0.99251 
3.5 0.11532 0.17418 0.26337 
4.5 0.55534 0.24066 0.47834 
5.5 0.84749 0.8892 0.94527 
8.5 0.72803 0.68663 0.34263 
9.5 0.05624 0.00254 0.22956 
10.5 0.00041 0.02896 0.11342 
11.5 0.00820 0.20579 0.02235 
12.5 0.00074 0.04503 0.00981 






C9 vs. C3  
t-test p-value 
C8 vs. C3  
t-test p-value 
C8 vs. C9  
t-test p-value 
2.5 0.78622 0.27757 0.00456 
3.5 0.02872 0.19295 1.00000 
4.5 0.11590 0.95081 0.24364 
5.5 0.06392 0.21031 0.09999 
8.5 0.01431 0.03225 0.41726 
9.5 0.12086 0.88313 0.06305 
10.5 0.00564 0.14498 0.22647 
11.5 0.00805 0.23613 0.03543 
12.5 0.00337 0.12210 0.04310 
16.5 0.01824 0.89993 0.01173 
 
 
2.4 Discussion  
2.4.1 Progression of Apoptosis in CHO Cultures occurs in Several Phases  
 
By measuring the levels of activated executioner caspases (caspase 3 and 7), flow cytometry 
(FCM) assays allowed the progress of apoptosis to be quantified and tracked in both spinner flasks 
culture experiments, run A and B.  In addition, propidium iodide (PI), which detects membrane 
integrity, was added as a cell death differentiation stain.  This bi-color FCM assay allows cells to be 
classified into four subgroups: A) C3-PI- (healthy) cells were negative for caspase activation and intact 
plasma membrane; B) C3+PI- (early apoptotic) cells contained activated executioner caspases while 
still maintained membrane integrity; C) C3+PI+ (late apoptotic) cells had advanced into the stage 
where it could no longer exclude PI stain; D) C3-PI+ (primary and secondary necrotic) cells had no 
intact plasma membrane yet no activated caspases were detected [87].  The C3-PI+ subpopulation could 
include both necrotic and very late apoptotic cells whose caspases were inhibited, lost or degraded 
beyond detection by FLICA [87,92,93].  The detection of activated caspase outside of cells at the end 
stage of apoptosis process has been detected; while the presence of mostly procaspases has been 
secreted from necrotic cells [47,94].  It has been speculated that the elimination of caspase activity 
occurred in apoptotic cells where cleavage of cellular proteins have been completed.   
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Comparison between run A and B 
Between different runs, changes in the health condition of the cultures were generally 
consistent.  Viable healthy cells gradually decreased throughout the culturing period while cells became 
apoptotic and eventually died.  The degree of population-wise apoptosis in CHO-IgG-9β8 culture began 
rising from the initial basal level (<5%) after day 4.5 or 5.5.  Following the increase of live early 
apoptotic cells, which peaked at 15-20% between 5.5-8.5 days, a large and steadily increasing late 
apoptotic cell population began accumulating until the end of culturing process and contributed to 
approximately 50-60% of the culture population.  However, unlike run A, the accumulation of caspase-
negative dead cells in run B was observed soon after day 8.5.  To elucidate this deviation, two questions 
need to be answered: i) which type of cell produces the C3-PI+ signal, and ii) if the lack of C3-PI+ cells 
in run A was due to fewer FCM analyses, meaning the presence of C3-PI+ subpopulation would be seen 
if additional analyses were performed past day 11.5.   
 
If there was indeed very few C3-PI+ cells in run A, it is unlikely that these cells were made up 
of very late apoptotic cells (i.e. secondary necrotic cells).  Since high level of C3+PI+ cells were 
already present in run A by day 10.5, some of these cells should have already advanced into the C3-PI+ 
stage before the last FCM time point.  However it is possible that the observed trend is real if C3-PI+ 
cells were mainly contributed by primary necrosis.  One possible explanation of having primary 
necrotic cells in run B could be the effect of having higher cell densities in the spinner flasks.  The peak 
viable cell density in run B is between 1.4-1.6x10
6
 cells/mL instead of 1-1.2x10
6
 cells/mL as seen in 
run A.  Having a higher cell number in run B implies that less nutrient and resources were available per 
cell, and more waste products and contents of dead cells were released into the medium.  For example, 
elevation of ammonia and lactate, which were known waste products in CHO cultures, has been shown 
to induce necrotic cell death [23].  When cell densities of the four subpopulations were examined 
(Figure 2-5) instead of percentage, it appears clearer that a larger number (larger by 0.2x10
6
 cells) of 
apoptotic cell death occurred in run B before the elevation of C3-PI+ dead cells on day 8.5.  In addition, 
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from Figure 2-6, which displays the total number of cell deaths as measured by FCM, it can be seen that 
run A showed a two-day delay for reaching the same quantity of dead cells than run B.  Because the 
number of apoptotic and possibly necrotic cells increased faster and greater in run B, which had the 
same amount of nutrient and medium to start with, it would be possible that the resource limitation 
caused many dying cells to switch from apoptosis to necrosis instead [102].  The occurrence of necrotic 
cells might also self-amplify and caused more necrosis to take place in run B cultures near the end of 
the cultivation.    
 
On the contrary, this variation might be due to the fact that FCM sampling was stopped earlier 
in run A, thus missing the beginning of the elevation and resulting in the low level of C3-PI+ cells.  In 
this case, C3-PI+ cells cannot be caused by primary necrosis alone.  By day 11.5 which is the last 
sampling time point in run A, only 28% of the culture remained healthy (C3-PI-) and available for 
turning necrotic since the majority of the remaining cultures were already apoptotic.  Besides, in run B 
the accumulation of these caspase-negative cell deaths began as early as day 8.5 when healthy cells still 
dominate the culture at 60%.  These evidence weakened the idea that necrosis has yet to take place.  In 
the alternative case, one could argue that the degradation of apoptotic cells gave rise to most of these 
caspase-negative cell deaths.  Since late apoptotic cells did not accumulate as much nor as fast in run A 
until after day 10.5 (Figure 2-5) when they suddenly increased in numbers, it might be reasoned that the 
conversion from late apoptotic into very late apoptotic cells had not occurred by day 11.5 in run A.  
Since apoptosis was documented to occur within 1-3 hours and FCM analyses were done at least 24 
hours apart, the total apoptotic cell counts plotted in Figure 2-7 might better represent the situation.  As 
the early apoptotic cells counted in one time point could already be in the very late apoptotic stage with 
degraded caspases in the next FCM analysis time point, the total apoptotic cell counts included the 
transformation of cells from early apoptotic to very late apoptotic stage and from late apoptotic to very 
late apoptotic cell stage. 
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General trend of apoptosis progression in culture 
Although the time of apoptosis initiation in an unsynchronized and non-induced culture varied 
considerably, the different phases of apoptosis progression in the culture as a whole could still be 
observed.  From day 0 to day 4.5, the cultures could be considered healthy and viable, where cells 
proliferate normally.  During this period of time, nutrient concentrations were decreasing and waste 
product levels were increasing, both of which are potential triggers for apoptosis.  The deterioration in 
extracellular conditions led to the initiation of apoptosis in cells after day 4.5.  At this time, not many 
apoptotic cells were yet in the state where degradation of proteins and the loss of membrane integrity 
had occurred.  However, between day 4.5 and 8.5, more apoptotic cell death progressed from the early 
stage into the late phase where the plasma membrane became permeable.  From day 8.5 onward, the 
proportion of late apoptotic and caspase-negative dead cells continuously increased and eventually 
accounted for a large portion of the culture. 
 
2.4.2 The Dominant Apoptotic Pathway Triggered in CHO Cultures 
 
Although some cells are likely to undergo apoptosis via the extrinsic pathway as exhibited by 
the activation of caspase 8 in some cells, the dominant trigger for apoptosis seems to be related with 
intracellular cell death stimuli as shown by the steep increase of activated caspase 9 early in the 
culturing process.  As early as 5.5 days after seeding, CHO cultures showed an average of 70% cells 
with active caspase 9 and intact plasma membrane as compared to only less than 15% of the culture 
exhibited active caspase 8 and caspase 3.  The high percentage of live caspase 9 positive cells was 
maintained until day 8.5 where its decrease concurred with the increase of more late apoptotic cells 
with no membrane integrity and some caspase-negative dead cells that could be caused by necrosis or 
the deterioration of late apoptotic cells.  Although death receptor-mediated cell death in some cell lines 
might engage a crosstalk with the mitochondrial pathway, it is more likely that the activation of caspase 
9 in this work corresponds to the onset of mitochondrial and/or ER pathway.  In addition to having an 
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earlier and a significantly larger amount of activation in caspase 9, prolonged cultivation of cell cultures 
are known to encounter nutrient limitation and accumulation of toxic waste products over time, both of 
which are linked to the intrinsic cell death.  Moreover, expression of recombinant protein in cell 
cultures can overload the ER folding system and lead to ER apoptotic cell death.  Therefore, based on 
the known conditions of the CHO cultures in this study, the possibility of a type II extrinsic pathway 
occurring is not very high.  However, as the ER initiator caspase 12 can activate caspase 9, the 
detection of caspase 9 in this study alone is not enough to distinguish which intracellular compartment 
(mitochondria and/or ER) governs the initiation of apoptosis.  Currently, interactions and 
communication between the mitochondria and ER suggest a tight association and extensive crosstalk 
between these two initiation sites [53].  In addition to the interactions between mitochondria and ER via 
calcium ion signalling, apoptosis is also being regulated by many Bcl-2 proteins localized on both 
organelles [103].  The mitochondria and ER are interconnected both physically and physiologically 
[104].  In fact, it remains unclear how distinct the mitochondrial and ER-mediated apoptosis really are.   
 
Ideally apoptotic cells triggered by both active caspase 9 and caspase 8 should converge to the 
activation of caspase 3.  However the average level of late apoptotic cells with active caspase 3 did not 
become dominant as expected towards the end of the culturing process.  It is possible that the consistent 
20% difference between caspase 9 active and caspase 3 active cells beyond day 9.5 was caused by the 
delay in the activation of executioner caspases and the continuous increase in the late apoptotic cells 
triggered by intracellular stimuli that had not yet activated caspase 3.  Alternatively, cells with activated 
caspase 3 are not expected to persist in the cultures for very long, as they will disintegrate.  Because the 
fast progression of apoptosis, apoptotic cells with activated executioner caspases are expected to last 




In agreement with FCM results obtained in this work, a CHO cDNA array study comparing 
mRNA expression over five days done by Wong and colleagues showed an increase in both caspase 8 
and caspase 9 mRNA levels within cells after exponential phase [69].  In Wong’s study, the 
upregulation of caspase 9 mRNA in the batch culture showed a slightly larger fold change than that 
observed for caspase 8, while the increase in caspase 8 mRNA level was much more persistent between 
day 3-5, which span the stationary and death phase of the CHO cell line employed.  From the lack of 
mRNA changes to proteins important to the ER-mediated apoptosis pathway (such as caspase 12 and 
BiP), it was concluded that the ER pathway was not significant in Wong’s study.  Nevertheless, the 
choice of detection technique in systematic studies can be an important factor that influences the 
observed results and their interpretations.  Unlike protein abundance measurement as in FCM or DIGE 
techniques, changes in mRNA cannot be directly translated to changes in protein activities, which in 
many cases are better represented by protein expression.  More detail comparison between results from 
Wong’s transcriptomic study and those of the proteomic analysis from this thesis will be presented in 




Chapter 3. Differentially Expressed Proteins  




 The main objective of proteomic analyses of CHO cultures at various phases of cultivation is to 
study the systemic changes at the protein level over time and to identify important mechanisms related 
to these changes, which are often encountered during protein production in the industrial bioreactors.  
Proteins that vary their expression level during extended cultivation will be examined and identified.  
These may include proteins that are responsive to the degradation of culture conditions such as the 
depletion of nutrients and accumulation of metabolic waste products.  Since cell death, in particular 
apoptosis, greatly influences the longevity and condition of mammalian cell cultures, it was anticipated 
that some changes in apoptotic proteins and apoptosis-modified proteins will be uncovered via a whole 
cell proteomic analysis.  The detection of differentially expressed proteins allow us to capture the 
intracellular responses prior to and when culture conditions become less than desirable.  Moreover, the 
identification of any proteins specific to an apoptotic pathway will shed light on the method of 
apoptosis initiation and reveal possible causes for it during prolonged cultivation in bioreactors.  
Studying the intracellular changes of CHO cells in a time course will broaden our knowledge on the 
behaviours and “natural aging” of cells in bioreactors, thus may contribute to the improvement of 
culturing process for industrial purposes.   
 
Protein samples were collected in run A for subsequent proteomic analyses using differential in 
gel electrophoresis (DIGE) and mass spectrometry (MS).  As a modified version of the traditional 2D 
gel electrophoresis technique, DIGE allows two protein samples to be separated on a single gel.  By 
staining each protein sample with a different fluorescent dyes, protein abundances between samples can 
be compared and analyzed.  Proteins that were either up- or down-regulated at various time points of 
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the cultivation will be distinguished from the whole cell proteome.  Following MS sequencing and 
database searching, identification of these proteins can then be obtained.   
 
In this study, based on the FCM caspase 3 and cell count results, four time points were selected 
for examining altered protein expressions in CHO cells undergoing prolonged cultivation and apoptosis.  
Cell samples from day 2.5 cultures, which were still in the proliferating exponential phase, were used as 
healthy and apoptosis-negative control samples.  Between day 4.5 and day 5.5, the cultures were at the 
end of exponential phase or the beginning of stationary phase.  Day 4.5 was sampled as an early 
stationary phase time point where levels of both early and late apoptotic cells were just starting to 
incline.  Cells collected on day 5.5 were considered as a mid-stationary phase sample where apoptosis 
had already progressed in the cultures to the stage with the peak amount of early apoptotic population.  
Lastly, day 8.5 marked the beginning of the death phase and contained equal ratio of late apoptotic 
(C3+PI+) to early apoptotic (C3+PI-) cells.  To avoid the interference of over-degraded cellular 
contents, protein samples beyond day 8.5 were not considered due to the large proportion of dead cells 
and possibly cellular debris in the whole culture.   
 
3.2 Materials and Methods 
3.2.1 Protein Extraction and Quantification 
 
Cells were harvested by removing an aliquot of 5 to 20mL depending on the cell concentration, 
from the 500mL spinner flasks at various time points during the culturing period.  Cells were washed 
three times with cold 1x phosphate buffered saline (PBS) solution (137mM NaCl, 2.7mM KCl, 10mM 
Na2HPO4, 17.6mM KH2PO4).  During each wash, the PBS-cell mixture was centrifuged at 1000rpm for 
5 minutes to remove the PBS wash buffer.  After the third wash, cell pellets were stored at -80ºC or 
immediately lysed as described below.   
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To extract protein, a lysis buffer containing 7M urea, 2M thiourea, 4% CHAPS (3-[(3-
Cholamidopropyl) dimethylammonio]-1-propanesulphonate) and 50mM Tris, pH 8.0 was used with a 
mammalian cell protease inhibitor cocktail (1μL per 10
6
 cells, P8340, Sigma, Oakville).  To achieve 
consistent protein concentration between 2 to 3 μg/μL, roughly 30-35μL of lysis buffer was used per 
10
6
 cells.  Lysis buffer-cell mixtures were mixed by rotating at 4ºC for 1 hour before the cell debris 
were pelleted by centrifugation for 30 minutes at 14000 rpm at 4ºC.  The protein-containing 
supernatants were then transferred into new Microcentrifuge tubes.   
 
Protein concentrations were measured using Bio-Rad protein assay (Cat. #500-0002, Bio-Rad 
Laboratories Ltd., Mississauga), which is based on the Bradford method [105], immediately after 
extraction following the manufacturer’s microassay procedure.  A linear standard curve was constructed 
with 2, 4, 6 and 8 μg/mL bovine serum albumin (BSA) standards and their corresponding 
spectrophotometer absorbance reading at 595nm.  Triplicates of each protein sample including the BSA 
standards were used to ensure accuracy of the assay.  The protein extracts were then stored at -80°C.   
 
3.2.2 Differential in Gel Electrophoresis  
3.2.2.1 Protein Sample Labelling 
 
Prior to running the Differential In-Gel Electrophoresis (DIGE) experiment, the choice of 
protein samples loaded in each gel and the corresponding CyDyes were chosen to avoid dye bias.  
CyDye 3 and 5 need to be alternatively used for labelling biological duplicates.  Table 3-1 shows the 
protein samples and corresponding CyDye labelling used in this project.  For each gel, 2 protein 
samples and an internal standard, each labelled with a different CyDye DIGE Fluor minimal dye (Cy2: 
#25-8010-82, Cy3: 25-8010-83, Cy5: 25-8010-85, GE Healthcare, Quebec), were loaded.  Fifty 
microgram of each protein component yielded a total of 150μg protein mixture loaded per gel.   
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             Table 3-1. DIGE experimental design 
Gel No. Spinner flask ID Cy3 Cy5 Cy2 
1 1 D2.5 D4.5 internal std 
2 1 D5.5 D2.5 internal std 
3 1 D2.5 D8.5 internal std 
4 2 D2.5 D4.5 internal std 
5 2 D5.5 D2.5 internal std 
6 2 D2.5 D8.5 internal std 
7 3 D4.5 D2.5 internal std 
8 3 D2.5 D5.5 internal std 
9 3 D8.5 D2.5 internal std 
10 4 D4.5 D2.5 internal std 
11 4 D2.5 D5.5 internal std 
12 4 D8.5 D2.5 internal std 
 
The internal standard was prepared by pooling an equal amount of all protein samples that were 
to be analyzed by DIGE.  Having the same protein mixture in the internal standards for all 12 gels made 
subsequent gel image mapping and cross-gel spot matching possible.  After staining each of the three 
protein components with 1μL of 200ρmol/μL CyDye working solution, the light sensitive samples were 
incubated on ice for 30 minutes before 1 μL of 10mM lysine was added to stop further labelling 
reaction.  After another 10 minutes incubation on ice in the dark, all three individually stained protein 
components were combined into one mixture.  Finally, 9μL of 1M dithiothreitol (DTT), 2.25μL of pH 
3-10NL IPG buffer (#17-6000-88, GE Healthcare, Quebec) and sufficient rehydration buffer (7M urea, 
2M thiourea, 4% CHAPS, 0.002% bromophenol blue) were included to obtain a total sample volume of 
450μL for each gel.   
 
3.2.2.2 Gel Strip Rehydration 
 
Combined DIGE protein samples were pipetted evenly into the grooves of the Immobiline 
DryStrip Reswelling Tray (#80-6371-84, GE healthcare, Quebec), which could hold maximum 12 
immobilized pH gradient (IPG) gel strips.  24cm pH 3-10NL Immobiline DryStrip gel strips (#17-6002-
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44, GE Healthcare, Quebec) were warmed at room temperature for 5 minutes and positioned gel side 
down into the reswelling tray.  By gently lifting and sliding the strip over the surface of the sample 
solution with a forceps, the entire strip became coated with the sample.  Once no bubbles remained 
under the strip, the strip was overlaid with roughly 2.5 mL of PlusOne DryStrip Cover fluid (#17-1335-
01, GE Healthcare, Quebec) to prevent evaporation and urea crystallization.  The strips were allowed to 
rehydrate on a level surface in the dark for 12 hours.   
 
3.2.2.3 Isoelectric Focusing 
 
After rehydration, the strips were transferred to and placed gel side up in the manifold ceramic 
tray (#80-6498-57, GE Healthcare, Quebec), which then was covered with 120mL of DryStrip cover 
fluid oil.  Two paper wicks, each wetted with 150μL ultrapure water, were placed partially over the 
ends of each gel strip.  Once all the strips had been positioned and lined up, electrodes were positioned 
on top of the tray, in contact with the paper wicks.  Isoelectric focusing (IEF) was carried out on Ettan 
IPGphor II Isoelectric Focusing Unit (#80-6505-03, GE Healthcare, Quebec) using the following 
protocol with no additional rehydration step:  
Step 1. 500V (1 hr) 
Step 2. Gradient to 1000V (3 hrs) 
Step 3. Gradient to 3000V (3 hrs) 
Step 4. 3000V (2 hrs) 
Step 5. Gradient to 8000V (3 hrs) 
Step 6. 8000V (10:30 hrs)  
Step 7. 500V (24 hrs) 
 
Once step 6 was finished, IEF phase was completed and strips were maintained at 500V for a 
maximum of 24 hours.  Alternatively, each IPG strip could be removed and placed in an equilibration 




3.2.2.4 SDS-PAGE Phase 
 
Gel Casting 
All DIGE non-fluorescent clear glass plates, plastic spacers and gel casters were washed with 
deionized (DI) water prior to usage.  DIGE gel plates were further washed with ultrapure water, rinsed 
with 70% ethanol, and wiped dry with KimWipes.  For each gel, a short and long glass plates were 
aligned and pressed together firmly to form a gel cassette.  The DALTsix gel caster (#80-6485-46, GE 
Healthcare, Quebec) was assembled by alternatively inserting gel plate cassettes and plastic spacers.  
Plastic spacer blocks were used when there were less than 6 gel cassettes.  Spacer sheets were added to 
ensure the height of the plate sets was the same as the edge of the caster.  Fresh 12% acrylamide gel 
solution was made after the gel caster had been assembled.  Enough gel solution was poured slowly into 
the caster until the solution level was about 0.5cm below the edge of the short plate.  To avoid the gel 
surface drying out, 1mL of water was layered carefully in between each plate cassette.  Once the gel 
solidified, the plate cassettes were removed from the caster and the outer surfaces were rinsed with DI 
water to remove any gel residues.  The top surfaces of the gels were layered again with DI water or 2X 
running buffer (50mM Tris base, 384mM glycine, 0.4% SDS).   
 
Equilibration  
Each IPG strip was incubated in 15mL equilibration buffer (6M urea, 50mM Tris-HCl pH 8.8, 
30% glycerol, 2% SDS, 0.002% Bromophenol blue) containing fresh 1% DTT for 30 minutes in the 
dark on a rocking platform, followed by another half hour incubation in equilibration buffer containing 
fresh 2.5% iodoacetamide (IAA). 
 
Electrophoresis 
Each IPG strip was inserted into a gel cassette where it evenly contacted the top edge of the gel.  
After all bubbles trapped between the gel and the strip were removed , the liquid covering the gel 
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surface was decanted and replaced with agarose sealing solution (25mM Tris base, 192mM glycine, 
0.1% SDS, 0.5% agarose, 0.002% bromophenol blue) to immobilize the gel strip.  A maximum of 6 gel 
cassettes were placed into the cassette carrier, and any unused slots were filled with spacer blocks.  The 
upper buffer chamber (UBC) (28-9057-86, GE Healthcare, Quebec) was fitted firmly onto the carrier.  
Prior to electrophoresis, 4.5L of 1x electrophoresis running buffer (25mM Tris base, 192mM glycine, 
0.2% SDS) was cooled to 10°C in the lower buffer chamber (LBC) of the DALTsix Electrophoresis unit 
(#80-6485-08, GE Healthcare, Quebec) using the MultiTemp III Thermostatic Circulator (#18-1102-77, 
GE Healthcare, Quebec).  After the carrier had been positioned in the electrophoresis unit, more 1x 
running buffer was added until the maximum fill line indicator was reached.  The UBC was filled with 
2X running buffer (50mM Tris base, 384mM glycine, 0.4% SDS) until it levelled with the buffer in the 
LBC. Electrophoresis began at 1W per gel for half an hour and continued at 17.5W per gel until the dye 
front reached the bottom of the gels.   
 
3.2.2.5 Gel Visualization, Data Analysis and the Generation of Protein Spot Pick List 
 
Gel cassettes containing DIGE gels were rinsed with DI water and wiped dry.  Using the 
Typhoon 9400 scanner (#63-0055-78, GE Healthcare, Quebec), gels were scanned at a PMT setting of 
600V and 200 micron resolution with 3 different filters: 520 BP40 Cy2, 580 BP30 Cy3 and 670 BP30 
Cy5.   Each gel resulted in 3 different gel images with file extension “.gel”, corresponding to the 3 
CyDye labelled samples.  Using the software Image Quant 5.2 (GE Healthcare, Quebec), all gel images 
were cropped to the same size and loaded into DeCyder v6.0 software (GE Healthcare, Quebec).  Each 
of the 12 gels was subjected to spot detection in the DeCyder Differential In gel Analysis (DIA) module 
with estimated number of spots set to 2000.  Next, spots in all 12 gels were matched to each other in the 
DeCyder Biological Variation Analysis (BVA) module using the “match all” option.  Due to the 
number of protein isoforms, which showed up as horizontal “trains of protein spots,” there were many 
mismatched spots between the images from the 12 gels.  As a result, spot merging and landmark 
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settings were used to improve the quality and accuracy of automatic matching.  Subsequently, t-test 
statistical analyses were performed between day 2.5 to day 4.5 samples, day 2.5 to 5.5 samples, and day 
2.5 to 8.5 samples using the statistical programming language R (see 2.4.5.1 and Appendix A.1).  
Protein samples collected at different time points from the same spinner flask were treated as paired 
data in t-tests.  Lastly, DeCyder’s built in paired ANOVA test was done to examine changes across of 
proteins from all 4 time points.  In addition, p-value results from both t-tests and ANOVA tests were 
converted to false discovery rate (FDR) in R (see 2.4.5.1 and Appendix A.1).  To select proteins of 
interest, an FDR cut-off of 0.1 was used.  The final spot picking list was generated from the combined 
results of the statistical tests.   
 
Data extraction and statistical test analyses using R 
Raw standardized abundance data of all detected spots were extracted from DeCyder software 
after BVA analysis was performed using R scripts (see Appendix A.1).  The DeCyder software 
represented protein abundance fold changes or ratios that were less than 1 by their negative reciprocal, 
meaning a 10 fold down regulation of protein X between 2 samples would be displayed as -10 instead 
of 1/10.  This also indicates that the standardized abundances, which were adjusted based on the 
internal standard of each gel, were presented this way and must be converted back prior to subsequent 
statistical analyses.  Once adjusted and scaled logarithmically, the standardized abundances were 
subjected to paired t-test analysis with unequal variance in R.  For each protein spot, the average ratios 
between replicates, t-test p-values and the corresponding FDR values were calculated using R.   
 
For the one way paired ANOVA test, the post matching BVA file was analyzed without the 





3.2.3 Mass Spectrometry  
 
Protein spots that differed in expression between time points were subsequently excised from 
preparative gels loaded with high amount of protein and trypsin in-gel digestion before finally analyzed 
by the mass spectrometer. 
 
3.2.3.1 Preparative Gels  
 
A high total amount of protein (500, 750 and 1000 μg) containing a mix of all 16 protein 
samples were loaded onto 24cm pH3-10NL IPG strips and 12% polyacrylamide gels to obtain spots 
with sufficient and detectable amount of proteins.  The 2D gel electrophoresis procedure was similar to 
that of the DIGE (see section 3.2.2) with a few modifications.  One major difference was that the inner 
side of the shorter plate must be treated with Bind Silane solution to facilitate binding of the gel piece.  
Gel plates were washed with detergent, water then 70% ethanol.  After drying using KimWipes, 5mL of 
Bind Silane solution (4mL ethanol, 100μL acetic acid, 5μL Bind Silane and 0.9mL DI water) was 
distributed evenly across one side of the plate with KimWipes.  The treated plate was dried for an hour 
in the flow hood before washing with 70% ethanol and final drying.  The gel plate cassette was 
assembled with the treated side facing inward.  Subsequent SDS-PAGE was performed as mentioned 
previously.   
 
After the second dimension SDS-PAGE, the untreated glass plate was removed from the 
cassette.  For each gel, 500mL fresh colloidal Coomassie blue staining solution (10% ammonium 
sulphate, 0.12% Coomassie Blue G-250, 10% phosphoric acid, 20% methanol) was needed to visualize 
protein spots.  After all other ingredients had dissolved, methanol was added slowly drop by drop to 
avoid destroying the Coomassie blue colloids.  The gel piece with the attached plate was immersed and 
incubated in the staining solution overnight at room temperature on a rocking platform.  Subsequent 
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destaining with ultrapure water was done overnight.  The gel piece was scanned at 633nm using the 
Typhoon 9400 scanner with no filter, PMT 600V and a resolution of 100μm.  Spot matching between 
DIGE and preparative gels was done manually.  Excised gel pieces were stored in water at room 
temperature until gel spot picking.  
 
3.2.3.2 MS Sample Preparation: In gel Protein Digestion 
 
To reduce contamination of keratin, all procedures were followed carefully and potential 
sources of contamination minimized.  All equipments including tweezers, scalpel and flow hood were 
cleaned thoroughly with 100% acetonitrile (ACN) and let dry.  All pipette tips and low retention 
Microcentrifuge tubes were rinsed twice with 100% ACN and let dry overnight in a flow hood.   
 
Protein spot excision 
An in-gel digestion protocol was used to create a peptide mixture from each protein spot 
selected from the DIGE experiment.  Each spot was excised using a clean scalpel, cut into 
approximately 1 mm
3
 cubes and transferred into a 0.6mL low retention Microcentrifuge tube.  All the 
following steps required incubating the gel pieces in a reagent while vortexing for a period of time 
before the tubes were centrifuged briefly and the liquid phase removed.  All steps were performed at 
room temperature, unless specified otherwise.   
 
Destaining 
Gel pieces were washed three times for 5 minutes in fresh 100μL ultrapure water.  To remove 
Coomassie blue stains, gel pieces were vortexed for 10 minutes in 100μL of 50mM NH4HCO3 in 50% 




Reduction and Alkylation  
After a 5 minute dehydration step of incubating gel pieces in 100μL of ACN, all excess liquid 
was removed.  Next, 100μL of reduction solution (10mM DTT in 100mM NH4HCO3) was added to the 
dehydrated gel pieces which were incubated for 30 minutes in a 50ºC water bath.  The gel pieces were 
then dehydrated twice in 100μL of ACN for 5 minutes each time at room temperature.  100μL of 55mM 
iodoacetamide in 100mM NH4HCO3 was used to rehydrate and alkylate the gel pieces.  After 30 
minutes of incubation in the dark at room temperature without vortexing, all liquid was removed 
following a brief centrifugation.   The gel pieces were washed with 100μL of 100mM NH4HCO3 for 15 
minutes and dehydrated with ACN for 5 minutes.  Next, the gel pieces were dried for 20 minutes on a 
SpeedVac.   
 
Trypsin digestion 
Sufficient 50mM trypsin in acetic acid was added to fully rehydrate the gel pieces.  Between 2 - 
12μL is typically necessary for each protein spot.  The digest tubes were incubated on ice for 10 
minutes to allow gel pieces to fully absorb the trypsin solution.  To remove excess trypsin, 50μL of 
100mM NH4HCO3 was used to wash the gel pieces for 5 minutes.  After all liquids were removed, a 
fresh aliquot of 50μL 100mM NH4HCO3 was mixed to the digest tube which was then allowed to 
incubate on ice for 5 minutes before transferring to a 37ºC water bath  for a 16-18 hour digestion.  
 
Peptide extraction 
Immediately following the digestion, sample tubes were briefly vortexed and centrifuged.  For 
each digest, a 0.6mL Microcentrifuge tube (collecting tube) was prepared with 5μL of 5% formic acid 
(FA) in 50% ACN prior to peptide collection.  To extract peptides, 50μL of ultrapure water was added 
to the digest mixtures.  After a 2 minute vortexing and a brief centrifugation, the digests were sonicated 
for 10 minutes in a 37ºC heated water bath.  With a 30 second centrifugation at 14000rpm to spin down 
all liquid, the peptide-containing supernatant was transferred to the collecting tube.  Subsequently, 
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75μL of 5% FA in 50% ACN was added to the sample tube, which was then subjected to another 2 
minute vortexing and brief centrifugation.  The second sonication required 5 minutes and was followed 
by another quick 30 second centrifugation before transferring the supernatant to the collecting tube.  
Finally, another fresh aliquot (75μL) of 5% FA in 50% ACN was mixed in with the gel pieces.  The last 
extraction step involves no sonication but just vortexing for 2 minutes and pop-spin centrifugation 
before transferring the supernatant to the collecting tubes.  The peptide samples were completely dried 
in the collecting tubes using the SpeedVac. 
 
ZipTip cleanup 
For MS analysis at the University of Waterloo MS facility, samples were de-salted and cleaned 
up using ZipTip C18 pipette tip (Cat. #ZTC18S096, Millipore).  The dried peptides resulted from 
ZipTip cleanup were resuspended with 10μL of 0.1% FA solution.  Samples analyzed by the Proteomic 
Core facility of the Atlantic Research Center at the Dalhousie University required no ZipTip cleaning 
nor FA resuspension.  To start the ZipTip Cleanup process, a 0.6mL Microcentrifuge elution tube 
containing 5μL of 50% ACN was prepared for each protein sample.  The ZipTip C18 pipette tip was 
wetted at least 3 times with fresh 10μL 50% ACN, then equilibrated at least 3 times with fresh 10μL 
0.1% FA.  All liquids were drawn and expelled carefully into a container without introducing air 
bubbles into the column.  To bind the peptides to the ZipTip, the acidified digests were slowly and 
repeatedly drawn into the tip and expelled back into the collecting tube 10 times.  The ZipTip was then 
washed 2 or 3 times with 10μL 0.1% FA before eluting into the elution tube by drawing the 5μL of 50% 
ACN into the tip and expelling it back to the elution tube 10 times slowly.  At the last ejection, all 
liquids were expelled completely.  To protonate peptides and prevent trypsin autolysis, 1μL of 1% FA 
was immediately added to the eluted peptide sample to achieve a final concentration of 0.2% FA in 
50% ACN.  If the initial estimated protein amount was above 100-150ng, samples was diluted further 
with 5μL of 50% ACN and 1μL of 1% FA. Despite whether ZipTip cleanup was performed, all 
prepared peptide samples were stored in a -20ºC freezer until ready for MS analysis.  
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3.2.3.3 MS Protein Sequencing 
 
The majority of the MS/MS analyses were done using Waters/Micromass Q-Tof Ultima Global 
machine at the University of Waterloo Chemistry department’s MS Facility.  Nano injection, positive 
electrospray ionization (ESI) with Quadruple-Time Of Flight (QTof) detection was used.   
For low abundance protein spots, MS/MS analyses were performed by the Proteomics Core facility at 
the Atlantic Research Center of the Dalhousie University using LC Packings Ultimate and Applied 
Biosystems QTRAP 2000.  Separation of peptide extracts by C18 reverse-phased nano-LC was 
performed before the ESI MS/MS analysis with Quadruple Ion trap (QIT) detection.   
 
3.2.3.4 MS Data Analysis – Identification using PEAKS and MASCOT Tools 
 
Two separate software packages were used for analysis: MASCOT MS/MS Ions Search 
(Matrix Science Inc.) and PEAKS (Bioinformatics Solutions Inc.).  When matching protein 
identification of MS/MS data using MASCOT online, the parameters used were listed in Table 3-2.   
Similar protein identification analyses were also performed using the commercial software, PEAKS 
v2.5 with setting as listed in Table 3-3 below.  Results from both MASCOT and PEAKS methods were 










  Table 3-2. MASCOT parameter setting 
Parameters* Values** 
Database MSDB*** 
Taxonomy All entries 
Enzyme Trypsin 
missed cleavages allowed up to 1 
Fixed modifications Carbamidomethyl (C) 
Variable modifications Oxidation (M) 
Peptide tolerance 0.2 Da for QTof; 0.3 Da for QIT 
MS/MS tolerance 0.1 Da for QTof; 0.3 Da for QIT 
Peptide charges 
+2, +3 for QTof;  
+1, +2 and +3 for QIT 
Data format 
.dta for QTof;  
Mascot generic for QIT 
   * Any unlisted parameters were unset or following the default setting.  
  **  QTof refers to analysis performed with QTof detection. QIT refers to analyses performed    
        by Dalhousie University with the Ion Trap detection  
 *** Initial searches were done with the MSDB database.  Unsuccessful searches were  
       performed again in NCBI (nr) DB and Swiss-Prot DB. 
 
 Table 3-3. PEAKS protein identification and auto de novo options 
Parameters Values** 
Search in database MSDB 
Parent mass error tolerance 0.2 Da for QTof; 0.3 Da for QIT 
Fragment mass error tolerance 0.1 Da for QTof; 0.3 Da for QIT 
Enzyme and PTM Trypsin with Cam 
Instrument 
Quadrupole-TOF for QTof; 
Ion Trap for QIT 
Centroid and deconvolute for 
analysis 
yes 
  * Any unlisted parameters were unset or following the default setting.  
  **  QTof refers to analysis performed with QTof detection. QIT refers to analyses performed    
        by Dalhousie University with the Ion Trap detection  
 
For PEAKS, results were evaluated by percentage where 100% indicates a perfect match 
between the protein ID to the sequence data and 0% indicates no match.  On the other hand, MASCOT 
uses a score based system with no upper bound.  For each MASCOT protein search, the resulting score 
was derived from individual ion p-values and converted into a nonprobablistic based value.  The higher 




Based on repeated flow cytometry analyses throughout CHO cultivation, protein samples for 
four time points during the cultivation of four spinner flask CHO cultures in run A were prepared.  To 
examine the differences at the protein level that may contribute to the onset, progression and effect of 
apoptotic cell death in prolonged cultures on top of the changes brought by the degradation of culture 
conditions over time, protein samples were compared with quantitative 2D gel electrophoresis.  Protein 
extract from cells collected on day 2.5 was used as a healthy control.  Day 4.5 was considered to be in 
the early stationary phase, day 5.5 in the mid-stationary phase and day 8.5 in the early death phase.  
Correlation between various cultivation phases to apoptosis progression was made by flow cytometry 
assays that detect activated caspases in cells.  The levels and stages of apoptotic cell deaths in cultures 
were shown to be increasing with time.  Since apoptosis in individual cell from initiation to death 
progressed within hours, proteomic analysis of culture examines the changes population-wise.  In this 
study, three DIGE comparisons were done per culture, resulting in a total of 12 gels.  By detecting and 
quantifying abundance of the protein spots resolved on each gel, protein expression changes between 
time points could be visualized.  The four CHO culture replicates allow the significance of these 
observed changes to be validated by statistical tests.  Based on statistics, a list of potential differentially 
expressed protein spots was generated.  After screening to remove non-protein spots and ones with low 
fold change or abundance, the resulting subset of spots was then subjected to identification by mass 
spectrometry.  The results are presented below.      
 
3.3.1 Spot Detection in DIGE Images 
 
Figure 3-1 shows a typical DIGE gel image displaying Cy3 and Cy5 channels.  Spots in 2D gel 
images correspond to proteins of a particular molecular weight and isoelectric point.  When viewing 
with Image Quant TL, protein spots stained with CyDye 3 showed up green while ones dyed with 
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CyDye 5 were red.  Relative quantities of proteins are measured by fluorescence using a scanner laser, 
and can be observed to a degree by the colors seen in the overlapped images.  When the 2 protein 
samples contained roughly equal amount of a protein, the corresponding spot on the gel is yellow.  If a 
protein was more abundant in one sample, then the color of that spot would be more red or green 
depending on the dye used in the dominant sample.  As expected for most proteomic analyses, the 
majority of the spots in all 12 gels were yellow, indicating no large differences in abundance.   
 
 
Figure 3-1. A sample DIGE gel image showing day 2.5 and day 4.5 protein extracts from one 
spinner flask of run A.  Isoelectric focusing, which separates proteins by charge horizontally across a 
gel strip, was conducted over a nonlinear range from pH 3 to pH 10.  Subsequent SDS-PAGE, which 
separates proteins by mass, was performed.  Day 2.5 was stained with Cy3 (green) and day 4.5 proteins 
were stained with Cy5 (red).   
pH 3                     pH 10 
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Following the initial visual inspection in Image Quant TL, gel images were processed via 
Differential In Gel Analysis (DIA) in the DeCyder software.  Table 3-4 showed the number of protein 
spots detected in each of the 12 gels.  For comparison of spots between gels, spots detected in these 12 
DIA were then matched against each other using the DeCyder 2D Software Biological Variation 
Analysis (BVA).  Final numbers of matched spots across gels were also shown in Table 3-4 below.  By 
default, the gel with the most number of spots detected was considered as the master image for BVA 
matching.   
 
       Table 3-4. Number of spots detected and matched in all 12 DIGE gels 
Gel number Protein samples Number of spots detected 
Number of spots matched 
across 12 gels 
1 SP1 D2.5 vs. D4.5 1711 1210 
2 SP1 D2.5 vs. D5.5 1814 1281 
3 SP1 D2.5 vs. D8.5 1903 1287 
4 SP2 D2.5 vs. D4.5 1925 1252 
5 SP2 D2.5 vs. D5.5 1890 1278 
6 SP2 D2.5 vs. D8.5 1727 1180 
7 SP3 D2.5 vs. D4.5 1860 1387 
8 SP3 D2.5 vs. D5.5 1866 1417 
9 SP3 D2.5 vs. D8.5 1815 1360 
10* SP4 D2.5 vs. D4.5 1924 1924 
11 SP4 D2.5 vs. D5.5 1812 1351 
12 SP4 D2.5 vs. D8.5 1807 1345 
* Gel 10 was the master gel for cross-gel matching 
 
3.3.2 Generation of Candidate Protein Spot List using T-test and ANOVA 
 
As the biological relevance of small fold changes is difficult to interpret, a common practice in 
DIGE analysis is to establish both a statistical threshold and a fold change threshold, both which have to 
be passed in order for a spot to be considered differentially expressed.  Since it was expected that some 
biologically relevant changes might have subtle fold changes, to avoid filtering out proteins that were 
regulated slightly in response to the changes occurring in cultures as cells aged and became apoptotic, 
only a fixed FDR threshold was used to determine potential proteins of interest.  For each statistical test, 
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an FDR cutoff of 0.1 or 10% was applied for the initial compilation of a list of differentially expressed 
proteins from samples collected at different time points.  The size of the un-screened list from all three 
t-tests and ANOVA are listed in Table 3-5.  Manual screening of the t-test lists was done to eliminate 
non-protein spots such as dust, spots with fold change less than 1.1, and spots with very low abundance 
that were unlikely to be identified successfully by mass spectrometry (Table 3-5).  Between day 2.5 and 
day 4.5, only two proteins changed their expression level significantly.  From day 2.5 to day 5.5, 
significantly different abundance was detected for eight protein spots.  Between day 2.5 and day 8.5, 59 
proteins had varied expression.  As expected, the number of differentially expressed proteins increased 
as the culture aged and had a greater proportion of apoptotic cells.  The total number of unique 
differentially expressed protein spots, based on t-test scores, was 62 proteins (see Figure 3-2a).  
  
Table 3-5. Number of differentially expressed proteins obtained from t-tests and ANOVA 
Statistical test 
Number of differentially 
expressed proteins based 
on FDR cutoff only 
Number of differentially 
expressed proteins after 




t-test: day 2.5 vs. 4.5 3 2 2/0/0 
t-test: day 2.5 vs. 5.5 15 8 8/0/0 
t-test: day 2.5 vs. 8.5 183 59 33/26/0 
ANOVA 281 66 41/23/2 
* When comparing the changes across all 4 time points in ANOVA test, a few spots did not show 




Figure 3-2. The number of differentially expressed proteins from T-test and ANOVA. 
 
On the other hand, manual screening of the ANOVA list focused mostly on the consistency in 
fold change direction between time points and also whether the spot had very low protein abundance.  
After screening, the ANOVA test yielded 66 potential candidates from the original 281 spots.   
 
More than 70% of the protein spots were in common between the two lists (see Figure 3-2b), 
leading to 79 unique spots when combined.  The close agreement between the different statistical tests 
further supported the selected spots as potential candidate for subsequent mass spectrometry analyses.  
Since not all combinations of paired t-tests possible were calculated, it is expected that ANOVA would 
identified additional protein spots that were not selected based on the three t-tests performed.   
 
Figure 3-3 shows a single channel DIGE gel image displaying all 79 selected protein spots.  
Borders of each selected spot were highlighted in purple and labelled by the spot ID number.  Borders 
of remaining protein spots detected were outlined in grey.  Table 3-6 displays all 79 protein spots and 
their corresponding average ratios and FDR values from the statistical tests.  A fairly consistent 
a) T-tests              
Total unique spots: 62 
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direction of fold changes from day 2.5 to day 4.5, day 5.5 then day 8.5 was observed for 76 out of 79 
protein spots (see Table 3-6).  Since the fold changes were calculated from standardized abundances, 
which were adjusted by the internal standard abundances on each gel, the absolute fold change values 
should be comparable directly between the three ratios.  In general, many spots showed uni-directional 
changes to abundances through time, which were seen by the systematic increasing or decreasing in the 
three fold change ratios (see Appendix B, Figure B-1, Figure B-2, Figure B-3 and Figure B-4).  From 
the 79 candidate protein spots selected, 32 (40.5%) were continuously up regulated from day 2.5 until 
day 8.5, 44 (55.7%) were down regulated within this time period; while the remaining 3 (3.8%) showed 





Figure 3-3. Protein spots selected using DeCyder BVA software. Differentially expressed proteins 
were outlined in purple labelled with spot ID while remaining spots highlighted in grey.  Rough 




































































































Table 3-6. T-tests and ANOVA statistics of the 79 differentially expressed protein spots  

























157 1.346 6.72E-03 0.232 1.585 7.88E-03 0.174 1.806 1.78E-02 0.122 1.40E-05 5.13E-04 
256 -1.174 1.79E-02 0.297 -1.472 1.73E-01 0.475 -1.437 3.06E-04 0.030 2.50E-02 9.32E-02 
257 -1.196 1.74E-02 0.297 -1.289 5.37E-02 0.310 -1.452 1.86E-04 0.026 1.10E-03 1.27E-02 
259 -1.150 1.41E-01 0.527 -1.363 3.68E-02 0.261 -1.310 1.31E-03 0.055 2.10E-03 2.07E-02 
304 1.418 2.70E-03 0.169 1.486 1.67E-02 0.217 2.649 6.57E-05 0.024 3.70E-08 9.48E-06 
340 1.201 2.02E-01 0.584 -1.035 5.88E-01 0.809 1.820 2.25E-02 0.138 1.30E-02 6.29E-02 
372 -1.131 1.42E-02 0.277 -1.239 2.23E-02 0.229 -1.312 3.93E-03 0.073 3.90E-03 3.05E-02 
482 -1.127 6.16E-02 0.420 -1.153 4.66E-02 0.296 -1.175 5.89E-04 0.040 1.20E-02 6.06E-02 
486 -1.143 2.29E-02 0.316 -1.214 1.95E-02 0.217 -1.205 3.23E-02 0.161 2.90E-03 2.56E-02 
620 1.407 6.70E-02 0.436 1.368 2.25E-01 0.534 2.210 1.29E-02 0.103 1.90E-02 7.73E-02 
625 1.400 3.82E-03 0.192 1.539 1.54E-03 0.108 2.252 1.06E-04 0.024 1.10E-07 1.54E-05 
630 1.417 1.85E-02 0.297 1.519 3.39E-02 0.260 2.365 2.51E-03 0.066 7.60E-05 1.73E-03 
632 1.424 1.45E-03 0.165 1.527 2.07E-02 0.220 2.402 8.42E-04 0.046 3.30E-06 1.88E-04 
637 1.411 2.88E-02 0.336 1.538 9.20E-04 0.099 2.327 1.24E-04 0.024 8.20E-08 1.40E-05 
641 -1.256 8.25E-02 0.467 -1.245 1.26E-02 0.206 -1.398 3.86E-03 0.073 3.90E-04 6.25E-03 
642 -1.100 2.35E-01 0.617 -1.276 5.25E-03 0.165 -1.318 4.15E-03 0.073 5.50E-03 3.73E-02 
643 -1.089 1.94E-01 0.574 -1.126 1.16E-02 0.206 -1.290 1.11E-03 0.051 1.40E-02 6.52E-02 
646 -1.289 2.91E-02 0.336 -1.177 2.19E-02 0.228 -1.385 2.21E-02 0.136 6.10E-03 3.96E-02 
647 -1.106 8.98E-02 0.478 -1.151 3.18E-02 0.260 -1.287 7.93E-03 0.089 1.40E-04 2.81E-03 
648 1.333 6.86E-02 0.443 1.415 1.66E-01 0.467 1.915 2.39E-04 0.027 1.00E-03 1.21E-02 
653 1.395 6.27E-02 0.423 1.452 2.77E-03 0.133 2.205 5.10E-05 0.024 4.30E-06 2.10E-04 
654 1.245 5.39E-02 0.403 1.408 3.06E-02 0.260 1.505 2.81E-03 0.066 3.60E-03 2.93E-02 
666 -1.164 2.30E-01 0.615 -1.150 1.89E-01 0.494 -1.213 2.92E-03 0.066 8.70E-02 2.13E-01 
667 -1.133 3.80E-01 0.728 -1.184 1.37E-02 0.211 -1.219 5.99E-03 0.083 2.60E-02 9.55E-02 
687 -1.085 4.38E-01 0.758 -1.316 4.07E-02 0.279 -1.401 2.27E-02 0.138 2.50E-03 2.29E-02 
728 -1.012 6.48E-01 0.862 -1.119 7.67E-02 0.360 -1.119 7.67E-02 0.253 1.90E-02 7.73E-02 
764 1.342 2.32E-03 0.169 1.495 2.54E-04 0.090 2.079 1.98E-04 0.026 1.90E-08 6.49E-06 
765 1.372 8.85E-03 0.241 1.538 2.02E-03 0.121 2.164 1.22E-04 0.024 3.00E-07 3.42E-05 
766 1.359 1.15E-02 0.263 1.497 7.09E-03 0.170 2.148 5.75E-04 0.040 3.00E-06 1.88E-04 
770 1.294 7.82E-03 0.233 1.457 1.98E-02 0.217 1.971 1.42E-03 0.055 2.60E-05 8.08E-04 
771 1.341 3.11E-03 0.182 1.512 3.43E-03 0.142 2.096 8.85E-04 0.046 9.80E-07 7.73E-05 
779 1.137 1.38E-01 0.527 1.236 4.39E-02 0.292 1.090 3.89E-01 0.606 1.30E-02 6.29E-02 
808 -1.091 2.71E-01 0.643 -1.174 2.24E-01 0.533 -1.344 1.43E-03 0.055 1.20E-02 6.06E-02 
835 1.399 6.90E-03 0.232 1.449 7.07E-04 0.099 1.402 5.84E-03 0.083 2.80E-05 8.20E-04 
836 -1.110 3.47E-01 0.712 -1.202 1.47E-01 0.446 -1.410 5.44E-03 0.083 2.00E-02 8.04E-02 
842 -1.118 1.67E-01 0.553 -1.217 3.62E-02 0.260 -1.455 6.22E-04 0.040 2.70E-04 4.77E-03 
852 -1.116 7.28E-02 0.443 -1.224 1.41E-02 0.215 -1.469 8.08E-04 0.046 3.20E-06 1.88E-04 
858 -1.101 1.73E-01 0.558 -1.226 5.68E-02 0.314 -1.470 2.99E-03 0.066 1.10E-04 2.30E-03 
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859 -1.084 4.00E-01 0.740 -1.244 1.42E-01 0.441 -1.472 1.42E-02 0.107 4.00E-03 3.11E-02 
876 -1.110 2.37E-01 0.619 -1.163 5.06E-02 0.302 -1.190 7.22E-03 0.087 8.20E-02 2.09E-01 
886 1.495 1.89E-03 0.169 1.725 2.03E-03 0.121 1.829 4.12E-03 0.073 4.80E-08 9.84E-06 
888 1.428 5.77E-04 0.124 1.775 2.84E-04 0.090 1.706 6.74E-03 0.086 1.30E-05 4.94E-04 
905 1.080 1.02E-01 0.489 1.079 2.43E-01 0.547 1.103 7.19E-03 0.087 1.80E-01 3.32E-01 
924 1.356 1.86E-02 0.297 1.460 5.56E-03 0.165 1.447 1.12E-02 0.098 7.60E-05 1.73E-03 
943 1.337 1.74E-02 0.297 1.507 2.34E-03 0.130 1.466 4.96E-02 0.199 2.50E-03 2.29E-02 
979 1.202 6.40E-03 0.232 1.575 4.13E-02 0.280 1.484 2.55E-02 0.146 1.70E-03 1.82E-02 
1042 1.188 4.14E-02 0.371 1.322 3.04E-02 0.260 1.258 7.39E-02 0.249 3.90E-03 3.05E-02 
1094 1.216 3.48E-02 0.359 1.309 2.19E-02 0.228 1.141 1.63E-01 0.378 2.10E-03 2.07E-02 
1096 1.187 1.05E-01 0.489 1.292 2.45E-02 0.234 1.201 1.16E-01 0.313 1.40E-02 6.52E-02 
1141 1.226 5.64E-03 0.225 1.548 1.04E-02 0.202 1.565 2.99E-03 0.066 3.60E-04 5.95E-03 
1161 1.185 3.27E-02 0.349 1.520 5.23E-02 0.304 1.594 2.84E-03 0.066 2.50E-03 2.29E-02 
1165 -1.190 5.00E-05 0.029 -1.124 3.21E-01 0.619 -1.383 8.44E-03 0.089 4.90E-02 1.47E-01 
1250 -1.160 9.21E-03 0.241 -1.204 3.80E-03 0.152 -1.648 1.13E-03 0.051 3.50E-07 3.59E-05 
1254 -1.133 9.46E-02 0.483 -1.133 1.09E-01 0.400 -1.737 3.31E-03 0.069 5.20E-05 1.30E-03 
1266 -1.013 8.59E-01 0.945 1.213 4.26E-04 0.098 1.242 3.92E-02 0.174 7.90E-03 4.68E-02 
1311 -1.187 2.68E-03 0.169 -1.164 4.63E-03 0.162 -1.185 1.05E-03 0.050 7.50E-03 4.55E-02 
1339 1.340 1.12E-02 0.263 1.524 1.92E-02 0.217 1.567 1.08E-02 0.095 5.00E-04 7.22E-03 
1347 1.405 5.00E-04 0.124 1.573 9.24E-04 0.099 1.573 1.50E-02 0.111 6.30E-06 2.94E-04 
1348 1.238 4.36E-03 0.201 1.476 1.52E-02 0.216 1.438 7.48E-03 0.087 1.50E-04 2.96E-03 
1364 1.252 7.74E-03 0.233 1.437 1.71E-02 0.217 1.476 5.94E-03 0.083 6.50E-05 1.55E-03 
1367 1.393 1.71E-02 0.297 1.747 5.24E-03 0.165 1.851 5.49E-03 0.083 4.20E-06 2.10E-04 
1369 1.554 3.32E-03 0.188 1.932 1.17E-03 0.103 2.054 2.56E-03 0.066 5.20E-07 4.85E-05 
1376 1.450 2.04E-03 0.169 1.844 6.48E-04 0.099 1.950 2.61E-03 0.066 2.20E-06 1.50E-04 
1382 1.358 8.84E-03 0.241 1.863 3.39E-03 0.142 2.085 3.55E-03 0.070 7.00E-07 5.98E-05 
1398 -1.504 6.05E-02 0.418 -1.526 1.72E-01 0.475 -2.040 6.04E-03 0.083 N/A N/A 
1478 1.087 2.77E-01 0.649 1.282 1.23E-01 0.417 1.306 1.43E-01 0.352 1.40E-02 6.52E-02 
1667 -1.252 2.47E-02 0.321 -1.324 1.15E-03 0.103 -1.410 6.45E-04 0.040 7.80E-06 3.48E-04 
1670 -1.361 9.03E-03 0.241 -1.312 5.86E-03 0.165 -1.733 4.13E-03 0.073 6.90E-04 9.07E-03 
1675 -1.198 1.77E-01 0.566 -1.319 1.52E-03 0.108 -1.469 3.54E-03 0.070 2.10E-05 6.73E-04 
1722 -1.094 5.61E-02 0.412 -1.010 6.93E-01 0.868 -1.160 4.58E-04 0.040 4.30E-03 3.20E-02 
1756 1.021 6.98E-01 0.890 1.221 3.42E-03 0.142 1.229 1.23E-04 0.024 2.00E-03 2.05E-02 
1842 1.034 3.66E-01 0.724 1.135 2.67E-03 0.133 -1.081 1.03E-02 0.093 7.90E-04 1.00E-02 
1917 1.411 9.36E-02 0.483 1.442 5.48E-02 0.311 3.168 1.92E-03 0.057 2.40E-04 4.39E-03 
1918 1.433 2.09E-02 0.314 1.640 1.38E-02 0.211 3.108 8.47E-04 0.046 1.20E-07 1.54E-05 
1919 1.446 4.30E-06 0.008 1.568 1.43E-04 0.090 1.930 1.73E-04 0.026 2.30E-10 2.36E-07 
1920 1.428 1.14E-03 0.165 1.566 1.21E-03 0.103 2.549 2.75E-04 0.029 1.30E-08 6.49E-06 
1921 1.445 8.94E-03 0.241 1.592 3.26E-03 0.142 1.491 8.71E-03 0.089 1.10E-05 4.70E-04 
1922 -1.071 7.96E-02 0.461 -1.073 9.82E-02 0.385 -1.146 3.23E-03 0.068 2.00E-04 3.80E-03 
1923 1.191 6.01E-02 0.417 1.361 1.34E-02 0.211 1.269 3.32E-02 0.163 1.00E-03 1.21E-02 
Note: yellow highlighted FDR values fall below the 0.1 cutoff while the boldface values indicated spots 
were selected based on that particular statistical test after manual screening. 
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3.3.3 Identified Proteins of Interest  
 
Multiple preparative gels containing a mixture of all 16 protein samples were run for spot 
picking and protein identification.  Figure 3-4 shows a typical preparative gel obtained.  Manual 
matching between spots from the DIGE gels to spots on the preparative gels were performed based on 
relative disposition of landmarking protein spots.  Due to the difference in Coomassie and CyDye 
staining sensitivities, not all 79 spots selected from the BVA analysis could be picked from the 
preparative gel for subsequent mass spectrometry identification.  As a consequence, several preparative 
gels loaded with 500-1000μg of total proteins were prepared to improve the total number of spots 
available to be picked.   
 
Figure 3-4. A sample preparative gel loaded with 1mg of protein mixture containing all 16 
samples, and stained with Coomassie Blue. 
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Using ESI MS/MS and LC-MS/MS, identification from a total of 40 spots were obtained (Table 
3-7 and Figure 3-5). Out of these, only 28 identifications were unique and three spots were each 
matched to two distinct identifications.  From the original 79 protein spots, 32 spots were not subjected 
to MS analyses due to low abundance or slight differences in migration pattern.  Nevertheless, the 
differentially expressed proteins identified could be classified into four broad categories: cytoskeletal, 
chaperone-related, glycolytic, and others.  All cytoskeletal proteins identified, vimentin/α-tubulin, β-
tubulin and actin, were down regulated.  A significant proportion of protein spots were of chaperones 
(18 out of 40) and glycolytic (10 out of 40) proteins.  The molecular chaperones include calreticulin, 
ERp60, PDI, PDIA6, BiP, GRP94, GRP170, HSC70, HSP90β and FKBP52.  Except HSC70, HSP90β 
and FKBP52, all the chaperone proteins were up-regulated.  The glycolytic proteins: triosephosphate 
isomerase, phosphoglycerate mutase, pyruvate kinase isozyme M1/M2, phosphoglycerate kinase 1, 
glyceraldehyde-3-phosphate dehydrogenase, enolase-1 and lactate dehydrogenase chain A/C all 
increased their abundance over time during the cultivation period.  Lastly, various other proteins were 
identified to be 14-3-3 protein epsilon isoform transcript variant 1, galectin-1, peroxiredoxin-6, laminin 
receptor, 80K-H, galectin-3 and ATP synthase beta. 
  
Although the presence of apoptosis within the CHO culture was clearly indicated by flow 
cytometry results, not all changes brought by apoptosis were reflected explicitly by proteomic analysis.  
This can most likely be attributed to the fact that apoptosis was controlled both at transcriptional and 
post-translational levels [106] in addition to the degree of changes necessary to inflict apoptotic cell 
death.  Many of the apoptotic proteins involved were expected to maintain their expression level and 
function via mechanisms such as localization, association with other proteins and post-translational 
modification.  Since apoptosis requires a quick response and usually takes no longer than a few hours, 
post-translational modification seems more sensible and logical in many cases.  With this said, one 
should expect to observe any protein modification brought by the execution of apoptosis such as the 
cleavage of pro-caspases into their active forms, which have different MW and pI values than their 
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precursors.  However, not all desired results, including the cleavage of caspases, were obtained from the 
DIGE and MS experiment.    
 
On a side note, the absence of the anti-RhD MAb produced by the CHO IgG-9β8 cells was not 
among the list of differentially expressed proteins detected by DIGE.  Since this MAb was being 
secreted outside of cells, it is expected that only a small amount (that had yet to be secreted) would be 
present in the protein sample after the extraction procedure, which removes culture medium.    
 
Table 3-7. Protein identification from mass spectrometry analysis (See Appendix B, Table B-1 for 
full MS results)   
 


























93.8 BAD74030 5 60 P02544 3 
α-tubulin  n/a 74 Q3TIZ0 2 
β-tubulin 
1,2,3




-1.41 836 98.3 P83751 6 194 Q3UGS0 5 
-1.46 842 95.9 P20359 6 177 O35247 5 
-1.47 852 99.7 O76784 9 203 O35247 7 
-1.47 858 99.9 P60712 9 334 O35247 8 




































3.17 1917  93.1 Q8K3H7 8 131 Q8K3H7 5 




2.25 625 95 Q91Z81 8 110 Q91Z81 5 
2.37 630 85 P11598 5 72 P27773 3 
2.40 632 92.4 Q91Z81 5 85 Q91Z81 4 
2.33 637 83 P11598 4 65 P27773 3 
2.21 653 66.7 Q91Z81 3 n/a 
PDI  
1,2,3
 1.93 1919 94.2 P05307 4 126 P05307 4 
PDIA6 
2.08 764  97.3 P38660 6 222 P38660 5 
2.15 766 89.1 P38660 4 96 P38660 3 
1.97 770 88.3 P38660 5 131 P38660 4 
2.10 771 95.8 P38660 6 88 P38660 2 
BiP  
1,2,3
 2.55 1920 99.8 P07823 11 205 P06761 5 
GRP94  
2,3
 2.65 304 99.6 Q3UBU0 7 210 Q3UBU0 4 
GRP170 
2
 1.81 157 92.8 Q9JKR6 11 262 Q9JKR6 8 
HSC70 
2,3
 -1.18 482  73.3 Q53HF2 10 234 P19120 5 
HSP90β 
3
 -1.31 372 n/a 53 P34058 6 
FKBP52  -1.29 643 n/a 168 P27124 3 
 


























2.05 1369 98.6 Q53HE2 16 153 P00939 2 
1.95 1376 84.4 P00939 6 121 P00939 3 
Phosphoglycerate 
mutase1  
















1.26  1042 65.5 P00355 5 225 P17244 5 
1.27 1923 98.3 P00355 7 218 P17244 5 
Enolase-1 
1,2,3






1.14 1094 77.1 P07864 2 149 P00340 2 




























14-3-3 epsilon  -1.15 1922 72.2 Q1HPT4 3 213 Q4VJB6 3 
Galectin-1 
2,3





 49.2 O35244 3 63 O08709 3 
Laminin receptor 1 
1
  -1.19 876 78.5 P08865 3 165 P26452 3 
80K-H  1.82* 340 49.5 Q3U518 2 101 P14314 2 
Galectin-3 
1
 -1.65 1250 33 P08699 1(+3) n/a 
ATP synthase beta 
1,3
 -1.12 728  52.8 P46561 2 77 P00829 2 
 
Mascot reported two different proteins from a single MS analysis.  The two sets of matched peptides had no 
overlap.  PEAKS matches to only one identification.   
The top hit matches to a Hsc70 fragment thus the mass is much less than 70kDa.  This record was still an 
unreviewed UniProtKB entry.   
 TPI and Prx6 were identified when analyzing spot 1376 on two gels.   
* Abundance across 4 time points did not increase or decrease in the same direction throughout. See Table 3-6 
for all 3 fold changes.  Appendix B Figure B-1 also displayed the changes in abundance for all replicate cultures. 
 
Note: The accession numbers reported are the most current version in UniProt.  Some PEAKS and MASCOT 
matching resulted in protein records that are obsolete due to various reasons such as deletion and 
record/database merging.   
 
Protein identification, spot pattern and location were cross referenced with the following CHO 2D reference 
maps: 
1. CHO-K1 cells in Ham’s F12 medium, 10% FBS [107] 
2. Derivatives of CHO DUKX cells in serum-free DMEM/F-12 based medium with protein hydrolysate and a 
nutrient mixture [108] 






Figure 3-5. MS identified differentially expressed protein spots from the comparison of healthy 
(day 2.5) to aging/apoptotic (day 4.5, 5.5 and 8.5) CHO protein samples.  Red protein ID indicates 
upregulation occurred over time while blue indicates a reduction in expression.  Estimates of molecular 
weight and pI were obtained from the protein identifications.  Abbreviations: ATPB, ATP synthase beta subunit; 
BiP, Binding immunoglobulin protein; ERp60, Endoplasmic reticulum protein 60kDa; FKBP52, FK506-binding protein 52; 
GAPDH, glyceraldehydes-3-phosphate dehydrogenase; GRP, glucose-regulated protein; HSC70, Heat shock cognate protein 
70kDa; HSP, heat shock protein; LAMR1, laminin receptor 1; LDH, L-lactate dehydrogenase chain; PDI, protein disulfide 
isomerase; PGM, phosphoglycerate mutase; PGK, phosphoglycerate kinase 1; PK, pyruvate kinase isozyme M1/M2; Prx6, 








































































































Results from run A proteomic analysis shown a wide variety of proteins whose abundances 
changed after the onset of apoptosis.  However, as mentioned, the majority of the differential expressed 
proteins were not restricted to only apoptotic mechanisms nor did they provide pathway specific 
information.  As a result, run B was subjected to more extensive FCM assays, which measured initiator 
caspases 8 and 9 on top of the caspase 3/7 test (see Section 2).  It appears that the under non-induced 
and un-manipulated culturing conditions, prolonging cultivation period mainly triggers CHO cell death 




Of the 79 protein spots determined to have altered expression from the DIGE experiments, 40 
protein spots were isolated and identified, providing 28 unique protein identifications.  Since several 
proteins including PDIA6 and actin have many isoforms within the cells, the actual number of unique 
proteins present was less than the number of protein spots.  The existence of these isoforms could easily 
be noticed from 2D gels as a series of horizontal “trains” of spots, which have similar mass but varying 
pI.  In addition to the presence of isoforms, many of the spots had intensities below the workable or 
detectable limit either during excision from the preparative gel or mass spectrometry analyses.  The 
differentially expressed proteins sequenced successfully were categorized into four main groups based 
on their most known cellular functionalities: cytoskeletal, chaperone-related, glycolytic and others.  The 
changes in their abundance caused by the degradation of culture conditions and/or the onset of 
apoptotic cell death during prolonged cultivation are discussed in the following subsections.   
 
3.4.1 Cytoskeletal Proteins 
 
In healthy mammalian cells, the shape and organization is maintained by the cytoskeleton, 
consisting of filamentous actin, microtubules, which are polymers of α- and β-tubulin, and intermediate 
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filaments, which include vimentin, cytokeratins and lamins [110-112].  Numerous cytoskeletal proteins 
are known substrates of activated caspase 3 during apoptosis.  Depolymerization of polymers and 
degradation of these proteins causes many morphological changes occurred during the execution phase 
of apoptosis.   
  
When actin is cleaved, two fragments are produced: actin N-terminal 32kDa (Fractin) and 
15kDa (tActin) [110], leading to the disruption of actin, which was observed during apoptosis in 
various cell lines [113-115].  The disintegration of actin polymers is crucial for the reorganization of the 
actin network during apoptosis to warrant the orderly dismantling of dying cells [116].  Furthermore, 
the tActin fragment from caspase cleavage can undergo N-myristoylation and translocate to 
mitochondria [117].  It has been shown that tActin functions downstream of caspase activation and can 
trigger cell shrinkage observed during apoptotic cell death [115].   
 
Intermediate filaments are responsible for maintaining cell integrity during normal conditions 
[112].  When cells undergo apoptotic death, the cleavage of vimentin disrupts intermediate filaments 
into aggregates, which closely resemble ones seen in apoptotic cells, and generates a pro-apoptotic N-
terminal fragment able to amplify the cell death signal in a caspase dependent manner [118].  
Furthermore, truncated vimentin can also interfere with the assembly of normal vimentin into 
intermediate filaments [119].  Vimentin is said to be proteolyzed by caspase during the induction of 
apoptosis when the majority of cells are still viable, hence its cleavage precedes the cytoskeleton 
reorganization typically seen in apoptotic cell death [118].   
 
Both subunits of tubulin heterodimers, α-tubulin and β-tubulin, have been reported as substrates 
of caspase-mediated proteolysis.  Examination of the cleavage site in α-tubulin indicated a small 
fragment from its carboxyl end is removed by caspases [120].  In a separate study, the C-terminus of 
tubulins was shown to be a regulatory region for microtubule polymerization/aggregation [121,122].  
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Cleaved α-tubulin enhances microtubule polymerization rates in vitro and increases its capacity to 
polymerize and possibly affect the tubulin dynamics [112,121].  The dismantlement of microtubules 
during the early apoptotic phase then reassembly in later apoptotic stage have been observed in cells.  
Based on evidence from HeLa cells, it was hypothesized that microtubules are responsible for the 
anchorage or transportation of chromatin to apoptotic blebs at the later phase of apoptosis execution 
[112]. 
 
In accordance with the above reviews and studies, the spots identified as tubulin, actin and 
vimentin in the present study were significantly down regulated in CHO apoptotic cells.  Actin was 
identified from at least five protein spots that differ only in their isoelectric points.  Both β- and γ 
isoforms were matched to similar sets of MS peaks and yielded the same score from the MASCOT 
protein database searches.  However, vimentin and α-tubulin were identified from a single spot due to 
the small number of peptides sequenced.  Since their corresponding molecular weights and pI (53 
kDa/pH5.06 and 50 kDa/pH4.96 respectively) are similar, it is not surprising that they resolved into the 
same spot.  PEAKS analysis resulted in a 93.77% score for vimentin while MASCOT scores for both 
results were not very high.  The confident PEAKS hit favours the identification of spot as vimentin but 
MASCOT results were nevertheless statistically significant.  Hence, the decrease in spot intensity could 
correspond to either a decrease in only one of the two proteins, or a combination of changes in the 
expression of both proteins.  Although exhibiting a smaller fold change than α-tubulin, β-tubulin was 
also down-regulated in this study.  However, the spot identified as β-tubulin also was identified as ATP 
synthase beta from the same MS analysis.  β-tubulin yielded higher score in MASCOT when comparing 
to that of ATP synthase beta, but it was not identified according to PEAKS.  Similar to the case with 
vimentin and α-tubulin, overlapping likely occurred due to comparable MW and pI.  More detail and 




3.4.2 Molecular Chaperone and Folding Enzymes 
 
Many cellular or ER stresses including oxidative stress, amino acid depletion, protein over-
expression and inhibition of glycosylation reactions, can lead to the accumulation of misfolded proteins 
within ER lumen and the activation of the unfolded protein response (UPR) [67].  As an initial response 
for dealing with these stresses, the UPR enhances cell survival by triggering three separate signalling 
pathways, namely ATF6, IRE1/XBP1 and PERK/ATF4 systems.  These pathways together attenuate 
global protein translation, increase translation of UPR target genes such as chaperones and folding 
proteins, and cause the degradation of misfolded proteins [67,123].  Hence, it is not surprising to 
identify a significant number of ER chaperone proteins from comparative proteomic analyses of stress 
conditions.   
 
From the DIGE experiment of the present study, a total of ten unique protein identifications 
obtained from the mass spectrometry analyses belong to the chaperone-related category.  HSC70, 
HSP90 and FKBP52 are the only down-regulated proteins identified in addition to being the only 
cytosolic chaperones.  Meanwhile, the remaining seven chaperone proteins, calreticulin, ERp60, BiP, 
GRP94, GRP170, PDI and PDIA6 function mostly in the ER and exhibited large fold change as cells 
aged and died during prolonged cultivation.  They are among the most differentially expressed proteins 
with an upregulation of 1.81 to 3.17 fold change (see Table 3-6 and 4-15) when comparing abundance 
between day 2.5 and 8.5.  As described in more detail below (Section 3.4.2.1-3.4.2.3), these seven 
proteins participate in the two known chaperone systems in the ER, namely the calnexin/calreticulin 
chaperone system and the BiP/GRP94 chaperone system [123].  It is worth noting that although ER 
chaperones can be roughly divided into two systems, association between components from different 
chaperone cycles have been reported frequently largely due to their multifunctional roles.   
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All seven ER-localized chaperones and folding proteins identified in the present study are 
known UPR inducible proteins.  Their induction by cellular stresses have been demonstrated in 
previous studies using microarray, Western blots and 2D gel electrophoresis [124-130] among a list of 
UPR affected proteins.  The presence of cis-acting elements, namely unfolded protein response element 
(UPRE) and the ER stress response element (ERSE) [67], in the promoter region of a gene suggests it 
being a target of UPR.  Along with the induction of many ER chaperones, the downregulation of 
FKBP52, which was observed in the present study, had been identified in cells treated with 
Tunicamycin, which inhibits N-glycosylation of proteins, and cells over-expressed with ATF6 [124].  
Although not all known UPR target proteins have been identified in every past study, the detection of a 
few members can still mark the activation of ER stress response.  For instance, the induction of BiP has 
been viewed as a classic marker for UPR induction [130].  Hence, the presence of seven ER stress 
proteins in the present study strongly suggests ER stress activation in the prolonged cultivation of CHO 
cells.   
 
That being said, the roles of ER chaperones and folding enzymes in apoptotic cell death of 
CHO cultures should not be overlooked.  Although it is likely that some changes in the protein 
expression are better explained as a consequence of UPR, others could also correspond to the 
progression of apoptosis.  In addition, while UPR is the initial response to ER stresses, the apoptotic 
pathway will be triggered eventually if a problem persists.  As a result, many of the observed fold 
change in protein levels might in fact be the net result of induction and/or repression by both survival 
and death pathways.  In the subsequent sections, the versatile functions of each identified chaperone 






3.4.2.1 Proteins Identified from the Calnexin/Calreticulin Chaperone System in ER 
 
Calreticulin 
Calreticulin is a multipurpose 46-60kDa [131,132] ER soluble/luminal protein that participates 
in lectin-like chaperoning, Ca
2+
 storage and signalling, regulation of gene expression, cell adhesion, and 
autoimmunity [133,134].  By forming a complex with calnexin and other ER chaperone proteins, 
calreticulin interacts with glycoproteins and promotes their proper folding in conjunction with ERp60 
[133,135].  In contrast to the BiP chaperone system which hydrophobically interacts with polypeptides, 
lectin chaperone binds to glycans or bulky hydrophilic extensions of proteins [136].  Utilizing its high 
capacity calcium binding site [133], calreticulin also functions to keep intracellular calcium ions out of 
the cytosol, as high concentrations in the cytosol can be toxic to the cells [53].   
 
Upregulation of calreticulin has been observed upon the induction of cellular stresses such as 
the depletion of ER Ca
2+
 store [134], hyperosmotic stress, heat shock, UV exposure and amino acid  or 
glucose deprivation [68].  Since transcription activation of UPR target genes is controlled by two cis-
acting elements, UPRE and ERSE [67], the presence of ERSE in the promoter region of calreticulin 
suggests that its transactivation following ER stress should be the result of UPR activation [137].  As a 
result, the increased expression of calreticulin observed in CHO cultures of the present study could be 
due to UPR triggered by the deterioration of culture conditions as nutrients became limiting and waste 
products accumulated.   
 
In contrast to the UPR survival pathway, calreticulin has also been associated with the 
progression of apoptosis.  When over-expressed, calreticulin increased cell sensitivity to apoptosis by 
increasing the amount of calcium stored in the ER [133], along with an increase in the mitochondrial 
cytochrome c released [138].  On the other hand, calreticulin deficient cells were more resistant to 
apoptotic signals due to the decreased ER Ca
2+
 stores [138].  Additionally, when localized to cell 
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surface, calreticulin has been suggested to function in the clearance of apoptotic cells.  Together with 
the well known apoptotic cell surface recognition factor phosphatidylserine, calreticulin signals and 
drives the engulfment of apoptotic cells[132,133].  Upregulation and redistribution of calreticulin on the 
cell surface during apoptosis was observed prior to postapoptotic membrane permeability [132].  It 
appears sensible to suggest that calreticulin was up-regulated initially to cope with UPR.  Since the 
culture condition continued to worsen, the accumulated levels of calreticulin sensitized cells to 
apoptosis and may signal for the phagocytosis of apoptotic cells.   
 
When separated on 2D gels, two differentially expressed spots of similar pI but varying 
molecular weights were identified to be calreticulin. Their changes in abundance were the largest two 
observed among the 79 spots selected from the DIGE analysis (Table 3-6).  The estimated molecular 
weights from the distance migrated by the two clearly separated spots deviated roughly by 10kDa.  It is 
unclear why there were two isoforms and how they differ in function.  However because both isoforms 
exhibited a similar fold change, around 3 between day 2.5 and 8.5, they might not possess different 
function or be regulated separately in aging CHO cultures.  
 
ER protein 60 (ERp60) 
Another important protein of the calreticulin chaperone systems identified is the ERp60, which 
is also known as ERp57, ERp61, PDIA3 and glucose-regulated protein (GRP) 58kDa [139].  As a 
member of the protein disulfide isomerase (PDI) and glucose-regulated protein family, it is responsible 
for the correct folding of misfolded glycoproteins in the ER lumen through the creation and 
rearrangement of disulfide bonds [139,140].  As mentioned previously, its chaperone function requires 
the complex formation with ER-retained calreticulin and calnexin which bind glycoproteins as they 
emerged from the ER membranes [133,140].   
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Besides localization to the endoplasmic reticulum, ERp60 can also be found in various other 
locations including the nucleus, the cytosol and the mitochondria.  Recent studies have shown that the 
ERp60 associated mitochondrial µ-calpain, which is an ubiquitous calcium-dependent neutral cysteine 
protease, is able to cleave the inner-mitochondrial-membrane (IMM)-bound apoptosis inducing factor 
(AIF) (~62 kDa) and release the functional cleaved form, tAIF (~57 kDa) into the intermembrane space 
(IMS).  It was suggested that mitochondrial ERp60 proteins, which reside mostly at the outer membrane, 
refold the µ-calpain large subunit into functional conformations via disulfide bond formation.  Most 
importantly, this ERp60-calpain complex may act as the initiator for the mitochondrial apoptotic 
signalling [139,141].  However, how ERp60 came to be localized in the mitochondria, as well as 
whether induction of ERp60 expression is necessary for its participation in the mitochondria are 
unknown.  In support of the results from Ozaki and colleagues [139,141], over-expression of ERp60 
have been found to attenuate the induction of pro-survival BiP, increase caspase 3 activation and 
exacerbate hyperoxia and tunicamycin-induced apoptosis in human endothelial cells [140].  In this 
study [140], a negative correlation between the abundance of ERp60 and BiP proteins was observed, 
suggesting that ERp60 likely regulates apoptosis through BiP [140].  Also, it was demonstrated that the 
knockdown of ERp60 suppresses the cell surface exposure of calreticulin, which abolishes phagocytosis 
labelling.  Interestingly, the interaction between calreticulin and ERp60 has been shown necessary for 
the cotranslocation to the cell membrane [131,140], further suggesting a reason for the simultaneous 
regulation of these two proteins as observed in the present study.   In any case, the simultaneous 
increase of ERp60 and calreticulin synthesis during apoptotic cell death has been reported in 
lipopolysaccharide-induced apoptosis in PC12 cells [142]. 
 
When comparing CHO proteomes at various time points during culturing, at least five ERp60 
isoforms were detected on the 2D gels with comparable positive fold change between 2.21 to 2.4.  
Although the presence of phosphorylated ERp60 has been reported, the functions of the different 
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isoforms remain unclear [140].  Nevertheless, as previously reported, the increase in ERp60 abundance 
correlates with the increase in the apoptotic population within the culture.   
 
3.4.2.2 Proteins Identified from the BiP/GRP94 Chaperone System in ER 
 
The BiP/GRP94 chaperone system functions by the formation of a protein complex consisting 
of BiP, GRP94, PDI, ERp72, GRP170, UGGT, PDIA6, cyclophilin B and SDF2-L 1.  Typical 
substrates of this system contain hydrophobic residues in the unfolded regions.  BiP can bind to certain 
calnexin/calreticulin substrates if N-glycosylation is blocked [123].  BiP, GRP94, GRP170, PDI and 
PDIA6 were among the differentially expressed proteins identified by DIGE analyses.  All five 
components were up-regulated by a fold change of roughly 2 as cultures became more apoptotic on day 
8.5.   
 
GRP proteins are known to be inducible by undesirable conditions including glucose starvation, 
low pH, anoxia, calcium ionophores and stresses that disrupt ER function [123].  As a result, it is not 
unexpected to observe upregulation of a variety of proteins in the BiP/GRP94 chaperone system as 
CHO culture conditions deteriorated over time.  HPLC assays of the various free amino acids (personal 
communication with Saeideh Naderi) in the culture medium over time showed an increase in lactate and 
ammonia concentration as the culture aged.  Elevated lactate and ammonia levels in cultures are known 
for their inhibitory effects on cell growth [143].   
 
BiP 
Immunoglobulin heavy chain-binding protein (BiP), also known as GRP78 and HspA5, is the 
most abundant member of the heat shock protein (HSP) 70 family [144,145].  It is a multifunctional 
protein that binds and maintains ER calcium homeostasis, acts as a chaperone for preventing protein 
misfolding and aggregation within the ER, and suppresses activation of UPR [140,145].  The substrate 
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binding domains (SBD) of BiP interacts with hydrophobic oligopeptides of unfolded proteins.  Upon 
releasing from BiP, the folding and assembly of the substrate occurs [145].  In addition, BiP has been 
reported to participate in translocation of, at least some, proteins across the membrane into the ER, 
opening the Sec61 channel, binding to incoming polypeptides and closing the channel to prevent 
uncontrolled efflux of calcium ions from the ER.  Once translocated, the precursor protein then become 
the substrate of BiP [145,146]. 
 
Under normal conditions, BiP binds and suppress ER stress sensor proteins, PERK, IRE1α and 
ATF6, which can activate ER stress signalling pathways including UPR [67].  When sequestered by 
misfolded polypeptides, BiP dissociates from these sensor proteins allowing them to activate signal 
transduction for UPR [140,145].  BiP is one of the UPR target proteins induced upon the activation of 
IRE1 as the initial pro-survival combat against the ER stress [67,147].  Its over-expression has been 
shown to protect cells against ER stress-induced apoptosis while the reverse leads to UPR activation 
and apoptotic cell death [140].  However, induction of BiP expression has been noted in two separate 
apoptosis studies [148,149].  The observed 2.55 fold induction of BiP protein levels in apoptotic (day 




GRP94, which belongs to the HSP90 family, is an ER luminal resident chaperone.  Its many 
designations include endoplasmin, glycoprotein gp96, calcium binding protein CaBP4, tumor rejection 
antigen TRA-1 and ERp99 [150,151].  Although GRP94 seems to not be crucial for cell viability, its 
function is not redundant for the maturation of cell surface ligands and receptors [152], including 
immunoglobulin heavy chains, integrins, and toll-like receptors [136].  Other than surface proteins, 
some proteins localized in the secretary pathways are also identified as GRP94 substrates [150].   
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GRP94 is the most abundant glycoprotein in the ER [136].  Its upregulation occurred in 
response to various stress conditions including glucose starvation, ER calcium store depletion and over-
expression of misfolded proteins [150].  Along with other glucose regulated proteins such as BiP, 
GRP94 is thought to protect cells against cell death [153].  The combined upregulation of BiP and 
GRP94 likely was part of the initial effort to cope with the ER stresses in prolonged cultures.  
Interestingly, GRP94 is constitutively expressed in most cell types and transcriptionally co-regulated 
with BiP [123].  In agreement with this and the result of another 2D gel study [148], protein abundances 
of BiP and GRP94 both increased when comparing CHO protein samples from day 2.5 to day 8.5.   
 
GRP170 
Glucose regulated protein 170 (GRP170), also known as hypoxia up-regulated 1, is one of the 
nucleotide exchange factors in the ER lumen that can replace the ADP bound to BiP with ATP [136,145] 
thus regulate their conformational changes, which facilitate the binding and releasing of substrate 
proteins.  Moreover, it has been shown that GRP170 is a major calcium-binding protein in the ER [154].  
The participation of GRP170 in protein refolding, preventing protein aggregation and facilitating 
translocation across ER membranes has been observed [155].  Although its exact role and mechanism 
have yet to be resolved, it was suggested that along with co-chaperones, GRP170 can facilitate protein 
folding without other major chaperones like BiP [155].   
 
GRP170 was up-regulated by 1.8 fold after CHO cultures aged by 8.5 days.  Again, this 
induction may be the result of UPR as cells attempted to cope with the deterioration conditions of an 
aging culture.   
 
PDI and PDIA6 
Members of the protein disulfide isomerase (PDI) family contain CXXC motifs in their 
thioredoxin domains.  Oxidoreductases members catalyze the formation of disulfide bonds via thio-
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disulfide exchanges, while members with isomerase activity rearrange non-native linkages into native 
disulfides [136].  The enzymes PDI, PDIA6 and ERp60 are all members of the PDI family [156].   
 
The multifunctional PDI protein not only functions as oxidoreductase and isomerase, it can also 
act as a chaperone [136].  It inhibits the aggregation of misfolded proteins, including ones without 
disulfide bonds [157].  Protein disulfide isomerase family A, member 6 (PDIA6) is also referred as PDI 
P5, ERP5, calcium-binding protein 1 (CaBP1) and thioredoxin domain-containing protein 7 (TXNDC7).  
Most PDI family members have C-terminal ER-retention signals.  For example, PDI and PDIA6 both 
have the KDEL sequences.  Yet PDI family members have been reported to be involved in many 
cellular processes taking places in various compartments [158].  It is still unclear which and how 
members are involved in these non-ER processes.  With that said, there are still many unanswered 
questions regarding each PDI member’s roles in protein folding and degradation, as well as the 
mechanisms and regulations of their many functions [136].  Nevertheless, at least four PDIA6 isoforms 
with similar molecular weights but varying pI were separated on the DIGE gels and identified with 
mass spectrometry analyses.  All isoforms had a fold change of approximately +2 when comparing 
abundance from 2.5 days old cultures to that of 8.5 days old samples.  On the other hand, PDI appeared 
to resolve into a single spot on 2D gels, with roughly 2 fold change as well.  The expressions of both 
PDI and PDIA6 likely were up-regulated as occurred to BiP, GRP94 and GRP170 upon the initiation of 
UPR.  In support, PDI has been reported as one of the up-regulated apoptosis-modified proteins 
[148,149].   
 
3.4.2.3 Cytosolic Chaperone Proteins 
 
Heat shock cognate protein 70kDa (HSC70), heat shock protein 90 beta (HSP90β) and 
FK506-binding protein 52 (FKBP52) were the only cytosolic chaperone proteins identified by MS 
analyses.  As a member of the Hsp70 family, the principle role of HSC70 is to shield the hydrophobic 
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resides of newly synthesized proteins as they emerge from the ribosomes [159].  HSP90β, also known 
as HSP84, is a mammalian ubiquitous cytosolic member of the HSP90 protein family, which functions 
as a somewhat substrate-specific molecular chaperone, associating with various intracellular proteins 
including steroid hormone receptors, actin, tubulin and some kinases [160].  FKBP52, also named p59, 
FKBP4, HSP56, p52 and Hsp-binding immunophilin (HBI), is a multifunctional protein exhibiting 
peptidyl-prolyl cis-trans isomerase (PPIase) activity.  Its role as one of the HSP90 co-chaperones in the 
steroid receptor heterocomplex has been well studied.  For example, upon the binding of hormone to the 
glucocorticoid receptor/HSP90 complex, FKBP52 is recruited and promotes the nucleus translocation 
of the complex by interacting with a motor protein, dynein [161].   
  
Among all 10 chaperone-related proteins identified (see Table 3-4), HSC70, HSP90β and 
FKBP52 were also the only proteins that decreased in abundance as the culture aged and the degree of 
apoptosis increased.  All three proteins were similarly reduced in abundance, decreasing by 1.17, 1.31 
and 1.29 fold respectively on day 8.5 as compared to those on day 2.5.  Both HSC70 and HSP90β are 
constitutively expressed proteins in normal growing mammalian cells [160,162,163].  The concurrent 
changes observed in the three proteins might be attributed by the fact that HSC70 and FKBP52 proteins 
can act as co-chaperones for HSP90 [161,164].   
 
Other than being involved in protein folding, HSC70 and HSP90 have additional functions.  
HSP70 isoforms promote cell proliferation and survival by acting as co-chaperones responsible for 
substrate loading into HSP90 and neutralizing the effects of several pro-apoptotic proteins such as AIF, 
APAF-1 and BAX in both the intrinsic and extrinsic pathways [164].  It has been shown that inhibition 
of either HSP90 or HSC70 can lead to apoptosis in certain cancerous and normal cell lines [165-168].  
Hence, it is not surprising to see their down regulation in culture containing significant portion of 
apoptotic cells.  However it is unclear whether the decrease in HSP70 and HSP90 was a means to 
remove pro-survival signals and chaperones in order for the cells to undergo apoptosis or merely a 
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consequence of apoptosis.  In another study, hyperthermia-induced cell deaths have been observed in 
cells with low HSC70 expression [162].   
 
Furthermore, HSP90 is a known chaperone of the major activator of the stress response, HSF1 
[169].  Activation of the heat shock response is a result of the release and homotrimerization of HSF1 
transcription factor from the HSP90-containing multi-chaperone complex [164].  It was postulated that 
with the increased accumulation of chaperone substrates when UPR occurs, the availability of HSP90 
for inhibiting HSF1 polypeptides decreased, thus lifting  the suppression on HSF1 and causing the 
transactivation of hsp genes [170].  Since all chaperones except HSP90, HSC70 and FKBP52 identified 
by DIGE and MS analyses were up-regulated, the removal of HSF1 suppression by decreased HSP90 
abundance might be contributing to the increased translation of other heat shock protein chaperones.   
 
3.4.3 Glycolytic Proteins and other Metabolic Enzymes 
 
Six of the ten glycolytic enzymes were positively regulated as CHO cultures became more 
apoptotic.  Figure 3-6 shows the ten reactions of glycolysis while highlighting the last six consecutive 
steps, which correspond to the reactions catalyzed by the differentially expressed proteins.  Listed in the 
order within the pathway, these proteins are triosephosphate isomerase (TPI), glyceraldehydes-3-
phosphate dehydrogenase (GAPDH), phosphoglycerate kinase (PGK), phosphoglycerate mutase (PGM), 
enolase 1 and pyruvate kinase (PK) isozyme M1/M2.  In addition, L-lactate dehydrogenase (LDH) 
chains have been identified.  LDH processes the end product of glycolysis, which is pyruvate, into 
lactate.  The fact that more than half of the glycolytic enzymes were induced strongly indicates the 
significance of their participation during prolonged cell cultivation and possibly apoptosis.  It is also 
quite intriguing that every enzyme responsible for the latter half of the glycolysis pathway was 
simultaneously induced.   
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Figure 3-6. Up-regulated enzymes of the glycolysis pathway as apoptosis progressed.  The average 
fold change between day 2.5 and day 8.5 cultures were shown beside each up-regulated enzyme.  Dotted lines 
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3.4.3.1 Changes in Energy Metabolism and the Regulation of Glycolytic Enzymes  
 
From the MS analyses, seven metabolic enzymes were found to be up-regulated to various 
extents.  Six of these were directly involved in the breakdown of glucose molecules into two pyruvate 
molecules, generating two ATPs in the process.  In addition, L-lactate dehydrogenase (LDH) A and C 
chains were also detected from identical mass spectrum peaks.  LDH is a metabolic enzyme responsible 
for converting pyruvate into lactate [173].  It is an alternative route for processing pyruvate.  Given that 
all seven enzymes exhibited an increased abundance as apoptosis progressed, it is not unreasonable to 
deduce that the amount of glycolysis reactions occurring in the cells rose as the result of more available 
enzymes.  At first glance, the induction of glycolytic proteins when glucose supply was diminishing in 
cultures over time seems contradictory.  However, this phenomenon can be explained if the increase in 
glycolytic enzymes was a tactic to maintain adequate energy levels within cells when the actual glucose 
concentration decreased.  For this reason, the induction of enzymes might be activated by the depletion 
of glucose concentration prior to the initiation of apoptotic cell death simply as a cellular response to 
maintain the necessary glycolysis rate.  Alternatively, it is also possible that the upregulation was post-
apoptotic attempt to maintain energy level for the proper execution of apoptosis.   
 
Since apoptosis is an energy driven mechanism, the induction of glycolytic enzymes, which can 
accelerate ATP production, might be necessary for providing the energy required for the execution of 
apoptosis.  Following glycolysis, subsequent energy extraction from pyruvate can either occur via the 
tricarboxylic acid (TCA) cycle, which yields a high number of ATP per pyruvate, or by its conversion 
to lactic acid, which only generates one NAD
+
 molecule in the process (Figure 3-7).  In a study by 
Swiderek and colleagues, higher glucose consumption rates were reported along with increased mRNA 
levels of several glycolytic enzymes when cells were under severe hypoxia or anaerobic conditions, 
which led to apoptosis [174].  It was concluded that as a survival strategy, cells generate more energy 
by increasing glycolysis in order to compensate for the inefficient energy production under an oxygen 
108 
limited state and maintain an adequate energy reservoir [174,175].  It has been noted that in non-
cancerous normal cells, the coordinated induction of almost all genes encoding glycolytic enzymes has 
been found important for the adaptation to hypoxia, which stabilizes and activates the hypoxia-
inducible transcription factor HIF-1 [172].  Some of these HIF-1 targets include hexokinase-2, TPI, 
GAPDH, PGK, aldolase A, enolase 1 and LDH-A [174,176].  However, oxygenation in small-scale 
stirred tank bioreactors via surface aeration and mixing is often sufficient [177].  The lack of oxygen 
limitation in CHO cultures maintained in spinner flasks has recently been demonstrated, especially with 
the use of loose side caps that allow the transfer of oxygen from the atmosphere [178].   
 
The slight increase in the cellular LDH level in this experiment correlates with the 
accumulation of lactate typically observed in CHO cultures.  From amino acid assays (pending 
publication and personal communication with Saeideh Naderi), CHO IgG-9β8 supplemented with 1-
4mM glutamine usually started off with a low lactate concentration around 3-5mM which quickly 
increased to 12mM in 2-3 days and remained fairly constant until the end of culture process.  The 
induction of LDH levels also reached its peak (at approximate 1.2 fold change) as early as day 4.5 (see 
Table 3-5).  Since only four time points were chosen for DIGE analyses, the LDH induction trend 
which appeared later than the lactate production might be due to the lack of more data points before day 
2.5.  In addition to the generation of energy, another possible explanation for the slight increase of LDH 
relates to whether glycolysis can be completed.  While LDH catalyzes the conversion of pyruvate to 
lactate, it oxidizes NADH and replenishes NAD
+
, which is essential for the completion of glycolysis 
reactions (see Figure 3-6 and Figure 3-7) [172].  Due to its influence on glycolysis reactions and 
progress, it is not surprising to have LDH expression increase when the demand for energy increases.  
In Swiderek’s study [174], higher lactate production was also noted in hypoxia and anaerobic cultures.  
The authors suggested that the glucose metabolism switched from the TCA cycle to anaerobic 
glycolysis.  Altogether, these evidences and reports suggest that in the case of prolonged CHO cultures 
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undergoing apoptosis, LDH may be induced for the same reason, which is to provide enough energy to 
the cells.   
       
Figure 3-7. Conversion of pyruvate to lactate by lactate dehydrogenase (LDH). 
 
3.4.3.2 Relationship between Glycolytic and Apoptotic Pathways 
 
Besides maintaining energy reservoir when cells are stressed and/or undergoing apoptotic cell 
death (see Section 3.4.3.1), the changes in glucose metabolism might also have pro-apoptotic 
consequences.  Although how changes in energy metabolism actively induce apoptosis is still unclear at 
the moment [171], it has been shown that decreases in glucose level, mitochondria membrane potential 
and oxidative phosphorylation can induce mitochondrial cristae remodelling, releasing cytochrome c 
into the IMS, making it readily available for release into the cytosol [171,179,180].  As for the 
prolonged CHO cultures in the present study, since the depletion of glucose continued to persist and 
worsen over time, eventually mitochondrial cristae remodelling and the release of cytochrome c into the 
IMS likely occurred.   
 
In addition to influencing the remodelling of mitochondria and release of cytochrome c in the 
IMS, glucose metabolism can also affect the reduction of reactive oxygen species (ROS).  ROS can be 
elevated during apoptosis or generated by mitochondria under stress conditions such as insufficient 
oxygen levels within cells which can also lead to apoptosis [171,181,182].  By regulating the levels of 
metabolic enzymes including glucose-6-phosphate dehydrogenase (G6PDH) and PFK, glucose-6-
pyruvate 




Abbreviation: FC, fold change 
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phosphate (G6P) molecules are diverted from glycolysis to a pathway that generates cellular antioxidant 
glutathione (GSH) (Figure 3-6).  This increase in GSH level leads to the reduction of ROS and the 
prevention of apoptosis [171].  Although these proteins were not among the differentially expressed 
metabolic proteins identified in CHO apoptotic cells, the availability of enzymes catalyzing the latter 
half of the glycolysis reactions could be crucial in influencing the amount of G6P molecules that fall 
through the two pathways.  With the presence of more glycolytic enzymes, G6P molecules were likely 
diverted to undergo glycolysis metabolism instead of the pentose phosphate pathway, which generates 
GSH.  Interestingly, it has been shown recently that the oxidation of cytosolic cytochrome c by ROS is 
required to fully activate caspases and apoptosis [183].  Altogether, these findings suggest that the 
increased glycolytic reactions promote the release of mitochondrial cytochrome c and elevation of 
cellular ROS concentration, both of which are required for the execution of apoptosis.   
 
3.4.3.3 Non-Metabolic Functions of Metabolic Enzymes  
 
For a long time, glycolytic enzymes have been regarded as housekeeping proteins and 
associated only with the metabolism of glucose in cells [172].  Changes of glycolytic protein levels in 
studies usually were interpreted as changes to the metabolism of nutrients as availability decreases or 
culture condition deteriorates.  However, more and more studies seem to indicate that additional non-
metabolic functions of these glycolytic enzymes exist.  For example, the nuclear localization of several 
glycolytic proteins including enolase-1, GAPDH and LDH has been noted.  Evidence presented in 
several studies suggests that the nuclear form of these enzymes participate in transcription and/or DNA 
replication.  Several studies also show that tyrosine phosphorylation of some glycolytic enzymes may 
affect their subcellular localization [172].  Some studies were able to explicitly associate cell survival 
and cell death with a small number of the glycolytic proteins such as hexokinase and GAPDH, although 
the exact mechanisms are still far from being understood [172,184,185].   
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In this project, enolase-1 was identified as differentially expressed based on the one-way 
ANOVA test, and showed slight upregulation when comparing day 4.5, 5.5 and 8.5 protein samples to 
that of day 2.  Based on the initiation of translation at different in-frame AUG start codons, the ENO1 
gene can encode for 48kDa enolase-1 and 37 kDa MYC promoter-binding protein MPB1, whose 
expression induces growth suppression and cell death [172,186].  The spot identified as enolase-1 
indeed had an estimate MW of 50kDa from the gel electrophoresis migration.  When expressed in vitro, 
the alternative translations of enolase-1 and MPB1 have been detected simultaneously by Western blot, 
with the latter expressed at a lower abundance [186].  In contrast, simultaneous downregulation of 
enolase-1 and MPB1 was caused by retinoic acid treatment of human carcinoma cells [187].  If indeed 
the observed induction of enolase-1 corresponds to an increase in MPB1 (which was not identified by 
DIGE and MS analyses in this study), it would correlate nicely to the actively occurring deaths in the 
CHO culture as determined by flow cytometric assays.   
 
As for GAPDH, although its cytosolic form typically functions as a catalyst in the glycolysis 
pathway, it has been associated with DNA repair, transcriptional regulation and apoptosis in several 
studies [172].  Many apoptotic stimuli can activate inducible nitric oxide synthase to produce nitric 
oxide (NO) in the cells.  These nitric oxides S-nitrosylate GAPDH, rendering it catalytically inactive 
and able to bind to a nuclear localization signal containing E3-ubiquitin-ligase called Siah1.  The 
subsequent translocation of GAPDH-Siah1 complex to the nucleus then induces apoptosis by the 
acetyltransferase p300/CREB binding protein-mediated pathway [188].  Significantly increased 
GAPDH expression has occurred during apoptosis that was induced by various factors including 
prolonged culture, nutrient withdrawal and cytotoxic agents [172].  Its pro-apoptotic function was 
further supported by its over-expression and antisense inhibition, which led to the induction and 
inhibition of apoptosis respectively [189].  Therefore, in addition to its role in glycolysis, upregulation 
of GAPDH proteins could also be due to its pro-apoptotic functions.  In support of the above studies, 
two GAPDH isoforms of identical weight and slightly different pI were separated on the CHO DIGE 
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gels in the present study.  They were on average up-regulated by 1.26 and 1.27 fold from day 2.5 to day 
8.5.   
 
3.4.4 Other Proteins and their Potential Roles in Apoptosis  
 
14-3-3 epsilon  
Expression of 14-3-3 epsilon protein showed a small but statistically significant 1.1 fold down 
regulation at the late death phase (day 8.5) time point.  This downregulation was also significant based 
on ANOVA comparison of abundance across all four time points.  Members of the 14-3-3 protein 
family interact with a diverse numbers of cellular proteins including transcription factors, biosynthetic 
enzymes, cytoskeletal proteins, apoptosis factors and signalling molecules via their phosphor-serine or 
phosphor-threonine binding activity [190,191].  Under normal conditions, 14-3-3 proteins prevent the 
initiation of apoptosis by binding and inactivating various proteins in the apoptosis pathway, such as 
Bad and Bax.  In the presence of death signals, 14-3-3 proteins become phosphorylated, leading to a 
conformation change followed by the release of pro-apoptotic substrates and the triggering of apoptosis.  
The interaction between 14-3-3 proteins and their substrates mostly are regulated by the 
phosphorylation of ligands and 14-3-3 [190,192].  However, during apoptosis, the dissociation of client-
14-3-3 complex has been suggested to occur when 14-3-3 proteins are truncated [192].  14-3-3 isoforms 
including 14-3-3 epsilon, have been identified as direct substrates of caspases during apoptosis 
[193,194]; cleavage results in the decrease of full length 14-3-3 expression as observed in many 
proteomics studies [195,196].  Based on evidence from previous studies, the observed decrease of 14-3-
3 epsilon in CHO cells after the onset of apoptosis could likely be involved in the regulation and release 
of pro-apoptotic proteins from 14-3-3 suppression.  Of course, it cannot be ruled out that the decreased 
in 14-3-3 abundance might also be related to other pathways.  The absence of expression change on day 
4.5 and 5.5 might be due to the time required before sufficient activated caspases accumulated and the 
cleavage of 14-3-3 became noticeable by proteomic analysis.  Although the measured fold change was 
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small, its consistency across replicates (see Appendix B Figure B-4a) and significance based on two 
statistical tests render 14-3-3 likely to have undergone a real biological change.   
 
Laminin receptor 1 
Laminin receptor 1 (LAMR1), also known as 37/67 kDa laminin receptor (LR), laminin 
binding protein (LBP), p40 ribosome-associated protein and ribosomal protein SA, is a multifunctional 
protein that can act as a structural component of the ribosome, mediates cellular adhesion and possesses 
laminin receptor activity [197,198].  The 37kDa form has been clearly identified as a precursor to the 
67kDa form, although the exact mechanism is unclear [199,200].  Based on the distance migrated in the 
DIGE gels, the LAMR1 identified in this study was the 37kDa precursor.  Until day 5.5 (the mid-
stationary phase) of the culturing process, the abundance of LAMR1 remained constant.  Based on t-test 
analysis between day 2.5 and day 8.5 protein samples, spot 876 which was subsequently identified as 
LAMR1,  was determined statistical significant with a fold change of -1.19.  The induction of apoptosis 
in specific cell lines has been demonstrated by knocking down 37LBP/67LR with antisense cDNA [201] 
as well as using siRNAs [197].  It has been suggested that LAMR1 is an essential protein for 
maintaining cell viability.  Cleavage of LAMR1 in apoptotic cells has been reported and proposed to 
have a pro-apoptotic effect [202].  In accordance with these findings, down regulation of LAMR1 was 
observed in this study.   
 
Galectin-1 and Galectin-3 
Galectins are beta-galactoside-binding proteins that regulate various cellular activities including 
differentiation, apoptosis, cell growth, and tumor progression [203,204].  They can interact with cell 
surface and extracellular matrix glycoproteins, as well as cytoplasmic and nuclear proteins.  Galectin-1 
functions as a homodimers of two 14-kDa polypeptides, while galectin-3 forms oligomers [205].  Both 
galectin-1 and galectin-3 can bind to integrins [204].  Several studies have shown that galectin-1 can 
inhibit cell growth and promote apoptosis in T cells [206], in particular the activation of type II 
114 
extrinsic pathway [206,207].  However, a slight down regulation of galectin-1 was observed during the 
early death phase (day 8.5) in this study, when significant percentage of the cultures was apoptotic.  The 
reason behind this decrease is unclear, however it could be associated with the role of galectin-1 in 
other bioprocesses.  As a side note, small but statistically insignificant positive fold changes were 
observed on day 4.5 and day 5.5 of this study before the reduction in abundance was resulted on day 8.5.   
 
Galectin-3, also known as IgE-binding protein, 35 kDa lectin and carbohydrate-binding protein 
35 (CBP 35), is the only known member of the galectin family that possesses an anti-apoptotic function 
[205].  It has been shown to inhibit apoptosis in different cell lines and against stimuli.  The means by 
which galectin-3 inhibits apoptosis remain unclear.  However, there is some evidence on the 
involvement of Bcl-2 [205], phosphorylation of galectin-3 [208] and translocation of galectin-3 into the 
perinuclear membrane [209].  As the CHO cultures aged, the level of galectin-3 remained constant 
during the early time points.  A slight downregulation was observed on day 8.5.  This delayed 
downregulation might be an indicator that the anti-apoptotic galectin-3 was only removed in the later 
stage of apoptosis when cell deaths were dominant or unavoidable in the culture.  However, due to the 
unsynchronized nature of cultures in this experiment, a small change in protein abundance might be 
masked and remained unnoticed until later stages when higher percentage of the population exhibited 
the same characteristic.   
 
Peroxiredoxin 6 
Peroxiredoxin 6 (Prx6) is a thiolspecific antioxidant enzyme and the only member of the 
peroxidredoxin family that has the ability to remove H2O2 and phospholipid hydroperoxide in the 
plasma membrane [210].  Its expression has been found to be up-regulated upon oxidative stress 
induced apoptotic cell death [211] while over-expressing Prx6 in cells protects them against oxidative 
stress [212].  In another study, Prx6 was found to stabilize mitochondrial function by protecting against 
mitochondrial dysfunction and reducing the production of ROS from mitochondria in mice hepatocytes 
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subjected to ischemia-reperfusion injury, which is known to generate ROS [210].  Since several 
mitochondrial changes occur during apoptosis, including changes in ROS production and membrane 
potential [171,182], the upregulation observed might be a defense against the accumulation of ROS in 
cells.    
 
As discussed in section 3.4.5, Prx6 was identified in conjunction with TPI from the same spot 
(#1376) on multiple preparative gels.  If overlapping of the two proteins happened, the fold change 
measured would not reflect the true expression change for either protein.  However, when comparing to 
2D gel data from Hayduk and colleagues [107], Prx6 was similarly identified in a spot right below 
PGM as in this study.  Although Prx6 had a lower score than TPI, Hayduk’s identification supports the 
match of spot 1376 to Prx6.   
 
Protein kinase C substrate 80K-H 
The protein kinase C substrate 80K-H, also known as glucosidase II beta subunit, is the 
regulatory subunit of α-glucosidase 2.  It induces glucose transporter 4 cell membrane translocation by 
its interaction with protein kinase Cδ and munc18c [213].  A recent study has shown that 80K-H can 
directly enhance the IP3- and ATP-induced release of Ca
2+
 by interacting with the cytoplasmic C-
terminal tail of IP3 receptors [213].  As a result, it might participate in the ER apoptotic pathway.   
 
Based on the ANOVA test, spot 340 was determined to be differentially expressed although 
none of the individual t-test analysis was significant statistically.  Although both PEAKS and MASCOT 
analyses identified 80K-H as the protein in this spot, the scores were not very high.  In addition, the 
reported molecular weight of 60kDa for 80K-H does not match to the estimated MW of 90kDa from the 
distance migrated during electrophoresis.  With the above particulars, the detection of 80K-H and 
whether its expression did alter significantly over time in the cultures need further verification using 
techniques such as Western blot.      
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ATP synthase subunit beta, mitochondrial 
Mitochondrial ATP synthase subunit beta (ATPB) is the major catalytic subunit of ATP 
synthase, which converts ADP into ATP at the mitochondria membrane [214].  It was identified along 
with β-tubulin in spot 728, which was one of the down-regulated protein spots when comparing CHO 
cells after prolonged cultivation to ones that were healthy.  Reduced level of ATPB is related to the 
bioenergetic dysfunction of mitochondria [214,215] as the cellular ATP level shows a positive 
correlation with ATPB abundance [214].  In a proteomic study comparing control versus digoxin-
treated human endothelial cells, apoptosis was detected and an increase of ATPB expression was 
observed two days after treatment.  The preservation of ATP allows cells to undergo apoptosis instead 
of necrosis [214] because unlike necrotic death, apoptosis requires energy to be carried out.  It is clear 
that this unexpected result obtained from the CHO DIGE result in this study conflicts with that of 
previous studies.  However, a constant mitochondrial ATP level but a reduced ATPB abundance in rice 
mitochondria has been reported two hours after apoptosis was induced by salt stress [216].  The author 
in the rice study suggested that ATP synthase might not be the main producer of ATP in mitochondria 
during the early stage of apoptosis.  This discrepancy between studies calls for further investigation.    
 
On a side note, both β-tubulin and ATPB were detected in CHO reference maps by Hayduk 
[107] and Van Dyk [109] with very similar pI although β-tubulin was slightly heavier than ATPB.  It is 
likely that overlapping of these two proteins occurred during electrophoresis or from imprecise spot 
picking.  Overlapping protein spots render any expression change difficult to determine.  With this said, 
it is possible that the observed decreased expression solely reflect the downregulation of β-tubulin, 






3.4.5 Some Concerns with Identified Proteins 
 
Although statistical tests were performed for the selection of differentially expressed proteins, a 
small number of the protein spots chosen and identified will be false positives.  When examining the 
lists of potential proteins whose expression varied during the course of cell culturing, a few concerns 
came up.  An issue arose from MS analysis when multiple identifications per protein spot were obtained.  
First, peroxiredoxin-6 (Prx6) and TPI were detected from two different preparative gels but 
correspond to the same DIGE spot 1376.  Both proteins have molecular weight around 25-26kDa but 
TPI had much higher scores from both PEAKS and MASCOT analyses.  Since different peak sets were 
matched for each protein, TPI might overlap with Prx6 during separation.  This provides some 
uncertainty in the actual identity of spot 1376 and the cause of increased abundance over time.  Because 
TPI was identified from two nearby protein spots that showed simultaneous upregulation, the 
contamination from Prx6 should not decrease the likelihood of TPI being a differentially expressed 
protein.  Moreover, Prx6 has been identified in the spot immediately below PGM in a different study 
[107].  The similar pattern observed supports the match of spot 1376 to Prx6 and that overlapping of 
two proteins onto the same spot likely occurred.   
  
In addition, spot 728 also matched to two proteins, namely β-tubulin and ATP synthase beta 
while the neighboring spot 646 matched to vimentin and α-tubulin.  Although the identifications 
vimentin, β-tubulin and ATP synthase beta have been reported in CHO reference maps in distinct spots 
[107,109,217], the exact location of the corresponding spots still cannot be resolved and mapped to the 
DIGE gels in this study.  As the resolution between maps varied and identifications were not complete 
in all maps, it was hard to confidently match between gels.  However, the detection of all three proteins 
in neighboring spots in other CHO reference maps indicates that some degree of overlapping occurred 
in this study.   
 
118 
The main sources for the concerns mentioned here are the known limitations of the proteomic 
experimental techniques employed, such as noise in the DIGE data and low resolution during 
electrophoresis.  With this said, the potential roles of these proteins in prolonged culture and apoptosis 
were still examined and discussed.  In future work, subsequent verification of important proteins of 
interest can be conducted using other techniques such as Western blot.     
 
3.4.6 Comparison with previous Proteomic and Transcriptomic Studies of Apoptosis  
 
Since the initial CHO protein reference map constructed in 1999 by Champion et al. [108], 
which successfully sequenced and identified 25 protein spots, few other attempts have been made.  
Published CHO 2D maps to date include works from Van Dyk et al. [109] with 28 identifications, Lee 
et al. [217] with 24 identifications and lastly, Hayduk et al. [107] with 224 identifications in 2004.   
 
Genomic or proteomic studies involving CHO cells have been performed to investigate the 
effects of sodium butyrate (NaBu) treatment, which can enhance protein production while sacrificing 
cell viability [218], to compare two CHO cell lines with different metabolic profiles and specific 
antibody productivities [219], to study protein profiles of CHO cells in resting and proliferating phases 
[220], to understand cellular response to hyperosmotic pressure [217] and to determine the cellular 
differences of high-producing Bcl-xL transfected cell line from non-transfected cells under typical 
culturing conditions [203] and when sodium butyrate was added [221].    
  
Currently, there are no studies on proteomic expression of non-induced apoptotic cells that 
occurred in prolonged cell cultures, regardless of the cell types.  With the exception of a transcriptional 
profiles of non-induced apoptotic cell death in batch and fed-batch CHO cultures [69], strategies taken 
by most apoptotic studies focused on examining changes when specific apoptotic pathway was induced 
by a particular agent.  The CHO cDNA microarrays utilized by Wong and colleagues in their CHO 
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transcriptome study [69] were made from cDNA clones obtained from sequencing CHO cDNA library 
and contained probes for 4608 express sequence tags [222].  While their objectives were similar to 
those of this proteome study, comparison studies using microarrays were limited to the probe sets built 
on the microarray chips, especially when the majority of the apoptotic genes were probed with mouse 
sequences.  From the analyses of 170 apoptosis signalling genes present on CHO and mouse 
microarrays, the authors reported a total of 47 genes with greater than two fold change (up and down) 
during batch and fed-batch cultures.  During the stationary phase, which coincides with nutrient 
depletion (glucose and/or glutamine) and loss of viability, the upregulation of apoptotic genes including 
FasL, FADD, Rip1, caspase 8 seems to support the involvement of the extrinsic apoptotic pathway.  
Meanwhile, upregulation of caspase 9 was detected briefly during early stationary phase and decreased 
until death phase.  In addition, upregulation of caspase 9/3/7 inhibitor XIAP was observed along with 
NAIP, another member of the IAP protein family.  Although upregulation of Bim and Bad was detected, 
the absence of Bax and Bak was reported insufficient for Bim and Bad to induce apoptosis.  These 
changes suggest that the mitochondrial pathway was not the major apoptotic pathway triggered.  
Although the number of probes associated with ER pathway was small, the author also concluded the 
insignificance of this pathway.  Therefore, evidence from this study seems to indicate that the Fas-
mediated extrinsic pathway was the dominant mechanism for apoptotic cell deaths in these IFN-γ 
producing CHO batch cultures.  Interestingly, grp78 mRNA was not differentially expressed in Wang’s 
study however, the protein itself was up-regulated by 2.55 fold on day 8.5 according to DIGE results of 
this project.  When comparing Wang’s microarray results to the flow cytometry caspases assays 
performed in this study, it is clear that the major pathway initiated in the two studies differed.  All 
evidences from FCM analyses support the onset of mitochondrial/ER apoptosis while Wang and 
colleagues favoured the execution of an extrinsic pathway.  It is possible that this difference is cell line 
specific or influenced by the expression of recombinant proteins.  CHO IFN-γ cell line in Wang’s study 
produces a recombinant human interferon gamma, which has been documented to activate Fas death 
receptor signalling [42,223,224].  Therefore, the observed transcriptional changes in the CHO IFN- γ 
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batch culture might not be universal or applicable to other CHO cell lines, such as CHO IgG-9β8.  
Nevertheless, Wang and colleagues utilized the results from their microarray study and created four 
apoptosis-resistant CHO lines which target early apoptotic signalling genes Fadd, Faim, Alg-2 and 
Requiem [31].  All four gene-targeting strategies resulted in a 24 hour delay in the onset of apoptosis, 
prolonging batch culture and enhancing IFN-γ production.  Since specific productivities of the 
apoptosis-resistant lines were similar to that of the parental CHO IFN-γ line, improvement in 
production was due to prolonged culture viability instead.   
 
Proteomic studies on other cell lines treated with apoptotic inducers 
Apoptosis triggered by various agents has been studied in various cell lines with different 
approaches [221,225-227].  For example, comparative 2D gel electrophoresis of sodium selenite-
induced apoptosis in human leukemia NB4 cells has been performed and confirmed by RT-PCR and 
Western blot [226].  Out of the 26 down-regulated and four up-regulated identified proteins which had a 
minimum 1.5 fold change, only α-tubulin, β-actin and LAMR1 were also identified in CHO IgG-9β8 
cultures.  However, instead of decreasing in abundance, α-tubulin and β-actin were both up-regulated in 
NB4 cells. The remaining proteins include regulators of signal transduction such as Rho GDI beta and 
alpha, members of the mitogen activated protein kinase family, proteins that regulate c-fos, c-myc and 
c-jun mRNA expression, metabolism related proteins and lastly proteins associated with DNA damage.  
Although the authors suggested the involvement of JNK pathway in the selenite-induced apoptosis, no 
definite conclusion on the apoptotic pathway triggered or the mechanisms was made.   
  
In another study, Fas-induced apoptosis in human Jurkat T cells was analyzed using stable 
isotope labelling with amino acid (SILAC) leucine instead of CyDyes [225].  Using this method, 28 out 
38 apoptosis modified protein spots on 2D gels were identified with a minimum 1.5 fold change 
between normal and Fas-induced apoptotic cultures.  Similar to the apoptotic NB4 proteome, most (31) 
altered protein spots were down-regulated while the remaining seven spots increased expression.  On 
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top of that, one of the up-regulated spot was actually a degraded fragment of heterogeneous 
ribonucleoprotein (hnRNP) K, which had been identified in two other spots with decreased abundance.  
Of all 28 identified proteins, only LAMR1, which decreased expression, was also identified in CHO 
IgG-9B8 cells.  The remaining protein identifications include mRNA processing proteins such as 12 
different hnRNP proteins, transcription associated proteins such as ribosomal proteins, RNA helicase, 
elongation factor Tu and transcription factor BTF3, PARP fragments, Rho GDI beta and actin-binding 
tropomyosin alpha chains.  Although there are overlaps between the sets of apoptosis-altered proteins in 
these experiments, depending on the experimental design, cell lines and apoptotic inducers used, the 
resulting list of proteins might vary considerably and exhibit low correlation [228].  This was in fact 
demonstrated by Thiede and colleagues in the comparison of their SILAC results to the results of silver-
stained 2D gels analyzing Fas-induced apoptosis in Jurket cells using the sample preparation and gel 
systems [229].   Although a similar number of protein spots was subjected to MS analyses, only 21 as 
opposed to 28 spots were successfully identified and among these 21 spots, just 13 identifications were 
common.   
 
Quantitative proteomic analyses of cisplatin-induced apoptotic Jurket T cells with SILAC and 
SDS-PAGE has also been conducted [227].  Cisplatin is thought to inhibit DNA replication and 
transcription, leading to cell death by apoptosis.  In this proteomic study, 26 proteins with abundance 
changes greater than 1.5 fold were identified and 19 were already known to be involved with apoptosis.  
Upregulation in 14 proteins and downregulation in 12 proteins were observed.  Nine RNA-binding 
proteins including five hnRNP proteins, p54nrb, pre-mRNA splicing factor SRp30C and RNA-binding 
protein 4 and seven cytoskeletal proteins which include actin, α-tubulin and β-tubulin were identified in 
this study.  However, contradicting to the downregulation of actin, α-tubulin and β-tubulin in “aging” 
CHO cultures, which include a mix of healthy, apoptotic and dead cells, cisplatin-induced apoptotic 
Jurket cells showed an increase in these cytoskeletal proteins.   
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In contrast to the above, some studies have reported a similar subset of proteins affected by 
apoptosis to the ones observed in the present work.  For instance, a proteomic study examining ionizing 
radiation-induced apoptosis of human prostate cells revealed mostly ER stress response/chaperon and 
cytoskeletal proteins [148].  Upregulation of ER proteins including GRP94, calreticulin, calnexin, 
GRP78, GRP75, HSP70 and PDI, as well as downregulation of cytoskeletal proteins were reported in 
this particular study.  Similarly, in a quantitative proteomics study examining staurosporine-induced 
apoptosis, the detection of many molecular chaperones and ER proteins such as GRP94, BiP, ERp60 
and HSP70 proteins, and cytoskeletal proteins like vimentin and α-tubulin was made [125].  It was 
concluded that the treatment of staurosporine provokes an ER stress and induces the UPR in this study.   
 
Many researchers have tried studying apoptosis with a particular proteomic approach.  
However, correlation between different studies was usually low and inconsistent.  This deviation might 
be due to differences in the cell line, apoptotic inducer, proteomic techniques and experimental designs 
used [228].  For instance, the heterogeneous nature of non-induced CHO cultures likely influence the 
DIGE results obtained in the present study as they were the combined results from cells at different 
stages.  Furthermore, as opposed to the proteomic analyses of prolonged cultures that lasted two weeks 
in this project, the majority of the induced apoptosis studies performed by other research groups were 
done in much shorter time frames, which usually were few hours after treatment.  In these induced 
studies, it is expected to observe responses more restricted to apoptosis as abrupt changes were brought 
uniformly to all cells.  On the other hand, in the prolonged cultures, cells were slowly subjected to the 
degradation of culture conditions and the eventual onset of apoptosis.  Many of the up-regulated 
proteins identified were ER chaperone and metabolic enzymes, which likely increased their activities to 
cope with the initial cellular stresses and changes of metabolism as nutrient depleted.  Lastly, technical 
variations can significantly affect the number of observed changes made in these studies.  For instance, 
the probes used in a microarray study directly influence which and what types of genes will be 
monitored.  In the case of 2D gel electrophoresis, sample preparation and electrophoresis set up such as 
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the pH range and cell lysis buffer used greatly control the set of proteins that will resolve on the gels 
allowing subsequent comparison and analysis.  Therefore, depending on the experimental design and 
set up, the list of differentially expressed proteins identified may not capture all the biological 
significant changes.     
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Chapter 4. Conclusions and Future Directions 
 
4.1 Flow Cytometric examination of Apoptosis in CHO IgG-9β8 Cultures 
 
The detection and monitoring of the progress of apoptosis in culture over time were done by 
quantifying the level of activated executioner caspases in cells with a flow cytometer.  It was shown 
that in the exponential phase or the first 4.5 days of cultivation, CHO cultures were predominantly 
viable and healthy.  An increasing number of cells showed signs of apoptosis initiation after day 4.5 
(early stationary phase).  Between day 5.5 to day 8.5, more early apoptotic cells progressed into the late 
apoptotic phase where membrane integrity was lost, indicating the death of the cell.  After day 8.5 
(early death phase), the number of dead cells including both necrotic and apoptotic cells continued to 
increase.  Eventually dead cells contributed to an overwhelming portion of the culture, which was about 
70% of the culture on day 16.5.   
 
When the cellular levels of two major initiator caspases, namely caspase 8 and caspase 9, were 
examined by FCM, it was apparent that the activation of caspase 9 was the dominant trigger for 
apoptotic cell death in non-induced CHO cultures.  These results suggest the involvement of 
mitochondrial and/or ER-mediated apoptotic cell death, both of which trigger the activation of pro-
caspase 9 upon the detection of various intracellular stress stimuli.  Subsequent proteomic analysis has 
detected the induction of many ER chaperone and folding proteins, indicating that the unfolded protein 







4.2 Proteomic Changes in CHO Cells Undergoing Apoptosis in Batch Cultures  
 
From the changes of protein abundance between samples in the DIGE experiment, a total of 79 
protein spots were selected for subsequent MS sequencing.  The successful MS analyses of 40 spots 
yielded 28 unique protein identifications.  These proteins include four cytoskeletal proteins, ten ER and 
cytosolic chaperone proteins, seven glycolytic and metabolic enzymes and seven other miscellaneous 
proteins.   
 
Since actin, α-tubulin, β-tubulin and vimentin, are known caspase substrates, their reduction in 
aging and apoptotic cell cultures were expected.  The degradations of these cytoskeletal proteins 
affected actin filaments, microtubules and intermediate filament networks, resulting in many of the 
observed phenotypes of apoptosis such as the loss of cell shape, cell shrinkage and the reorganization of 
cytoskeletal structures prior to blebbing and apoptotic body formation.   
 
Except for the three cytosolic chaperone proteins, the seven identified ER chaperones all 
showed an increase in expression during prolonged cultivation.  In addition to being responsible for the 
proper folding of glycoproteins in the ER, calreticulin and ERp60 have various apoptotic roles.  For 
example, calreticulin labels cells for phagocytosis following its translocation and insertion into the 
plasma membrane.  As for ERp60, it indirectly assists the release of membrane bound apoptosis 
inducing factors (AIF) into the intermembrane space, allowing them to be released into the cytosol 
during apoptosis via the intrinsic pathway.  The remaining ER chaperones, BiP, GRP94, PDI, GRP170 
and PDIA6 form complexes that facilitate folding of hydrophobic residues.  As opposed to calreticulin 
and ERp60, these five chaperones are known for their pro-survival functions only.  Both BiP and 
GRP94, in particular, have been thought to protect cells against apoptosis upon ER stress.  On the 
contrary, three cytosolic chaperones, HSC70, HSP90β and FKBP52 were identified as down-regulated 
proteins modified by either cellular stress or apoptosis.  HSC70 and FKBP52 function as co-chaperones 
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of HSP90β and assist the folding of substrates such as hormone receptors, actin, tubulin and some 
kinases.  Members of the HSP70 family have a strong cytoprotective role, thus their downregulation in 
CHO cells could allow cells to remove anti-apoptotic proteins.  In contrast, the decrease in availability 
of HSP90β upon stress has been shown to transactivate hsp genes.  Since HSC70 is also a member of 
HSP family, its 1.17 fold downregulation appears contradictory.  In any case, whether the reduction in 
these three proteins influences the fate of CHO cells, or was an indirect effect of apoptosis is unclear.  
Since unresolved ER stress can lead to apoptotic cell death, the presence of UPR might be an important 
factor contributing to the initiation of apoptosis in this study.  
 
Interestingly, six of the ten glycolytic enzymes showed an increase in protein abundance and 
were identified as triosephosphate isomerase (TPI), phosphoglycerate mutase (PGM), pyruvate kinase 
isozyme, phosphoglycerate kinase (PGK), glyceraldehydes-3-phosphate dehydrogenase (GAPDH) and 
enolase-1.  Moreover, L-lactate dehydrogenase (LDH), which converts the end product of glycolysis 
into lactate, was also up-regulated in prolonged CHO cultures.  It is likely that the increase in these 
metabolic enzymes was needed to ensure that sufficient energy was available for cell proliferation and 
maintenance as glucose level dropped from consumption over time and for the execution of the energy-
driven apoptosis.  Although the exact mechanisms and roles have not yet been elucidated, more and 
more studies have discovered non-metabolic functions of these enzymes.  Evidence suggests that 
nuclear forms of some of these enzymes participate in the regulation of transcription and DNA 
replication.  For instance, nuclear localization of enolase-1, GAPDH and LDH has been detected.  
Furthermore, hexokinase and GAPDH have also been explicitly associated with cell survival and 
apoptosis in recent studies.  It has been shown that over-expression of GAPDH induces apoptosis and 
the induction of GAPDH has also been reported in apoptotic cells in other studies.   
 
Finally, there are seven differentially expressed proteins with diverse roles that did not fall into 
the above three categories.  These identified proteins are 14-3-3 epsilon, laminin receptor 1 (LAMR1), 
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galectin-1, galectin-3, peroxiredoxin-6 (Prx6), 80K-H and ATP synthase beta subunit (ATPB).  Since 
LAMR1, 14-3-3 epsilon and galectin-3 all exhibit an anti-apoptotic role on top of their many diverse 
functions, the decrease of their expressions during prolonged cultivation could be interpreted as a way 
to remove pro-survival signals in dying cells and eliminate any unnecessary interference during the 
execution of apoptosis.  Under normal conditions, 14-3-3 isoforms prevent the initiation of apoptosis by 
suppressing pro-apoptotic proteins such as Bad and Bax.  When cleaved by caspase 3, 14-3-3 epsilon 
releases its pro-apoptotic client and can no longer prevent cell death.  While LAMR1 has been 
suggested essential for cell survival and galectin-3 has been shown to prevent apoptosis against various 
stimuli, the exact mechanisms of these activities are still unknown.  In contrast, the upregulation of 
Prx6 in this study probably was part of the initial pro-survival response as culture conditions degraded 
with time.  It has been shown that Prx6 protects against mitochondrial dysfunction and reduces the 
production of ROS from mitochondria.  As for galectin-1, ATPB and 80K-H, their identifications as 
stress response or apoptosis-modified proteins were not as confident in this study due to conflicting 
results with literature studies and inconsistent fold changes over time.   
 
4.3 Implications of this Work 
   
In this study, flow cytometry analyses successfully identified the activation of caspase 9 as the 
dominant apoptotic mechanism involved in triggering cell death in an anti-RhD MAb-producing CHO 
cell line, CHO IgG-9β8.   Progression of apoptosis was also monitored at the population level via the 
quantification of active caspases.  Since the apoptotic pathways reported in this study and that of 
Wang’s microarray study on an IFN-γ producing CHO line seem to differ, it suggests that the exact 
mechanism of apoptosis might be dependent on the cell line and/or culture conditions involved.  This 
information is extremely useful in the optimization of a cell line, as inhibiting the wrong apoptotic 
pathway would not enhance cell survival as much. 
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The main objective behind the quantitative proteomic study of this report was to associate 
cellular changes at the protein level during prolonged cultivation, which involves the onset and 
execution of apoptotic cell death, in MAb-producing CHO cultures.  The work presented in this study is 
the first proteome-wide investigation of non-induced apoptosis in mammalian cells.  Since no treatment 
was made to artificially induce cell death, the trigger for apoptosis in these cells was the process of 
prolonged cultivation as experienced in typical industrial bioreactors.  Despite the fact that many 
proteomic analyses of apoptosis in various cell lines have been done, strategies taken by these studies 
all involved inducing the cultures with particular apoptotic agents.  Treating cells with an apoptotic 
inducer results in a somewhat “artificial” response specific to the type of induced apoptosis.  Moreover, 
the exact mechanism and apoptotic pathway participated in these induced cell death usually were not 
understood explicitly.  Hence findings from these apoptosis studies may not be applicable to other 
culture settings.  From the DIGE and MS analyses of this work, many proteins expected to be modified 
by the degradation of culture condition and the onset of apoptosis in protein-producing CHO batch 
cultures were identified.  These include numerous chaperone proteins which, as expected, increased in 
their expression upon cellular stresses like nutrient depletion, and cytoskeletal proteins that are known 
substrates of caspases.  Apart from the common apoptosis-cleaved substrates and the stress-induced 
responses, the upregulation of six glycolytic enzymes responsible for the final six steps of glycolysis, 
and one post-glycolysis metabolic protein were surprising and unseen in previous studies.  Meanwhile 
the expression of several other pro- and anti-apoptotic proteins have altered and been detected in this 
study.  To name a few, 14-3-3 epsilon, peroxiredoxin-6, calreticulin and GAPDH are a few examples.  
On a side note, due to the small number of proteomics CHO maps available, the CHO IgG-98 DIGE 
gels and the corresponding protein identifications obtained in this study will be valuable additions to the 




This work is a component of a larger project that seeks to construct an appropriate culture 
optimization scheme that specifically targets the apoptotic mechanisms activated based on the identified 
differentially expressed proteins that were crucial for the onset and execution of apoptosis.  Overall, this 
study demonstrated that the major changes in aging CHO cultures, consisting significant levels of 
apoptotic cells, involve the regulation of stress response and energy metabolism related proteins.  
Proteins that solely modulate apoptosis were not readily apparent as differentially expressed proteins 
within the proteomic analyses.  Furthermore, the intracellular responses prior to the initiation of 
apoptosis include a complex network of changes that might be as important as the regulation of 
apoptotic proteins.  Although no direct apoptosis-regulating proteins were identified, the DIGE results 
have established the potential importance of UPR and energy metabolism in prolonged cultures and 
apoptotic cell death.  Along with the knowledge of the type of apoptotic pathway triggered, apoptotic 
proteins associated with ER stress, mitochondrial dysfunction and energy metabolism should be 
considered in the optimization of CHO IgG-9β8 cultivation.  As an example, apoptotic proteins crucial 
to the intrinsic and ER pathway can be inferred from literature and genetically modified to derive a new 
pro-survival cell line from CHO IgG-9β8.  The choice of target for modification can also be considered 
based on its influence and/or involvement in energy metabolism.  However as discussed in Section 4.4, 
additional apoptotic proteins that are more suitable for this purpose than the ones obtained thus far may 
be identified with further study.   
 
More importantly, this work provides the first proteomic analysis of non-induced apoptotic cell 
death occurring in a typical protein-producing cultivation process.  Despite the countless studies 
exploring apoptosis and the general acceptance that apoptosis is the major mode of cell death in 
bioreactors, the exact cellular changes occurred and the mechanisms involved during apoptosis in 
bioreactor cultures have not been investigated thoroughly and extensively.  Because the majority of 
apoptosis studies published so far rely on inducing cell death and triggering a specific type of apoptosis, 
this work can serve as a reference check to ensure the findings made from induced apoptosis are indeed 
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practical and applicable to cultures maintained in typical industry bioreactors.  As discussed in the 
subsequent sections, future work can be performed to further increase the number of identified proteins 
and extract more information.  Nonetheless, this work shows the potential of utilizing a proteomics 
approach in understanding intracellular changes occurring in prolonged CHO cultures where apoptosis 
was actively involved in inflicting cell death after the exponential phase.  It is the first step towards 
building the fundamental framework for optimizing cultivation process, prolonging longevity and 
maximizing protein production.   
 
4.4 Future Directions 
 
Additional flow cytometry analysis 
From the FCM data presented in this study, noticeably larger percentage of the cultures 
contained activated caspase 9 than caspase 8, strongly suggesting the role of mitochondrial and/or 
pathway in the onset of apoptotic cell death in CHO IgG-9β8 cultures.  Additional pathway-specific 
assays such as the detection of ER pathway-specific caspase 12 and the changes in mitochondrial 
membrane potential can be performed to determine the involvement of the two compartments.  To 
further elucidate and verify that caspase 9 was activated as the dominant initiator caspases for apoptosis 
in CHO cells, additional FCM analyses investigating the simultaneous presence of both activated 
caspase 8 and caspase 9 in individual cells could be done.  It is expected that a dot plot comparison 
between caspase 8 and caspase 9 intensity signals would demonstrate a larger cluster of cells showing 
higher caspase 9 signals versus caspase 8 signals.  Although the detection of all major caspases (for 
example caspase 3, 8, 9 and 12) in each cell would be more informative, currently there are only two 





Elaboration on proteomic analysis 
For future studies, a few modifications on the proteomic analysis can be done to increase the 
number of apoptosis-modified proteins detected.  First, the DIGE experiment could be repeated with a 
smaller range of pI charges instead of pH 3-10.  Isoelectric focusing using IPG gel strips at smaller 
ranges can better separate protein spots of close pI and increase the resolution of gels.  Especially at the 
extreme pI, protein spots were usually not well resolved and separated.  By targeting a specific region 
of pI, the occurrence of overlapping proteins will be reduced.  The increased number of spots resolved 
on the gel implies that more protein spots will likely be determined as differentially expressed by 
statistical tests.   
 
Secondly, the option of enriching apoptotic cells prior to proteomic analyses can be considered.  
Based on the number of potential differentially expressed protein spots obtained from t-test and 
ANOVA, the progress of apoptosis in day 4.5 and day 5.5 old cultures was either minimal or difficult to 
discern due to limitations in experimental techniques and design.  For example, cells from un-treated 
cultures contain unsynchronized cells at various cell cycle stages and apoptotic stages.  It is likely that 
due to the high percentage of healthy subpopulation, the early changes that occurred in the apoptotic 
subpopulation were masked and not observed.  To resolve this issue, apoptotic cell enrichment, which 
allows only the apoptotic subpopulations from a culture sample collected to be separated out for 
analysis, can be applied.  The noise from the non-apoptotic subpopulation will be eliminated.  Therefore, 
smaller fold changes that might be masked previously will be enhanced and fold changes that better 
reflect true alteration in protein abundances will result.  As of now, flow cytometry cell sorting and 
phosphatidylserine-binding magnetic beads can both separate and isolate apoptotic cells.  To avoid 
excessively decreasing culture volume with repeated sampling over the whole cultivation period, 
apoptotic cell enrichment was not performed in this study.  Since enrichment will filter out non-
apoptotic cells, higher number of cells must be collected for subsequent filtering and protein extraction.  
However, for future studies, more focus on the late stationary/early death phase of the cultivation period, 
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which was day 8.5 in this project, can reduce the total volume of cultures required and allow a larger 
volume to be collected for cell enrichment.  Since consistent changes in protein expression were 
observed from day 2.5 to day 4.5, 5.5 and 8.5, proteomic analysis between day 2.5 and day 8.5 likely 
will be sufficient.   
  
Finally, studying the changes to subcellular proteomes, such as mitochondrial, nuclear and ER 
proteomes, provides information on translocation which will be overlooked when studying the whole 
cell proteome.  Also, it may help to elucidate the exact role of many multi-functional differentially 
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Appendix A. Flow Cytometry Data Analysis 
 
A.1 Sample Flow Cytometry Dot Plot Raw Data 
 
For each spinner flask, FCM testing has been done throughout the cultivation period, measuring 
FLICA and propidium iodide (PI) intensities.  Resulting data were represented by dot plots, each 
containing 20000 data points (which correspond to cells).  Thresholds were set based on single-color 
control samples from day 2.5 of each spinner flask and applied to the remaining FCM data collected.  A 
sample set of FCM dot plots for each FCM methods (caspase 3, caspase 8 and caspase 9 analyses) was 
shown.   
 
A.1.1 FCM Caspase 3 Assay for a Culture in run A over Time  
 
FCM analyses measuring the activation of caspase 3/7 and PI permeability were performed to 
detect and monitor the progress of apoptosis within cultures.  Since executioner caspases such as 
caspase 3 and 7 are common proteins involved in the execution of apoptosis despite the initial trigger, it 
is the main method for detecting apoptotic cell death in this study.   Sample dot plots showing results of 
FCM caspase 3 analysis for a single spinner flask during the run A time course experiment were 
displayed in Figure A-1 below.  Table A-1 displays the thresholds for FLICA and PI intensity used in 
the four cultures of run A. 
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Figure A-1. FCM plots showing raw caspase 3 assay data from a sample culture in run A.  
Abbreviations: C3, caspase 3; D, day; PI, propidium iodide.  
 
































































Table A-1. Intensity thresholds for FCM caspase 3 assay in Run A 
Culture replicates FLICA caspase 3 threshold Propidium iodide threshold 
1 228 208 
2 240 208 
3 248 240 




A.1.2 FCM Caspase 8 and FCM Caspase 9 Assays for a Culture in run B over Time 
 
Levels of activated caspase 8 and caspase 9 were used to differentiate the type of apoptotic 
pathway triggered in CHO cultures, namely extrinsic and intrinsic pathway respectively.  Figure A-2 
shows the list of dot plots obtained from the FCM caspase 8 assays and Figure A-3 lists the figures for 
the FCM caspase 9 assays.   
 
              






















































                           
              
               
 
                
 
 

































































                
 
                
 
                
 


































































                
                
               
     
Figure A-2. FCM plots showing raw caspase 8 assay data from a sample culture in run B.  
Abbreviations: D, day; PI, propidium iodide.   






























































               
               
                






























e) D3.5 no dye                  f) D3.5 both dyes 

































               
 
                
 



































































FLICA C9 intensity 
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Figure A-3. FCM plots showing raw caspase 9 assay data from a sample culture in run B.  
Abbreviations: D, day; PI, propidium iodide.  
 
  




















































The following two tables separately display the thresholds for FLICA and PI intensity used in 
the four cultures of run B.  As the name implies, FLICA in the FCM caspase 8 method targets and 
measures the amount of activated caspase 8, while it corresponds to caspase 9 in the FCM caspase 9 
method.  Based on the FLICA and PI intensities, cells can be classified into four different 
subpopulations: C-PI-, C+PI-, C+PI+ and C-PI-.   
 
Table A-2. Intensity thresholds for FCM caspase 8 assay in Run B 
Culture 
replicates 




1 256 240 
2 236 236 
3 260 236 
4 268 244 
 
Table A-3. Intensity thresholds for FCM caspase 9 assay in Run B 
Culture 
replicates 




1 252 236 
2 252 232 
3 264 252 












A.2 Alternative Display of FCM Caspase 8 and FCM Caspase 9 Results 
 
The following figures show the proportion of the four cell subpopulations in the cultures over 
time based on the levels of activated caspase 8 and caspase 9.  Figure 2-8 is an alternative display of the 
combined data of Figure A-4a and A-4b below.  
 
Figure A-4. Comparison between the four subpopulations based on a) caspase 8 and b) caspases 9 
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Appendix B. Proteomic Raw Data and Analysis 
 
B.1 Statistical Analyses using the Programming Language R 
 
Before extracting the raw standardized abundance data of all detected spots from DeCyder 
software, all 12 gels were analyzed together in BVA to match spots across images and assign master 
spot numbers that could be shared between gels.  Abundance data for all protein spots was exported to 
R for t-test analysis using the script in section B.1.1.  
 
For the one way ANOVA p-value extraction, the post matching BVA file was analyzed without 
the DeCyder built in FDR correction. The p-values calculated by the DeCyder software were imported 
into R and FDR corrected with R script as in section B.1.2.  
 
B.1.1 R Scripts for T-tests Calculation  
# Function myTTest2  
# purpose: calculate t-test p-values and average ratios for each protein spot 
# Abundance data table X: each row = 1 protein spot and 1
st
 column = master spot ID 
# eqVar: Boolean. TRUE = t-test variance equals, FALSE = unequal variance 
# pair: Boolean. TRUE = paired t-test; FALSE = unpaired t-test will be calculated 
myTTest2 <- function (X, eqVar, pair){ 
 ctrlInd<- c(1:4) 
treatedInd <- c(5:8) 
 NApairs <- (is.na(X[treatedInd]))|(is.na(X[ctrlInd]))  
 if (sum(NApairs)> 2) {    # 4 pairs, if less than 2 pairs, t.test won't work. 
  return (c(NA, NA)) 
 } 
 else{ 
  obj<- t.test(X[treatedInd], X[ctrlInd], var.equal = eqVar, paired = pair) 
  if (pair==T){ 
   temp <- 10^obj$estimate 
   ind <- which(temp <1) 
   temp [ind] <- -1/temp[ind] 
   return (c(obj$p.value, temp))} 
  else  # not tested yet 




# Read in abundance data table from file into a table in R 
loc <- "C:\\Users\\Catherine Wei\\Documents\\My Dropbox\\bunneh\\CHO\\Gel Images &  
data\\DIGE\\Run 8 - DIGE Apr 1 2009\\Analysis\\Run8_allProteins_3.txt" 
channelNames <- read.table(loc, nrows = 1, sep ="\t")  # read in data table headings separately 
blah <- read.table(loc, skip = 5, sep ="\t", header = T)    # raw abundance data 
blah <-  as.matrix(blah) 
channelNames <- as.matrix (channelNames) 
dimnames(blah)[[2]] <- channelNames 
 
# only obtained standardized abundancies and removed volumes columns 
oddCol <- seq(1, 49, by = 2) 
abund <- blah [,oddCol] 
 
# reoder abundancies columns  
orderNew <- c(1,2,3,5,4,6,7,8,9,11,10,12,13,15,14,16,17,19,18,21,20,22,23,25,24) 
abund <- abund [, orderNew] 
 
# Convert negatives abundancies to REAL abun values > 0  
baddies <- which(abund<0) 
abund[baddies] <- -1/abund[baddies] 
unloggedAbund <- abund 
 
# For calcualting t-test, log the standardized abundances 
abund[,2:25]<- log10(abund[,2:25]) 
 
# Indices for the gel images involved in different t-tests.  Ex. D2D4 = t-test comparing day 4.5 to day  
# 2.5.  Ctrl_D2DX = Day 2 control data….for X = 4.5, 5.5 or 8.5 
Ctrl_D2D4 <- c(1,7,13,19) +1 
Ctrl_D2D5 <- Ctrl_D2D4 + 2 
Ctrl_D2D8 <- Ctrl_D2D5 + 2 
allCtrl <- c(Ctrl_D2D4, Ctrl_D2D5, Ctrl_D2D8) 
D4 <- Ctrl_D2D4+1 
D5 <- Ctrl_D2D5+1 
D8 <- Ctrl_D2D8+1 
 
############################## T-Test pvalues #################### 
# Assume un/equal variable, PAIRED t-test 
# pVal [,1:2] where colume 1 = p values; colume2 = average ratios/fold change 
pVal_D2D4 <- apply(abund[ , c(Ctrl_D2D4, D4)], 1, FUN = myTTest2, eqVar = F, pair = T)  
pVal_D2D5 <- apply(abund[ , c(Ctrl_D2D5, D5)], 1, FUN = myTTest2, eqVar = F, pair = T) 
pVal_D2D8 <- apply(abund[ , c(Ctrl_D2D8, D8)], 1, FUN = myTTest2, eqVar = F, pair = T) 
pVal_D4D5 <- apply(abund[ , c(D4, D5)], 1, FUN = myTTest2, eqVar = F, pair = T)  
pVal_D5D8 <- apply(abund[ , c(D5, D8)], 1, FUN = myTTest2, eqVar = F, pair = T) 
pVal_D4D8 <- apply(abund[ , c(D4, D8)], 1, FUN = myTTest2, eqVar = F, pair = T) 
 
################## False Discovery Rate ###################### 
fdr_D2D4 <- p.adjust(pVal_D2D4[1,], method ="fdr") 
fdr_D2D5 <- p.adjust(pVal_D2D5[1,], method ="fdr") 
fdr_D2D8 <- p.adjust(pVal_D2D8[1,], method ="fdr") 
fdr_D4D5 <- p.adjust(pVal_D4D5[1,], method ="fdr") 
fdr_D5D8 <- p.adjust(pVal_D5D8[1,], method ="fdr") 
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fdr_D4D8 <- p.adjust(pVal_D4D8[1,], method ="fdr") 
 
####################### Write results to file ######################### 
result <- cbind(abund[,1], t(pVal_D2D4), fdr_D2D4, t(pVal_D2D5), fdr_D2D5,  
 t(pVal_D2D8), fdr_D2D8, t(pVal_D4D5), fdr_D4D5, t(pVal_D5D8), fdr_D5D8,  
 t(pVal_D4D8), fdr_D4D8) 
colnames(result) <- c("Master No.", "pVal D2D4", "avRatio D2D4", "fdr D2D4", "pVal D2D5", 
 "avRatio D2D5", "fdr D2D5", "pVal D2D8", "avRatio D2D8", "fdr D2D8", "pVal D4D5",  
"avRatio D4D5", "fdr D4D5", "pVal D5D8", "avRatio D5D8", "fdr D5D8", "pVal D4D8",  
"avRatio D4D8", "fdr D4D8") 
write.table(result, paste(loc, "\\Run 8 pVal fdr ratios.txt", sep = ""), row.names = F, sep = "\t") 
 
B.1.2 R Script for FDR Correction of ANOVA p-values 
#copy the list of ANOVA p-values obtained from DeCyder into the clipboard 
pvalueList <- read.table(“clipboard”) 




B.2 Raw Abundance Data for the Differentially Expressed Proteins Identified 
 
Each figure below shows the abundance of a protein of interest at four time points of the 



























































Figure B-1. Abundance data of protein spots having cytoskeletal functions. 
 
  



























































































Figure B-2. Abundance data of protein spots identified as ER and cytosolic chaperones.  
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Figure B-3. Abundance data of protein spots identified as glycolytic and metabolic enzymes.  
  

















































































The detailed MS results from PEAKS and MASCOT analyses are shown in Table B-1 below.    
Table B-1. Mass spectrometry results from PEAKS and MASCOT analyses 


























93.8 BAD74030 53.6 5 12% 60 P02544 53.6 5.06 3 
α-tubulin  n/a** 74 Q3TIZ0 50.6 4.96 2 
β-tubulin  728 n/a** 188 P99024 50.1 4.82 5 
Actin (β/γ)  
836 98.3 P83751 36.3 6 20.1% 194 Q3UGS0 42.1 5.37 5 
842 95.9 P20359 41.6 6 16% 177 O35247 42 5.37 5 
852 99.7 O76784 41.8 9 23.9% 203 O35247 42 5.37 7 
858 99.9 P60712 41.6 9 22.5% 334 O35247 42 5.37 8 
859 99.8 O76784 41.8 10 26.6% 336 Q3UGS0 42.1 5.37 10 
 


























1917  93.1 Q8K3H7 48.2 8 23.5% 131 Q8K3H7 48.4 4.33 5 
1918 90.9 Q8K3H7 48.2 5 16.8% 84 Q8K3H7 48.4 4.33 3 
ERp60  
625 95 Q91Z81 56.7 8 16.8% 110 Q91Z81 57.2 5.98 5 
630 85 P11598 56.6 5 11.3% 72 P27773 57 5.98 3 
632 92.4 Q91Z81 56.7 5 9.9% 85 Q91Z81 57 5.98 4 
637 83 P11598 56.6 4 9.5% 65 P27773 57 5.98 3 
653 66.7 Q91Z81 56.7 3 6.9% n/a 
PDI   1919 94.2 P05307 57.2 4 9% 126 P05307 57.6 4.8 4 
PDIA6 
764  97.3 P38660 48.1 6 19.4% 222 P38660 48.5 5.04 5 
766 89.1 P38660 48.1 4 13.7% 96 P38660 48.5 5.04 3 
770 88.3 P38660 48.1 5 16% 131 P38660 48.5 5.04 4 
771 95.8 P38660 48.1 6 21.2% 88 P38660 48.5 5.04 2 
BiP   1920 99.8 P07823 72.3 11 22.5% 205 P06761 72.5 5.07 5 
GRP94   304 99.6 Q3UBU0 92.4 7 11.4% 210 Q3UBU0 92.7 4.74 4 
GRP170  157 92.8 Q9JKR6 111.1 6/5 6.6% 262 Q9JKR6 111.4 5.14 8 
HSC70  482  73.3 Q53HF2 53.4* 8/2 16% 234 P19120 42.2* 6.62 5 
HSP90β 372 n/a 53 P34058 83.6 4.95 6 
































1369 98.6 Q53HE2 26.7 10/6 31.7 153 P00939 26.9 7.1 2 
1376 84.4 P00939 26.6 4/2 12.5 121 P00939 26.9 7.1 3 
Phosphoglycerate 
mutase1  
1339 86.9 P18669 28.6 8 36.4 167 P18669 28.9 6.67 8 
Pyruvate kinase 
isozyme M1/M2  
654 96.2 P11980 57.7 6 12.6 147 P52480 58.3 7.42 5 
Phosphoglycerate 
kinase  




1042  65.5 P00355 35.7 5 21.1 225 P17244 36 8.49 5 
1923  98.3 P00355 35.7 7 28.6 218 P17244 36 8.49 5 
Enolase-1  779  90.9 P04764 50.6 4 11 213 Q9PVK2 47.5 6.62 4 
L-lactate 
dehydrogenase 
chain A/C  
1094 77.1 P07864 28.9 2 7.9 149 P00340 36.7 8.18 2 
1096*** 35.7 Q5R1W9 36.5 1/3 5.7 89 Q06BU8 36.8 7.01 2 
 























14-3-3 epsilon  1922 72.2 Q1HPT4 29.6 2/1 9.5 213 Q4VJB6 26.7 4.76 3 
Galectin-1  1842*** 42.1 P48538 14.6 2 18.7 42 P48538 15.1 5.52 2 
Peroxiredoxin-6  1376  49.2 O35244 24.8 3 13.8 63 O08709 24.8 5.72 3 
Laminin receptor 1  876 78.5 P08865 31.8 3 11.2 165 P26452 32.9 4.8 3 
80K-H  340 49.5 Q3U518 58.6 2 5.4 101 P14314 45.3 4.27 2 
Galectin-3 1250 33 P08699 27 1 (+3) 5.4 n/a 
ATP synthase subunit 
beta, mitochondrial 
728  52.8 P46561 57.5 2 6.1 77 P00829 56.2 5.15 2 
 
* The top hit matches to a Hsc70 fragment thus the mass is much less than 70kDa.  This record was still an 
unreviewed UniProtKB entry.   
** no match to this particular protein was resulted but a match to another protein for the same spot was resulted.   
*** MASCOT search with MSDB returned no hit so search was repeated with SWISS-PROT and NCBI-DB. 
 
Mascot reported two different proteins from a single MS analysis.  The two sets of matched peptides had no 
overlap.  PEAKS matches to only one identification.   
 Both b-tubulin and ATP synthase beta subunit were detected in reference maps by Hayduk and Van Dyk with 
very similar pI.  In both studies, β-tubulin had slightly heavier MW than ATP synthase beta.  It is likely that 
overlapping of these two proteins occurred during electrophoresis or from imprecise spot picking.  
 TPI and Prx6 were identified when analyzing spot 1376 on two gels.   
 
Note: The MASCOT mass and estimated pI were as reported by MASCOT ms/ms analysis. The PEAKS mass and 
sequence coverage were as reported by PEAKS analysis.  In both cases, the accession numbers reported are the 
most current version.  Some matching resulted in protein records that are obsolete due to various reasons such as 
deletion and record/database merging.  As a result, the reported accession number might correspond to a protein 
with slightly different sequence from the obsolete record.  In turns, this implies that the reported mass, pI and 
sequence coverage might not correspond perfectly to the reported accession number.   
 
